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Abstract
Honey is a food with high popularity, consumption and availability. The 
effective antibacterial activity of honey, without any reported bacterial resistance or 
side effects, increases its use in traditional medicine for treating many different kinds 
of infections.
Initially, this study examined the antibacterial activity of honey against 
Campylobacter jejuni. Six different types of honey, which were commercially 
available in the UK, Saudi Arabia and New Zealand, were assessed. Honey samples 
were introduced to Muller Hinton media in three different ways: filtration, 
autoclaving honey alone and autoclaving honey with media. C.jejuni NCTC 11168 
showed good sensitivity to all six investigated honey samples. The minimum 
inhibitory concentrations ranged between 2 and 10 % for filtered honey. Thermal 
treatment increased the activity of some honey types and the MIC was 4% for all 
honey samples, except for clear honey (C.)
Heating honey (2 %, v/v) with the medium resulted in an increase in 
antibacterial activity with C. jejuni, reducing to undetectable levels after 6 hours of 
incubation. A similar result was observed when honey was mixed with casein, 
followed by thermal treatment. This result indicates that thermal treatment generates 
a selection of new antibacterial agents in the honey-casein mixture (honey-casein 
MRPs).
Factors including temperature and the type of sugar and amino acid present 
were shown to be important in the generation of antibacterial activity. Heating 
honey, but not other sugars, with casein or some of its constituent amino acids (e.g. 
lysine) at 12 TC for 15 minutes was shown to be the optimal condition.
XIV
Further tests revealed that the mixture was effective in vivo and in vitro. A 
dramatic decrease in C. jejuni colonies to below the limit of detection was observed 
after 6 hours of incubation in UHT milk with 2 % honey-casein MRPs. The 
antibacterial activity was also confirmed in an animal model, and C. jejuni was not 
able to cause infection in Galleria mellonella larvae in the presence of 2% honey- 
casein MRPs. A significant reduction in the number of C. jejuni cells invading Caco- 
2 cells was observed when honey-casein MRPs were added to the medium. It is 
considered that after the treatment (with honey-casein MRPs), C. jejuni was viable, 
but they lost their culturability and entered a VBNC state according to LIVE/DEAD 
BacLight staining. The state was irreversible and C. jejuni was not able to recover 
after transferring to nutrient-rich media. The exposure of C. jejuni to honey-casein 
MRPs also changed the microbial cell morphology from spiral to coccoid shaped, as 
confirmed by TEM images. The mixture was also examined against other bacteria 
such as E. coli, S. typhimurium, L. monocytogenes, S. aureus and H. pylori; but, 
interestingly, the effects were more limited.
A high-performance liquid chromatography technique was used to assess the 
mixture (honey-casein MRPs). Developing the method for Maillard reaction products 
separation was successful and a higher number of peaks were observed.
This study, overall, has highlighted the importance of honey as an 
antibacterial agent, as well as a source of other useful compounds formed from 
honey and specific amino acids under appropriate conditions. These new agents may 
potentially be used as additives in a new strategy to improve food safety and reduce 
Campylobacter prevalence in foods.
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Chapter 1: Introduction
1. Introduction
The use of natural products is becoming an ever more popular approach in both 
medical treatments and in the preservation of foods. The increase in their popularity 
is due to their activities and generally very low toxicity. According to World Health 
Organisation (WHO) statistics (2008), 70-80 % of the population in developed 
countries have used natural products in their primary health care. Moreover, 80 % of 
people depend on these types of treatment in Asian countries such as China and 
India. Natural products can be utilised in the discovery of new antimicrobial drugs 
and in the treatment of infectious diseases. However, despite new developments in 
controlling disease, infectious diseases are still the second greatest cause of 
morbidity and mortality around the world due in part to the increase in drug 
resistance among large numbers of the bacterial strains. This means that new 
strategies are needed to prevent and treat infectious disease (Walsh and Amyes, 
2004). As a result several ancient methods have been re-evaluated and the 
substances/procedures employed historically to cure diseases are now attracting a 
renewed scientific attention. Scientists have found that natural materials are generally 
more acceptable to consumers and thus if these alternative approaches are effective 
this may reduce the reliance on more synthetic substances (Slover, et al, 2009). 
Furthermore, the study of such natural compounds may provide the discovery of an 
active component that could be used to prevent or reduce some environmental 
hazards or perhaps have an ameliorative effect on a disease process in mammalian 
cells (Mahady et al, 2008). The need to use these natural compounds is also 
increasing in order to combat the increase in resistance of pathogenic bacteria to
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antibiotics. Herbs, plants extracts, essential oils and honey are the most common 
sources for these new active compounds (Solver, 2009). These products have been 
found to be effective in several bacterial infections and inflammatory cases (Molan, 
2009). Some novel agents such as plant extracts have been approved as therapeutic 
alternatives for treatment against antibiotic resistant bacteria on the basis of their in 
vitro and in vivo efficacy. Allium sativa (Garlic), curcuma louga (Turmeric), Zingiber 
officiale (Ginger), Acacia farnesiaa L. (sweet acacia), Actinidia chinensis (Kiwi) and 
Rubus idaeus L. (Raspberry) are some examples of these extracts and their 
antibacterial activity was confirmed by Bensch et al, (2011) and Castillo et al, 
(2011). Moreover, in some cases these products/compounds can be used in 
combination with antibiotics to enhance their activity. Palaniappan and Holley (2010) 
studied the effectiveness of plant-derived natural antimicrobials including eugenol, 
thymol, carvacrol and cinnamaldéhyde and were paired with antibiotics (ampicillin, 
tetracycline, penicillin, bacitracin and erythromycin) and the activity was tested 
against Escherichia coli. Salmonella Typhimurium and Staphylococcus aureus and 
they were found to be effective in reducing the MICs of the antibiotics by up to 25%.
Many of these substances have been discovered to have similar inhibitory 
effects and mechanism of action compared to antibiotics and can cause damage to 
bacterial cell walls as well as affecting protein synthesis in bacterial cells and 
enzyme activity (Butler and Buss, 2006).
1.1 H oney
Honey is an example of a naturally available product and it is the only 
concentrated sweetener that can be found in nature. It has been used for several 
centuries in many countries as a treatment of disease even before knowledge existed 
on the causes of infection. It has been known to be very effective in almost all cases
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of infection and for the promotion of healing especially in bum injury and wounds 
(Mandai and Mandai, 2011). As a result, many studies have analysed honey 
composition and have studied the physical and chemical properties that may give rise 
to its ability to work against various microorganisms (Adams et al, 2008; Alvarez- 
Suarez et al, 2010).
It is evident that many different kinds of honey can be found around the world 
and as different regions will have different flora this will influence the production 
and activity of different sorts of honey. Acacia, Heather and Manuka are the most 
common honey varieties. Manuka honey is obtained from Manuka shrub 
(Leptospermum scoparium) in New Zeland and is believed to have a unique 
antibacterial factor called the unique manuka honey factor (UMF) (Wallace et al, 
2009). Furthermore, it is possible to differentiate honey into two main types: Floral 
honey is made from the nectar of blossoms (blossom honey) and honeydew honey 
which is prepared from the secretions of living parts of plants or excretions of plant- 
sucking insects (Sanz et al, 2005). This thesis will focus on floral honey.
1.1.1 Honey composition
Honey is a supersaturated sugar solution. Its composition is complex and 
variable and it contains at least 181 different substances (Alvarez-Suarez., 2010). 
These substances can mainly be divided into two groups; the major compounds such 
as the monosaccharaides (glucose and fructose) and the minor compounds including 
amino acids, enzymes, vitamins and minerals (Bentabol Manzanares et al, 2011). 
Some differences in honey composition are due to the differences between regions 
(floral sources) but seasonal differences can also be important (Molan, 1992). Bees 
collect many materials to produce honey which include flower volatiles, nectar, 
pollen and propolis. The botanical origin will also affect the composition of honey
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(Torly et al, 2004). Some components of these raw materials possess important 
antibacterial properties that can contribute to the total antibacterial activity of honey 
(Weston, 2000). However, the variation in constituents does not generally affect the 
main components, fructose and glucose, which are always the major sugars present 
in honey. Kashoniene (2010) reported that the compositional analysis of 26 samples 
of honey showed some important differences between different honey varieties but 
this did not include the sugar composition. Nevertheless, the content of individual 
carbohydrates did vary and ranged between 329.2 to 426.3 mg/g for both fructose 
and glucose (as the dominant components).
In Palka's study (Palka et al, 2007), the analysis of different types of honey 
demonstrated that honey contains 17 % water, 82.5 % sugars (38.5 % fructose, 31 % 
glucose, 7 % maltose, 4 % trisaccharides and 1.5 % sucrose) and 0.5 % protein as 
well as some mineral components. This is consistent with other studies (Anklam, 
1998; Ouchemoukh et al, 2010) and demonstrates the consistency amongst different 
varieties in terms of the key components.
Honey as described by Sanz et al, (2005) and Manzanares (2010) can be found 
as either a blossom honey or honeydew honey as described above. The major 
difference between them is the plant source used by the honeybees to produce the 
honey. Interestingly, honeydew honey contains a higher concentration of 
oligosaccharides and amino acids (Bogdanov, 2009). Several physicochemical 
parameters can be easily used in the routine classification of honeydew and blossom 
honey including the sum of glucose and fructose (G+F) and the electrical 
conductivity (Bogdanov et al, 2004). Blossom should have a G+F of 60 g/100 g or 
higher whereas in honeydew the G+F content is much lower at 45 g/100 g
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(Bogdanov and Gfeller, 2006) and has a F/G average ratio of between 1.2 and 1.3 
(Bentabol et al, 2011).
Honey colour is an indicator to the composition and plant source. Gomes et al, 
(2010) reported that the colour of honey reflects various components present such as 
minerals, pollen and polyphenols. Taormina (2001) reported that dark honey has a 
higher amount of pigments such as flavonoids. The colour of honey ranges from light 
yellow, through amber and dark reddish amber to a nearly black colour (Bertoncelj et 
al, 2007). According to the results of Estevinho, et a/.,(2008), dark honey has a high 
level of phenolic compounds and this has been shown to have a good correlation 
with its higher antibacterial activity. Molan (1992) also highlights that dark coloured 
honey obtained from the mountains of central Europe has a particularly high 
antibacterial activity compared to the light variant from the same region. Other dark 
coloured honeys have also demonstrated high antibacterial activity such as sweet 
chestnut honey {Castanea sativa). Manuka honey {Leptospermum scoparium) and 
Heather honey (Allen e? a/., 1991).
The moisture content of honey can also vary between different honey varieties 
and can be affected by climate, season and the moisture content of the original plant 
nectar. Nanda (2007) observed that honey moisture content ranged between 14.63 
and 21.8 %.
Protein content in honey is very low and ranges between 0.1 and 0.5%. 
Different proteins have been detected in different honey varieties which are 
predominantly related to different types of honeybee or different types of 
plant/flower (Marshall and Williams., 1987). Other important components of honey 
are the enzymes present which contribute to its antioxidant and antibacterial activity. 
These include glucose oxidase, invertase (a-glucosidase), catalase, diastase (a- and
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B-amylase) and peroxidase. It is believed that some enzymes in honey come from 
nectar (Serrano et al, 2006). However, it is known that a-amylase and a-giucosidase 
in honey come from bee salivary secretions (Vit and Pulcini, 1996).
1.1.2 Antibacterial properties of honey
The antibacterial effects of honey have been known in practical terms for over 
a hundred years in the absence of a proper understanding of their specific 
mechanisms of action. The first explanation of the antibacterial activity of honey was 
discovered and reported in 1892 by Van Ketel (Molan, 1992). Inhibine is the term 
was used to define the antibacterial agent in honey and ‘Inhibine number’ was used 
to describe the degree of dilution to which a particular type of honey keeps its 
antibacterial activity. These terms were coined by Dold and Witzenhausen in 1955 
and involve the formation of a scale of 1 to 5 equal to honey dilutions in 5 % steps, 
from 25 % to 5 % (w/v) (Table 1.1) (White et al, 1963).
Inhibine number Bacterial growth
Honey concentration
% w/w % v/v
5 No growth 6.10 5
4 No growth 11.9 10
3 No growth 17.4 15
2 No growth 22.7 20
1 No growth 27.8 25
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Although the measurement of the Inhibine number of honey has its merits there 
are several other methods that have been used to measure the antibacterial activity of 
honey. Some of these have been explained by Molan (1992) as follows:
1. The agar diffusion assay technique is a method in which a small quantity of honey 
or solution of honey is applied to the centre of a nutrient agar plate previously 
inoculated with a mierobial culture. During the time in which the plate is incubating, 
the honey diffuses out into the agar from its point of application. The size of the clear 
zone around the honey application site is a measure of the potency of the honey 
being tested. However, it is important to note that in this assay the effeetive 
antibacterial eoncentration can be lower than the concentration applied to the agar 
due to honey dilution during diffusion. 2. In a second method, honey is ineorporated 
into the nutrient agar or into the nutrient broth in whieh the bacterial culture is 
grown. By using a series of different coneentrations of honey within the broth or agar 
it is possible to determine the minimum inhibitory coneentration (MIC) for eaeh type 
of honey studied.
Many different ways can be used to measure the antibacterial activity of honey and 
the inhibition of microorganism growth can be deteeted in partieular by using a 
variety of biological methods such as measuring the dry weight of the micro­
organisms or the zone of growth inhibition on an agar plate. Measurement of 
absorbance using the spectrophotometrie determination of growth can also be used 
(Patton, et al, 2006). Further methods that focus on the assessment of a growth 
indieator (e.g. a spécifié metabolite such as lactic acid), or direct microscopic counts 
can also be used (Bogdanov, 1997).
MIC is used to determine the in vitro aetivity of an antibacterial substance and can be 
defined as the lowest eoncentration of an antibacterial agent that will inhibit the
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visible growth of mieroorganisms after an overnight incubation (Andrews, 2002). 
Patton et al., (2006) used a spectrophotometrie bioassay for the determination of 
bacterial sensitivity to honey in comparison with the standard methods of well/ disc 
diffusion and found that the spectrophotometric method had a greater sensitivity 
especially when used with low honey coneentrations. In general, it is important to 
appreciate that the results will depend largely on the technique and seientiflc 
judgment (Patton et al, 2006) and this need to be considered when comparing results 
using different methods.
1.1.3 Features of honey relevant to its antimicrobial activity
Many factors have been shown to contribute to the antibacterial activity of 
honey such as its high viscosity that helps provide a protective barrier to prevent 
infection. In addition, the mild acidity and hydrogen-peroxide content have obvious 
antimicrobial effects (Lusby et al, 2005).
1.1.3.1 Low water activity
Water activity is often used as a means to inhibit bacterial growth in foods. 
The water activity (aw) of honey ranges from 0.562 and 0.62, which means it 
provides a very low water availability to support the growth of any microorganisms. 
Many bacteria have their growth inhibited at water activities between 0.94-0.99 
whereas some bacteria have their maximum growth at a water activity of 0.99. In 
other words, the process of osmosis is an important feature in the antibacterial 
activity of honey and the extent of inhibition will depend on the concentration of the 
honey as well as the species of bacteria being studied (Molan, 1992). It is evident 
that undiluted honey, which can be used in the treatment of skin infeetions, has the 
ability to stop the growth of bacteria completely because of the high content of sugar;
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nevertheless this antibacterial action will be reduced when it is diluted by body fluids 
at the site of infection.
Although a high concentration of sugar and a low water activity will stop the growth 
of many microorganisms such as Staphylococcus aureus, studies have shown that 
often no effective bacterial inhibition occurs in the presence of ‘artificial’ honey 
which can be prepared using a mixture of mono- and disaeeharides at the same 
concentration as those present in honey. In addition, studying the effect of honey on 
the growth of bacteria such as S. aureus, which has a high tolerance of low water 
activity, gives clear evidence that the antibacterial activity of honey can also be 
attributed to other factors. S. aureus needs a a^ of lower than 0.86 for complete 
inhibition which is equivalent to a concentration of honey of 29 % (v/v) (Molan, 
1992). In contrast, S. aureus has been found to be completely inhibited by one honey 
variety at 17 % when impregnated in nutrient agar (Molan, 1992).
Moreover , a 1.8 % (v/v) concentration of Manuka honey has been shown to 
completely inhibit the growth of S. aureus during an 8 h incubation in a study by 
Willix et al, (1992) and according to a similar study by Cooper and Molan (1999), 
who used Manuka and Pasture honey from the same region in New Zealand, all 58 
strains of S. aureus could be inhibited by 2 -  3 % (v/v) of Manuka honey and 
between 3 and 4 % for Pasture honey which is much lower than 29 % honey that 
would be required if the effect was based on water activity. This highlights the 
presence of important components in diluted honey and their antibacterial properties.
Nevertheless, some bacterial strains are more sensitive to the osmotic effects of 
carbohydrate monomers and dimers than others as reported by Osato et al, (1999). 
Their work showed that 15 % (w/v) carbohydrate (fl-uctose, glucose, glucose and
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fructose combinations, or honey) concentration was sufficient to cause similar killing 
effects on all 28 isolates o f Helicobacter pylori.
1.1.3.2 Acidity
The acidity of honey is another important active factor in the antibacterial 
activity of honey. This is due to the presence of organic acids particularly gluconic 
acid (Kucuk et al, 2007) which is present at ~ 0.5 % (w/v) (Cavia et al, 2007). 
White et al, (1963) reported that gluconic acid is an effective antibacterial factor 
produced as a result of glucose oxidation by the endogenous glucose oxidase. As a 
result honey is an acidic substance with a pH between 3.2 and 4.5 whereas most 
bacteria grow in an optimal pH range between 6.5 and 7.5. This low pH can be an 
effective antibacterial factor in undiluted honey. However, it is important to note that 
the pH will not be enough to inhibit the growth of many bacterial species when 
diluted in a food or by body fluids (Molan, 1992).
1.1.3.3 Hydrogen Peroxide (H2O2)
Hydrogen Peroxide (H2 O2) is an important oxidizing and sanitizing agent (Ali, 
2004). It is produced enzymatically in honey and can be an important feature in its 
antibacterial activity. The enzyme, glucose oxidase, which is naturally present in 
honey, is inactive in undiluted honey because of the low pH conditions (White et al, 
1963). However, glucose oxidase is activated when honey is diluted which allows it 
to act on the endogenous glucose to produce hydrogen peroxide. Indeed, the 
maximum level of hydrogen peroxide produced can be obtained from a 30-50 % 
honey dilution (Molan, 1992). White et al, (1963) reported that the level of 
hydrogen peroxide in honey can range between 5 and 100 pg H202/g honey (which is 
equivalent to -0.146 - 2.93 mM). According to Bang et al, (2003) the production of 
hydrogen peroxide in some honey samples can increase continuously over time to a
11
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point depending on the dilution used. Indeed, H2 O2 levels in honey can reach 2.5 
mmol in 30-minutes and this can double on prolonged incubation. The level of 
hydrogen peroxide in a large number of honey samples was determined by Bogdanov 
(1984), Roth et ah, (1986), Bang (2003), Brudzynski et al, (2011), Brudzynski et al, 
.(2012) and Alwaili et al, (2013) (Table 2). The average level of H2 O2 in these 
studies was I mM. A similar range of hydrogen peroxide concentrations (1 mM to
2.5 mM) was enough to kill E.coli in 15 minutes (Brandi et al, 1987 & Imlay and 
Linn, 1986). A linear correlation between the honey content of hydrogen peroxide 
and the antibacterial activity of honeys was reported by Brudzynski (2006).
12
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Table 1.2 Levels of hydrogen peroxide (H2O2) in diluted honey.
Number of 
samples
Honey 
concentration 
(v/v %)
H2O2 content 
mM/1
Incubation
duration
(minutes)
Reference
31 NA 0-0.95 NA Bogdanov(1984)
90 14 0-2.12 1 hour Roth et al., (1986)
8 30-40 -2.5 30 mins Bang (2003)
8 25 0.24-2.68 NA
Brudzynski et al, 
(2011)
133
6.25, 12.5
and 25
0.4 - 2.6 0
Brudzynski et al, 
(2012)
5 10-100 0.34-1 .11 NA Alwaili et al, (2013)
•  NA: N ot available
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It is important to note that the level of hydrogen peroxide in honey is also 
determined by the presence and action of catalase. Indeed, Weston (2000) showed 
that an important relationship exists between the levels of this enzyme and glucose 
oxidase, and the resultant antibacterial effectiveness. Weston assumed that a high 
level of glucose oxidase would relate to a high level of hydrogen peroxide. 
Furthermore, a low level of catalase would also mean high level of hydrogen 
peroxide. This relationship can in part explain the high antibacterial effect of Manuka 
honey against some microorganisms as it is assumed that this honey has a low level 
of catalase activity but this needs more investigation.
It was originally believed that hydrogen peroxide is the only factor responsible 
for the antibacterial effect of diluted honey and this antibacterial activity of honey 
could be completely removed by the addition of catalase as shown by Adcock (1962) 
and Brudzynski et al, (2012). However, the sensitivity of bacteria to honey produced 
hydrogen peroxide can be influenced by the presence of honey phytochemical 
compounds (Brudzynski et al, 2011). To investigate the fact that the antibacterial 
activity of honey is not only due to the activity of glucose oxidase, some studies have 
shown that adding catalase to honey is insufficient to remove all the antibacterial 
activity. This highlights the role of other important factors that can contribute to the 
effect of hydrogen peroxide and the acidity in the antibacterial activity of honey 
(Weston, 2000).
1.1.3.4 Maillard reaction like products (honey Melanoidins)
Maillard reaction products in honey or what are called honey Melanoidins 
have been recently studied. Brudzynski and Miotto (2011) reported a good 
correlation between honey levels of Maillard reaction-like products (MRLPs) and its 
antibacterial activity of unheated honey. The production of these components was
14
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positively affected by high temperature. Mandai et al, (2010) showed that 
autoclaving honey enhanced its antibacterial activity against Escherichia coli. 
Pseudomonas aeruginosa and Salmonella spp.
This reaction is a condensation reaction between an amino group and the 
carbonyl group of a reducing sugar. The reaction was named after the French chemist 
Louis Maillard (Maillard, 1913) who first observed it. The product of the initial 
condensation reaction rearranges to form the Amadori rearrangement product (ARP) 
that subsequently degrades via an array of pathways. Melanoidins are the final stage 
of Maillard reaction and contain high molecular weight polymers (Borrelli et al, 
2002).
The large numbers of products that result are known collectively as Maillard 
Reaction Products (MRPs). The chemistry behind the Maillard reaction is highly 
complex involving a number of different pathways influenced by various physical 
and chemical parameters including pH, reaction temperature, sugar and amino acid 
contents. Some amino acids are more reactive in Maillard reaction (Kwak and Lim, 
2004).
Honey contains the amino acid proline as the main amino acid and is the 
measure of the level of total amino acids in honey (Bogondov, 1999). Moreover, the 
presence of different sugars such as fructose and glucose in honey leads to different 
reaction pathways (Reynolds, 1965). These contents, the acidity of honey and the 
high temperature increase the possibility of the production of MRPs in honey. MRPs 
include hydrogen peroxide (Kim et al, 1991) and dicarbonyl compounds such as 
glyoxal and methylglyoxal which have antibacterial activity (Marvic et al, 2008) and
15
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are found at high levels in some types of honey which have high antibacterial activity 
(Marvic et al, 2008, Adames et al, 2008).
1.1.3.5 Non-Peroxide antibacterial compounds
As a result of the studies which showed the antibacterial activity of catalase- 
treated honey, the Non-Peroxide Anti-Bacterial Activity (NPABA) was identified. 
This saw a rise in the number of studies that investigated the effect of numerous 
other substances beyond its peroxide activity.
1.1 3.5.1 Phenolic compounds
According to recent studies, honey has been shown to possess a high level of 
phenolic compounds which might contribute to its antibacterial activity. A study by 
Wahdan (1998) emphasized that phenolic acids and flavonoids are an important part 
of the antibacterial substances in honey. The phenolic acid level in honey can be 
affected by its botanical and geographical origin as it depends upon the source of the 
nectar. Moreover, it is evident that the season also has a noticeable effect on the total 
phenolic (TP) acid content of honey. To illustrate this Lachman et al, (2010) 
evaluated the total polyphenol content of honey varieties harvested in the period 
from May to August 2006 and found the highest TP acid content was found in the 
honey collected at the beginning of June (on average 170.21 mg/Kg) and July (on 
average 163.32 mg/Kg) whereas it was much lower in other samples (83.60 mg/kg) 
collected during the other months. Honey type also has an effect on its phenolic 
content. For example. Manuka honey has a phenolic acid content that ranges 
between 430-2706 mg/Kg compared with Kanuka honey (424-1575 mg/kg) collected 
at the same time and from the same site (Stephens et al, 2010). Viper’s bugloss and 
Heather honey were also studied by Ferreira et al, (2009) and the phenolic acid
16
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content was considerably lower and ranged between 132.17±0.05 and 727.77±0.23 
mg/Kg. Moreover, 40 samples of honey collected from different locations in Czech 
Republic were evaluated by Lachman et al, (2010) for their total phenolic content 
and composition. This study showed that the content was very low and ranged 
between 82.5 and 242.5 mg/Kg honey with the main phenols being flavonoids and 
phenolic acids. In terms of composition Biesage and Pyrzynsaka (2009) have 
reported some useful information in that all the honey samples that they assessed 
contained traces of similar phenolic compounds but in different amounts such as 
chlorogenic acid, vanillic acid, caffeic acid, syringic acid, myricetin and apigenin.
According to Yaoa et al, (2005), honey contains different kinds of phenolic 
acids such as gallic acid and coumaric acid which were the main phenolic acids in 
Australian tea tree, crow ash, brush box and heath honey. The TP contents ranged 
between 21.3 and 184.3 mg/Kg and the main phenolic acid in all honey samples was 
gallic acid with 4.52, 4.11, 1.39 and 3.63 mg/100 g, respectively, for the different 
honey types mentioned above.
High-performance liquid chromatography (HPLC) analysis has been used to 
identify the phenolic compounds in two honey extracts from north east Portugal by 
Estevnho et al, (2008). The results showed the presence of 14 phenolic compounds 
which were mainly phenolic acids and flavonoids. These phenolic acids included 
protocatechuic acid, /?-hydroxybenzoic acid, caffeic acid, chlorogenic acid, vanillic 
acid, / 7-coumaric acid and benzoic acid. The flavonoids were naringenin, kaempferol, 
apigenin, pino cembrin and chrysin. Other phenolic compounds were present in 
similar quantities but these were not specifically identified due to a lack of analytical 
standards. Furthermore, Weston et al, (2000) found two polar components 
(unidentified) with elution times of 44 and 47 min.
17
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Methyl syringate (MSYR) was the major product in phenolic extracts of active 
Manuka honey isolated by Weston et al., (1999). The result showed that MSYR 
comprised more than 45 % of the TP extract. A similar finding was observed by 
Kochi et al, (2005) who recorded a large peak on the chromatogram which was also 
identified as MSYR.
1.1.3.5.2 Methylglyoxal
Methylglyoxal (MGO; CH3-C0-CH=0 or C3H4 O2) is an important constituent 
of honey that has recently been shown to contribute to its antibacterial activity. 
According to Mavric et al, (2008), MGO has a high antibacterial activity with a 
minimum inhibition concentration (MIC) of 1.1 mM when tested against E. coli and 
S. aureus. An equivalent activity could be made by using a 15-30 % honey dilution 
which contains similar amounts of MGO. This clearly demonstrates that the 
pronounced antibacterial activity of New Zealand Manuka honey may be as a result 
that it is rich in MGO. Adams et al, (2008) also reported that the active antibacterial 
component in honey is MGO and demonstrated that the non-peroxide antibacterial 
activity of honey was similar to the antibacterial activity of MGO at the levels 
present in honey.
A good linear correlation has been shown to exist between MGO content and 
the antibacterial activity of Manuka honey (Atrott and Henle, 2009). Manuka honey 
is considered to have a unique factor (unique Manuka factor; UMF) responsible for 
its antibacterial activity and this is considered to be MGO. High amounts of MGO 
are found in Manuka honey ranging from 38 and 761 mg/Kg (up to 100 fold higher 
compared to conventional honey (Mavric, 2008). This is supported by the work of 
Adams et al, (2008) who reported a similar range of MGO (from 38 to 828 mg/kg) 
in 83 samples of Manuka and non-Manuka honey
18
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MGO concentration increases as Manuka honey matures and after storage (up 
to 120 days) at 37 °C. Adams et al., (2009) attributed this increase of MGO to the 
long term storage and non-enzymatic conversion of dihydroxyacetone to MGO. 
Dihydroxyacetone is a substance that occurs at high levels in the nectar from which 
Manuka honey is made.
1.1.3.5.3 Peptides
Peptides that have been characterized from the body fluids of bees that have 
either been injured or infected by bacteria, can also be involved in antibacterial 
activity. These fluids possess strong antibacterial activity and could also potentially 
contribute to antibacterial activity of honey (Weston et al, 2000).
Moreover, Brudzynski and Miotto (2011) reported a good correlation between 
honey colour, total phenolic content, levels of Maillard reaction-like products 
(MRLPs), antioxidant activity and the antibacterial activity of unheated honey. This 
demonstrates the wide range of compounds that could contribute to the antibacterial 
properties of honey.
1.1.4 Studies on the antibacterial activity of honey
Several research studies have investigated honey and its effect on many species 
of bacteria (Tables 1.3). It is evident that the antibacterial activity of honey can vary 
quite considerably. Bogdanov (1997) reported that some kinds of honey, such as 
those from rhododendron, eucalyptus and orange have relatively low activity, 
whereas those from dandelion, honeydew and rape have higher activity. Interestingly, 
it did not matter what fraction was assessed (acidic, basic, nonpolar or volatile). It is 
also clearly evident that different microorganisms have different susceptibilities to 
different types and concentrations of honey.
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Table 1.3: Examples of high and low activity honey
High activity honey Low activity honey
Dandelion Rhododendron
Honeydew Eucalyptus
Rape Orange
Recently, many aspects of the antibacterial properties of honey have been 
reviewed and the growth of bacteria has been tested in the presence of different 
concentrations of honey (Molan, 2009; Shahid, 2009).
In one early study Jeddar et al, (1985) evaluated the antibacterial effect of pure 
honey in vitro. They tested the growth of various Gram-positive and Gram-negative 
bacteria in media which contained different concentrations of honey, namely, 1 0  %, 
20 %, 30 %, 40 % and 50 % (w/v). Most pathogenic bacteria failed to grow at the 40 
% concentration of honey and above and the mechanism was explained through the 
following reasons:
1. The osmotic effect of the honey caused a shrinkage and disruption of the 
bacterial cells.
2. The low pH.
3. The presence of other substances in honey, which were unidentified, with 
bactericidal properties.
This study has been followed up by a sequence of other studies, with many 
different foci to measure and justify the antibacterial action of honey. Bogdanov 
(1997) studied the antibacterial activity of 11 types of honey, including the common
20
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varieties such as acacia, blossom, chestnut, lavender and orange and found that the 
inhibitory concentration of the different honey varieties ranged from 37 to 74 %. The 
pH of the honey was considered to be the most important and effective factor in 
inhibiting microorganism growth which ranged between pH 3 and 5.4.
Basson and Grobler (2008) tested the antibacterial potency of different honey 
varieties produced from indigenous wild flowers grown in South Africa. The result 
showed that no high activity occurred in the South African honey varieties and that a 
honey concentration above 25 % was necessary for antibacterial activity which was 
due to the osmolality and carbohydrate concentration.
In contrast to Jeddar's study, French et al, (2005) tested the antibacterial 
activity of two kinds of Manuka honey and pasture honey against 18 clinical isolates 
of coagulase-negative S. aureus and compared it with sugar syrup. The results 
showed that the activity of honey was 5.5 -  11.7 times greater than the sugar syrup. 
All 18 coagulase-negative Staphylococcus isolates were inhibited by concentrations 
of 2.7 -  5 % (v/v) honey whereas 27.5 -  31.7 % (v/v) of sugar syrup was needed to 
produce a similar effect. This study thus eliminated the role of osmosis at lower 
concentrations.
Honey has been shown to have a strong activity against many bacteria in both 
media and in culture. This was investigated by Alwaili et al, (2005) in which honey 
obtained from the United Arab Emirates was shown to have a moderate activity 
towards a variety of different pathogens. Using between 30 % and 100 % honey it 
was shown that the honey was able to prevent the growth of bacteria as well as 
inhibiting the growth of bacteria when it was added to a growing cultures.
Six types of honey were studied by Lusby et al, (2005) to investigate the 
antibacterial activity against 13 species of bacteria and 1 yeast species. Three types
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of honey (Lavender, Red stringy bark and Paterson’s curse) were y-irradiated with 15 
KGY whereas the other three (Manuka, Rewa rewa and Medihoney) were marketed 
as therapeutic honeys with antibacterial activity. All samples were tested at different 
concentrations (0.1 %, 1 %, 5 %, 10 % and 20 %( w/v)). No inhibition was observed 
at 0.1 % but the 1% concentration showed some inhibition with C. freundii, E. coli, 
M. phlei and three species of Salmonella. A progressive increase in the inhibition was 
reported for most honey samples at the highest concentration in this study (at 2 0  % at 
least 75 % inhibition) except K. pneumoniae which interestingly showed no 
inhibition at all.
The biological activity of three Turkish honeys was studied by Kucuk et al, 
(2007). The honey was obtained from Anatolia and included chestnut, Herero floral 
and Rhododendron. Overall samples had activity against all the test microorganisms 
and the extracts gave rise to moderate inhibition against only a few microorganisms 
e.g. H. pylori and S. aureus.
Al-jabri et al, (2003) studied the antibacterial activity of 24 samples of honey 
(16 from Oman and 8  from Africa) against three bacteria namely S. aureus, E. coli 
and P. aeruginosa. They found that 81 % of Omani honey and 8 8  % of African honey 
varieties assessed in the study had anti-staphylococcal activity. However, only 63 % 
of Omani honey samples and 62 % of African honey samples showed any activity 
against E. coli. Activity against P. aeruginosa was less common in Omani honey (38 
%) but more common in African honey (75 %).
Some researchers have studied the action of enzymes on the antibacterial 
activity of honey. Allen et al, (1991) tested 345 samples of honey against S. aureus 
in the agar well diffusion assay with phenol as the reference standard. The samples 
included Kanuka, Manuka, Heather and Kamah honey. The antibacterial activity
22
Chapterl: Introduction
ranged between 2 % to 58 % (w/v) with a median of 13.6 %. Interestingly, most 
honey samples showed no antibacterial activity in the presence of catalase except 
Manuka honey.
The nature of non-peroxide antibacterial activity in Manuka honey was 
reported by Snow and Manley-Harris (2004) using S. aureus in alkaline honey 
solution. The effect of a 10-fold excess catalase upon the antibacterial assay was 
examined. The results showed no statistical difference in the outcome between the 
normal amount of catalase and the 1 0 -fold excess which indicates that non-peroxide 
antibacterial activity was not due to residual hydrogen peroxide.
Cooper et al, (1999) studied the antibacterial activity of Manuka honey (Table 
1.4). The samples of Pasture and Manuka honey were used at different 
concentrations (ranging from 1 -  10 %) against S. aureus. The MIC was determined 
as 2 -  3 % (v/v) for pasture honey and 3 -  4 % (v/v) for Manuka honey. Solutions of 
pasture honey 25 % (w/v) showed no detectable antibacterial activity in presence of 
catalase but its activity was equivalent to 14.8 % phenol without catalase whereas the 
same solution of Manuka honey had activity was equivalent to 13.2 % with and 
without catalase.
Manuka honey was also tested against Campylobacter jejuni by Lin et al, 
(2009) and the results showed that 1 % (v/v) of Manuka honey was sufficient to give 
the minimum inhibitory effect (Table 1.4).
In a comparative study of Manuka honey and Tualang honey, (Koompassia 
excelsa) Malaysian honey, against an extensive spectrum of microorganisms. Tan et 
al, (2009) found that MlCs of Tualang honey ranged between 8.75 % and 25 % 
which means that Tualang honey has a similar antibacterial activity to Manuka honey 
and it may potentially be used for the same medical purposes (Table 1.4).
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A  study by Alnaqdyn in 2005 which characterized the effect of honey on the 
adherence of Salmonella to intestinal epithelial cells showed that a honey dilution of 
1:8) reduced the adherence from 25.6±6.5 to 6.7±3.3 bacteria per epithelial cell.
These studies confirmed the activity of honey varities and showed a very wide 
range of active concentrations depending on the type of honey was used and the 
bacteria were tested.
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Honey Bacteria MIC(% v/v) Reference
Pasture
Manuka
S. aureus 3-4
2-3 Cooper et al, 1999
Manuka (M l09) 
Pasture
Methicillin- 
resistant S. aureus 2.98 + 0.14 3.07 + 0.26 Coopéré/a/., 2002
Pasture 3.6+ 0.7
Manuka 
Sugar syrup
S. aureus 3.4+ 0.5 
29.9+1.9 French et al, 2005
Bluegum 25
Fynbos 50 Basson & Grobler
Pincushion S. aureus 25 2008
Manuka 25
2 2  samples of
Trigona Carbonaria S. aureus 2&3 Irish et al, 2008
honey
Stingless bee honey 
(Gama-irradiated at S. aureus 3.3 Room et al, 2009
15 kgy)
Tualang E.coli 225% Tan et al, 2009Manuka (UMF 10+) 2 0 %
Bluegum 25%
Fynbos E.coli 25% Basson & GroblerPincushion 25% 2008
Manuka 25%
Manuka Campylobacter spp 1 % Lin et al, 2008
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1.1.5 Using honey to treat infections
Infected mice have been used to study the effect of honey on wound infection. 
Al-waili (2004) used a wide range of concentrations (10-100 % (w/v)) of new honey 
(origin and type unspecified in the paper), stored honey, heated honey, ultraviolet- 
exposed honey and heated-stored honey in acidic, neutral and alkaline media to 
determine their activities against common human pathogens in comparison with a 
glucose solution. Samples with concentrations between 30 % and 100 % gave rise to 
complete prevent to the infection while the 1 0 0  % glucose sample did not for some 
microorganisms. Interestingly, heating honey at 80 °C and storing honey were 
reported as important factors which could cause a decrease in the antibacterial 
activity of honey.
In an in vivo experiment, a significant decrease in the count of E. coli cells in 
faecal samples from rats which were previously inoculated orally with E. coli and fed 
2g honey daily for 3 days was observed in comparison with glucose, fructose and 
sucrose fed controls (Shamala et al, 2002).
Moreover, Badet and Quero (2010) demonstrated that 10 % of Manuka honey 
was able to inhibit the formation of a biofilm of oral bacteria such as Streptococcus 
mutans and the result of this study suggests that honey might be able to reduce oral 
pathogens within dental plaque. Also, honey was active against biofilms formed by 
methicillin-susceptible Staphylococcus aureus (MS SA) methicillin-resistant 
Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa with activity rates 
ranging from 63-82%, 73-63 %, and 91-91 %, respectively, which was higher than 
the effect of single antibiotics commonly used (Alandejani et al, 2009).
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1.1.6 Comparison antibacterial activity of honey with antibiotics
As the antibacterial effects of honey have been shown to be quite potent the 
activities have been compared to some antibiotics. Importantly though the current 
abundance of antibiotic-resistant microbial species highlights the need to source 
other antibacterial substances. Adeleke et al, (2006) did a comparative study 
between the activity of honey and gentamicin against P. aeruginosa and E. coll 
Three kinds of pure honey were obtained from Ibadan and Abeokuta in south west 
Nigeria and were used undiluted and as fresh aqueous dilutions of 1:2, 1:4 and 1:6 in 
an agar diffusion method. Undiluted honey and its 1:2 to 1:6 aqueous dilutions 
showed activity of 100 % and 96.4 %, respectively against P aeruginosa and E. coli 
compare to gentamicin which showed similar activity when used in concentrations of 
8.0 and 4.0 pg/ml.
In another study, thirty samples of honey from different parts of Oman were 
investigated for their activity against S. aureus. Of these 43 % of honey samples 
showed excellent anti S. aureus activity. Thirty eight % of S. aureus strains were 
killed by 50 % honey in 30 minutes and 45 % after one hour. Gentamicin at the 
concentration of 4 pg/ml killed 70% of S. aureus after 30 mins and 8 8  % after one 
hour whereas the percentage increased when a combination of honey and gentamicin 
was used (92 % and 93 % at 30 mins and one hour, respectively) (Al-jabri et al, 
2005). In contrast, Agbaje et al, (2006) reported that 100% honey might not 
adequately proffer a total solution to the current problems facing bacterial 
chemotherapy when compared to 0.2 % Ciprofloxacin and 2.5 % tetracycline.
Overall, the antibacterial activity of honey has been proven although there are 
contrasting results between researchers as to what concentration is effective and what 
is not. It is clear that this feature is due to more than one factor but this needs more
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research to clarify this research area. Furthermore, the studies assessing the 
antibacterial activity of honey have not encompassed the effectiveness of honey 
against some bacteria which have become recently more common and harmful such 
as C. jejuni. Furthermore, the world today needs further assessments of natural 
substances which can be used to combat microorganisms without the concern about 
the side effects, overdose or high consumption.
1.2 Campylobacter
Nowadays, Campylobacter has become the major cause of bacterial enteritis in 
the developed world and remains problematic in developing countries. According to 
the recent statistical data from the Health Protection Agency, the number of 
Campylobacteriosis cases in England and Wales exceeded infections caused by 
Salmonella spp. Indeed, in 2012, more than 70 % of food poisoning cases were 
caused by Campylobacter (Table 1.5).
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Table 1.5 Epidemiological Data for causes of foodborne illness in England & Wales 
between 2007 and 2012.
Microorganism
Year (eases)
2007 2008 2009 2 0 1 0 2 0 1 1 2 0 1 2
E. coli 0157 828 950 1034 793 1182 795
Salmonella 11780 9885 9079 9133 9127 8355
Listeria
monocytogenes
227 182 213 NA 147 165
Campylobacter 51989 50009 57772 62684 64726 65032
* Source: The Health Protection Agency (HPA) 
** NA: not available.
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Clearly, the increased prevalence of cases of Campylobacteriosis is of major concern 
particularly as the statistics indicate that this increasing year on year. Camplyobacter 
is a relatively newly defined micro-organism in part owing to the fact that it was 
difficult to culture. A historical perspective is provided below.
1.2.1 History of Campylobacter
The initial discovery of Campylobacter was made by a German-Austrian 
paediatrician named Theodore Escherich in 1886. His observation and description 
led him to conclude that the spiral shaped, non-culturable bacteria he saw in faecal 
samples were Vibrio-like bacteria and these were later re-named Campylobacter. In 
1913, Vibrio-like bacteria were isolated from the foetuses of aborted ovines by 
Stockman and McFadyean (Altekruse et al, 1999). This was followed by the 
discovery of spiral shaped bacteria on the same ovine foetuses by Smith five years 
later (Butzler, 1984). This led Smith to conclude that these spiral shaped 
microorganisms and the vibrios isolated by Stockman and McFadyean were the same 
species. Vibrio fetus was then proposed as a name for these two strains. In 1927, 
Orcutt and Smith identified another cluster of Vibrio-like strains in the faeces of 
cattle with dysentery and named them Vibrio jejuni. Another strain was also 
discovered in 1944 by Doyle in the faeces of pigs with dysentery but this was 
classified as Vibrio coli (Vandamme, 2000).
By 1957, other strains of Vibrio were found to be associated with bacteraemia 
(Butzler, 1984). Two more strains were discovered by Florent in 1959, namely Vibrio 
fetus subsp. venerealis and Vibrio fetus subsp. intestinalis which caused infectious 
fertility problems and sporadic abortion, respectively. Several years later, the name 
Vibrio was changed to Campylobacter (in 1963) after Veron and Sebald noticed their
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differential characteristics: i.e. low composition of DNA base, non-fermentative 
metabolism and growth requiring less oxygen in comparison to the normal 
atmosphere (Vandamme, 2000).
Almost a decade later, in 1972, the procedures for Campylobacter isolation 
were developed by Dekeyser and then Campylobacter species were isolated for the 
first time from human stools. After this, the organisms rapidly became recognized as 
a significant cause of foodborne illness (Butzler, 1984).
During the 1980s, selective media for Campylobacter isolation were developed 
and there was a rapid increase in isolating Campylobacter from stool samples after 
the development of blood base selective medium by Skirrow in 1977. This made a 
huge impact on the ability of laboratories to isolate and identify Campylobacter. 
Since then, Campylobacter has become one of the most common bacterial causes of 
foodborne disease (Alios, 2001). By 2011 more than 64,000 cases of Campylobacter 
were reported in England and Wales (HPA, 2012).
Moreover, in 2000, the complete genome sequence of Campylobacter NGTC 
11168 was published (Parkhill et al, 2000). This made a huge impact in terms of 
Campylobacter research and helped in the investigation of the mechanisms that 
control, gene expression, colonization and virulence of Campylobacter (Gaynor et 
al, 2004).
1.2.2. General characteristics of Campylobacter
The word Campylobacter comes from a Greek word which means curved 
rod, and this greatly reflects the physical characteristic of this bacterium (Butzler, 
1984). Campylobacter are Gram-negative, microaerophilic, non-sporing curved or 
spiral shaped bacilli (Alios, 2001). Campylobacter has a rapid, corkscrew-like 
motility and each bacterium has a flagellum attached to either one or both ends
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(unipolar or bipolar flagellae). Typically, it is small in size and measures 0.2 to 0.5 
pm wide by 0.5 to 8.0 pm long (Butlzer, 1984). However, phase of growth has been 
shown to have an effect on the length of the cells. Indeed, in the mid-stationary phase 
they appear to be twice the length, compared to cells isolated from the exponential 
phase (Griffiths, 1993). Moreover, it is reported that under stress and when the 
conditions are not supportive, the shape of Campylobacter also changes to coccoid. 
This form is called the viable but non-culturable (VBNC) state (Rollins and Colwell, 
1986) and any detrimental change in the growth environment conditions for example 
the growth temperature will result in quick transformation to the VBNC state.
Campylobacter is catalase and oxidase positive and has the ability to reduce 
nitrite and nitrate but is unable to ferment or oxidize carbohydrates. This is due to the 
lack of glycolytic enzymes, mainly 6 -phosphofructokinase, in Campylobacter which 
prevents the metabolism of carbohydrate. As such, amino acids are the main source 
of energy (Parkhill et al, 2000).
The natural habitat for Campylobacter species is in the gut of birds and 
warm-blooded animals. Most Campylobacters colonize the mucosal surfaces of birds 
and mammalian intestine. Some species, however, colonize the oral mucosa while 
others are found on the crevices of the gums (Wassenaar and Newell, 2006).
Sixteen species have been identified and described in the genus of 
Campylobacter. However, Campylobacter jejuni and Campylobacter coli are the 
leading cause of the human infections (Skirrow and Blaser, 2000). Other species 
such as Campylobacter concisus and Campylobacter fetus have recently been 
considered as emerging intestinal pathogens in humans (Zhang et al, 2009).
Campylobacter jejuni and coli have a small genome of 1600-1700 kilobases 
(kb) which is approximately half the size of other enteropathogens (Chang and
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Taylor, 1990). The G+C content of Campylobacter is low with an average content of 
between 30-35 % (compared to other bacteria such as E. coli (51 %) and Salmonella 
typhimurium (51 %).
1.2.3. Isolation, growth conditions and requirements
Campylobacter was isolated for the first time by Butzler and Co-workers in the 
1970s. They used filtration to isolate the small motile cells from a human stool 
sample from an individual who was suffering from diarrhoea. The filtration of stool 
samples beeame the recommended method of isolating and identifying a case of 
Campylobacter infection. A 0.45-0.65 pm filter is used for the isolation of 
Campylobacter and this prevents the passage of most stool bacterial flora. The small 
bacteria sueh as Campylobacter species, however, will be permitted through. 
Following filtration an antibiotic-free medium is used for the isolation (Acheson et 
al, 2008). In 1977 Skirrow developed a selective media for Campylobacter isolation 
by adding a mixture of vancomycin, polymyxin B, and trimethoprim as a supplement 
to a basal medium base (Skirrow, 1977). After this development, which was more 
direct and easier than the filtration the use of selective media became the routine 
method for isolating Campylobacter in microbiology laboratories.
The discovery that Campylobacter is sensitive to oxygen led to the 
development of more selective media containing agents, for example, blood or 
pyruvate, as scavengers of reaetive oxygen species (ROS) as well as selective 
antibiotics (Corry et al, 1995). In addition, a microaerobic atmosphere is required as 
Campylobacter species, traditionally, have been assumed to grow only at low oxygen 
atmospheres (e.g. 5 % 0 2 and 10 % CO2) (Park, 2002), and these conditions are now 
used in most laboratories. However, there have been reports that these bacteria can
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grow aerobically but the conditions have not yet been used for routine culture and 
this finding awaits rigorous confirmation (Kaakoush et al, 2005).
Most species of Camplyobacter, are thermophilic for example, C. jejuni, C. coli 
and C. upsaliensis which can grow best at a temperature range between 37-42 °C 
with an optimal one of 42 °C (Butlzer, 1984, McClure and Blackburn, 2002). They 
are, however, unable to grow below 30 °C (Doyle and Roman, 1982).
Moreover, 0.5 % of sodium chloride (resulting in an aw of about 0.997) is 
required to give the best growth conditions for Campylobacter. Levels of sodium 
chloride of 1 . 0  % or more though retard growth or are inhibitory, as it is more 
sensitive to osmotic stress than other foodborne microorganisms (Park, 2002). This 
sensitivity to sodium chloride means that Campylobacter will not be able to grow in 
foods and beverages containing 2 % salt or higher (or aw below 0.987) (Abram and 
Potter, 1984). In a dry atmosphere, Campylobacter is unlikely to recover after food 
contamination unless the material is stored in moist conditions (Oosterom et al, 
1983)
The optimal pH for Campylobacter growth ranges between 6.5 and 7.5 with no 
survival evident below pH 4.9 or above pH9 (Doyle and Roman., 1982). These 
complex growth requirements give it a limited growth capability in the environment 
(Dasti et al, 2010).
Cephalothin is usually used in the isolation of Campylobacter from stool 
samples as most Campylobacter species are resistant to this compound whereas other 
stool flora are susceptible (Acheson et al, 2008). In general Campylobacter species 
grow slowly when cultured from stool samples (up to 96 hours) but can take an even 
longer time to grow from blood samples.
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Although rapid analysis methods have been developed to detect Campylobacter 
such as PCR and PCR-enzyme-linked immunosorbent assay, the diagnosis is not yet 
a standard practice (Lawson et al, 1993) because of the cost and the technical 
difficulties in carrying these out.
1.2.4 Transmission of Campylobacter to humans
Poultry are considered to be the main source for Campylobacter infection as 
these animals normally have Campylobacter residing in their intestinal flora (Mehle 
et al, 1982). Direct contact with contaminated animals through handling the birds 
can cause infection. The infection also occurs by the consumption of contaminated 
food such as undercooked meat, milk and eggs. Moreover, untreated water has been 
implicated as a source of Campylobacter infection (Fried-man et al, 2004).
The most common vehicles for infection are unpasteurized milk and undercooked 
chicken. The surface of eggs can also be contaminated by infected poultry faeces. In 
general, animal products are the main sources of Campylobacteriosis in the world 
and 20-30 % of cases are attributed to handling, as well as the preparation and 
consumption of broiler meat (EFSA, 2011). Other food types from animal sources 
have also been reported to be contaminated but with a low prevalence of 
Campylobacter, for example in sheep, its carriage was lower than that seen in other 
animals (Zweifel and Stephan, 2004). According to HPA report in 2011, 
contimentated chicken caused 56.5% of reported Campylobacteriosis then 35% by 
cattle and the lowest which was 4.3% caused by sheep (HPA, 2011). In addition to 
food, direct contact with domestic pets is another source of Campylobacter infection 
(Kapperud et al, 1992).
Moreover, the rate of infection and illness may be affected by the type of 
vehicle and Campylobacter may not be able to survive in the gastric acid of the
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infected host without the vehicle’s protection. For example, it has been observed that 
the illness rate was higher in a study by Black et al, (1988) when the volunteers 
ingested Campylobacter with sodium bicarbonate compared to using milk as a 
vehicle. In 1981, Mentzing reported an outbreak of illness caused by Campylobacter 
in water suggesting that water can be an important vehicle of Campylobacter 
(Mentzing, 1981).
Transfer of infection between people can occur. It is evident, however, that this 
route of transmission happens very rarely and only occurs from the handling of the 
faeces of an infected person (Blaser et al, 1983). Thus appropriate hygiene control 
measures are required to reduce this possibility.
1.2.5 Pathogenesis and virulence factors
Currently, the pathogenesis and virulence factors of Campylobacter 
infection are studied mostly using in in vitro assays as no cost effective animal 
model, is available that can mimic Campylobacter infection in humans (Dorrekk et 
al, 2001). In addition, Campylobacter does not express the same virulence factors 
known in other diarrhoea causing bacteria. Moreover, recent animal studies suggest 
that host dependent factors are involved in the process (Havelaar et al, 2009). In 
general, it is apparent that pathogenicity involves factors such as motility, 
chemotaxis, colonization and the formation of toxins (Wassenaar and Blaser, 1999).
1.2.5.1 Motility
Campylobacter motility is important in the colonization process. It plays a 
major role from the early stages of the infection process. Indeed, the combinations of 
the flagella, which provide motility, and the cork-screw movement of the bacterium, 
together allow the bacterium to penetrate the intestinal barriers (Newell et al, 1985). 
One single flagellum, which is made up of two proteins FlaA and FlaB, is needed to
36
Chapter 1: Introduction
colonize the intestinal mucous layer of the gastrointestinal tract (Lee et al, 1986). 
This has been shown using non-motile mutants (JlaA) that have been shown to be 
not able to adhere or invade the cells (Wassenaar et al, 1994). The main function of 
the flagellum is to drive the bacterium through the viscous mucosa in the host 
intestinal epithelium (Larson et al, 2008).
Initially, the role of bacterial motility is to access to the host cell surface. Then 
the bacteria maintain adherence and secrete proteins which contribute to the 
infection. After adherence, the microorganism can interact, survive and replicate 
within the host epithelial cells (Larson et al, 2008). This is followed by the 
appearance of symptoms of the infection (Black et al, 1988). Furthermore, sensing 
mechanisms and chemotaxis control flagellar locomotion (Yao et al, 1997). Studies 
have revealed that the colonization of the human host with Campylobacter takes 
place in the small intestinal cells first and then the bacteria move to the large 
intestine (Black et al, 1988).
1.2.5.2 Chemotaxis
Chemotaxis is another essential factor for Campylobacter colonization. It is the 
phenomenon through which bacteria can detect chemical gradients and move 
towards or away from them (Takata et al, 1992). Campylobacter is strongly attracted 
towards various compounds such as mucins and L-fiieose. Muein is a glycoprotein 
and is considered to be the main component of the gastrointestinal mucus. This 
ehemotactic behaviour is an important factor in the affinity of Campylobacter for 
intestinal tract (Hugdahl et al, 1988). Takata et al in 1992 studied three non- 
chemotaetic mutants of Campylobacter and found that ehemotactic responses control 
the bacterial movement, and as these mutants did not colonise a gut model, that this 
process plays an important role in the gut colonization.
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The key protein of the ehemotactic responses was identified as cheY. It was found to 
be responsible for the non-adherent and non-invasive phenotypes in C. jejuni mutants 
and without it C. jejuni was not able to colonize or cause diseases in animals (Yao et 
al, 1997). Che Y  also was found to have a role in the flagellar motor switching of 
Cjejuni (Marchant et al, 2002) where it might interact with the flagellar motor and 
cause a rotation (Yao et al, 1997). In 1992 Takata et al, (1992) studied mutants 
that were able to swim but did not display chemoattraetion to chemicals or colonize 
the mouse gut suggesting that chemotaxis is an important factor in colonization. 
Moreover, other proteins such as CheB and CheR have been identified to be involved 
in Cjejuni chemotaxis (Hendrixson et al, 2001). Whilst they have been found to 
have significant influence in Cjejuni chemotaxis, they are not essential for this 
behaviour to occur (Kanungpean et al, 2011).
1.2.5.3 Adhesion and invasion
Another important feature in Campylobacter pathogenesis is the ability to bind 
to the host cells (Adhesion). Also it has the capability to cross the mucus layer of the 
intestinal epithelial cells and cause damage resulting in an inflammatory response 
(Wooldridge and Ketley, 1997). The bacteria can then translocate across the layers 
and invade the cells (Everest et al, 1992). Both adhesion and invasion are dependent 
on Campylobacter motility (Nachamkin et al, 1993). Campylobacter mutants with 
low motility showed a decrease in the adherence and lost the ability to invade (Yao et 
al, 1994).
Other C. jejuni surface structures that are involved in the adherence process 
include flagella and membrane proteins (Grant et al, 1993). The first step in C. 
jejuni colonisation is to adhere to the host cells (Wassenaar and Blaser, 1999). CadF, 
a C. jejuni outer-membrane protein, was identified by Konkel et al, (1997). It was
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reported as one of the proteins able to mediate binding to host eells (Patrone et al, 
2013) as it binds to the glycoprotein fibroneetin whieh promotes intercellular 
adherence in mammalian cells (Konkel et al, 1997). Studying the ability of wild type 
C. jejuni and cadF mutants to adhere to and invade INT-407 epithelial cells 
demonstrated the importance of CadF as a pathogenicity factor (Krause- 
Gruszczynska et al, 2007). Moreover, several other loci have been identified to 
cause a reduction in C. jejuni adhesion to host eells such as aspA, and aspB, (Novik 
et al, 2010).
Adhesion and invasion is a direct way to damage the function of the epithelial 
eells; however, another indirect way is by the production of toxins which normally 
happens after the direct adhesion to the host intestinal eells (Wooldridge and Ketley, 
1997).
1.2.5.4 Toxins production
Toxins are produced by Campylobacter spp.s and play an important role in 
their virulence. Several studies have detected the formation of toxins by 
Campylobacter and have reported the production of cytotoxins and enterotoxins 
(Wessenaar, 1997). However, the Cytolethal Distending toxin (CDT) was the only 
toxin confirmed when the Campylobacter jejuni genome was sequenced for the first 
time (Parkhill et al, 2000). It has been found in most but not all Campylobacter 
jejuni and coli strains and has been found to cause cell death in certain cell types 
such as Caco-2 and HeLa (Pickett et al, 1996). Among all strains studied by Everest 
et a l,{1992) Campylobacter jejuni cytotoxins were active against different cell lines 
(e.g. HeLa and Caeo-2).
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1.2.5.5 Oxidative stress
Campylobacter is sensitive to oxygen and grows microaerophilieally and 
therefore needs to deal with toxie oxygen and its reduction products (Park, 2002). 
The oxidative stress defence system in Campylobacter spp.s is important in the case 
of exposure to reactive oxygen species (ROS) during noimal aerobic metabolism, 
transmission, and in facing the host immune defence. ROS include all components 
formed from oxygen by the sequential one electron reduction of oxygen such as 
hydrogen peroxide (H2 O2) and hydroxyl radicals ( OH) (Imlay, 2003). This system, 
whieh protects Campylobacter from oxidative stress damage, is thought to consist of 
a number of enzymes and proteins including superoxide dismutase (SOD) and 
eatalase. The ability of single mutants {sodE) and (katA) to survive in oxidative 
conditions was lower than wild type and these mutants were unable to colonize chick 
animal model (Palyada et al, 2009). This highlights the need for appropriate 
protection from oxidising species for colonisation and infection.
1.2.6 Campylobacter Infection and symptoms
Campylobacter is known to be one of the major causes of acute diarrheal 
illnesses worldwide. Only 500 organisms are needed to cause the infection 
(Robinson, 1981). However, studies have found that higher doses (up to 10  ^cfii) did 
not increase the infection duration or even the severity (Black et al, 1988).
An infection by Campylobacter is often presents as symptoms of back pain, 
headache, fever, diarrhoea and abdominal cramps (Alios, 2001). These symptoms of 
gastrointestinal disturbances usually occur within 24 hours. The diarrhoea is 
inflammatory with severe cramps (Wooldridge and Ketley, 1997). An infected person 
usually experiences abdominal cramping pain that cannot be localized and 
sometimes mimics the pain of acute appendicitis. On the first day of symptoms, an
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individual may pass four to 20 stools (Butzler, 1984). The average amount of fluid 
lost during the infection period is approximately 0.5 L liquid of diarrhoea whieh is 
passed five times a day (Black et al., 1988). These are described as loose stools and 
nearly a quarter of those diarrheal episodes may contain blood. Fever usually persists 
for 24 to 48 hours. Symptoms are usually gone after 2 to 3 days but in some eases, 
the illness may be longer than usual (Mitchell, 2007) but generally not longer than 
one week (Butzler, 1984).
On certain occasions, infection with Campylobacter can lead to long term 
adverse conditions. Such conditions would include Guillain-Barre Syndrome (GBS) 
and irritable bowel syndrome (Wierzba et al, 2008).
Guillain-Barre Syndrome (GBS) has been reported as the most serious 
complication of Campylobacter infection (Butzler, 2004). An episode of 
Campylobacter infection has been found to precede GBS in around 40 % of GBS 
patients (McCarthy and Giesecke, 2001) and these patients showed symptoms of 
GBS after one to three weeks of the onset of symptoms due to Campylobacter 
infection (Butzler, 2004). The risk of developing GBS during the period of two to 
six months after Campylobacter infection is approximately 100 times higher than 
individuals without a preceding infection (McCarthy and Giesecke, 2001). In cases 
of Campylobacter-Wvk&d GBS the symptoms are severe and require hospital 
treatment (Butzler, 2004). As a disease, GBS attacks the nervous system and causes 
weakness and areflexia. Host factors such as human lymphocyte antigen type have a 
role in the pathogenesis of GBS following C. jejuni infection (McCarthy and 
Giesecke, 2001). All cases of GBS correlated with Campylobacter infection are very 
acute and intensive hospital care and treatments are required to avoid a severe long­
term disability (Rees et al, 1995 and Butzler, 2004).
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Reactive arthritis is also a common condition that occurs after Campylobacter 
infection wherein the adult population is the usual target (Hannu, 2002). Moreover, 
Uveitis (inflammation in the front or baek part of the eye) and Crohn's disease may 
also be experienced by an individual after Campylobacter infection (Lever, 1984).
However, in most cases of Campylobacter infection the infection appears as 
mild diarrhoea and problems rarely develop post-infeetion (Shwerer, 2002). The 
Campylobacter infection case-fatality rate is very low (0.05 per 1000 infections) 
(Alios, 2001). In addition, Calva et al, (1988) performed a surveillance study which 
included 179 children under 5 years and showed that infections not always 
symptomatic.
1.2.7 Treatment of Campylobacter infection
In 1977, Skirrow described Campylobacter enteritis as a new disease and since 
that time many studies have been carried out to determine how to treat this infection. 
In most cases the patient will recover after few days and antimicrobial therapy is not 
required in a mild infection (Butzler, 1984). However, antibiotics may be necessary 
in cases with bloody diarrhoea, fever andprolonged illness (longer than a week) or in 
pregnancy cases (Alios, 2001). Among the antibiotics that have been tested against 
Campylobacter some of them such as fluoroquinolones, tetracycline and 
erythromycin have shown to be useful (Blaser, 1997). Until recently 
fluoroquinolones were the antibiotic of choice in Campylobacter infection, even 
before the result of the stool culture was known, as nearly all other bacterial 
gastroenteritis causes are also susceptible to this antibiotic. However, bacterial 
resistance to this antibiotic has been observed in the United Kingdom after the 
indiscriminate use of fluoroquinolones in food animal treatments (Sam et al, 1999).
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The increase in the resistance to quinolone therapy in the 1990s led to the 
consideration that erythromycin could be the optimal choice. Resistance to this 
antibiotic occurs at lower rate amongst the antibiotics that have been used against 
Campylobacter (Skirrow and Blaser, 1995). However, the result of the study by 
Mandai et al, (1984) showed that using antibiotic therapy (erythromycin) four days 
after the onset of C. jejuni infection symptoms does not affect the normal length of 
the clinical course of the illness. Whereas using the antibiotic before the third day 
can slightly help in reducing the duration of pain. Worthy of note is that in the 
absence of antibiotic treatment, patient faeces could remain positive for 
Campylobacters for 2 to 7 weeks after the infection (Blaser, 1997).
1.2.8 Antibiotic Resistant Strains of Campylobacter
Over the past years, many studies have been conducted to establish the 
occurrence of antibiotic resistant strains of Campylobacter. A study conducted by 
Saenz et al, (2000) revealed that there is high level of resistance amongst 
Campylobacter strains found in pigs to antibiotics such as ampicillin, gentamicin, 
and amikacin. Another study revealed that resistance to fluoroquinolones is also 
prevalent and this was attributed to the intake of imported chicken (Gaunt and 
Piddoek, 1996).
The data reported between 1989 and 2011 in England and Wales showed an 
increase in the percentage of Campylobacter isolates from patients which were 
resistant to antibiotics including ampicillin, ciprofloxacin, nalidixic acid, tetracycline 
and erythromycin (Nichols et al, 2013). In the Albert et al, (2009) study, 40 % of 
Campylobacter isolates (43 of 85) were tetracycline resistant including 19 isolates 
that carried the resistance gene on a 35 kb plasmid.
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To control the development of more baeterial resistance amongst foodbome 
pathogens the use of active antibiotics in food animals needs international control 
(Alios, 2001). However, with the increase in antibiotic resistance amongst bacteria 
and the side effects associated with the use of antibiotics in humans, it is evident that 
natural antibacterial agents such as honey may have a future role in controlling 
infection and are likely to become the subject of much more research. Natural 
products are potentially good alternatives for use in controlling and combating 
Campylobacter contamination in food as well as Campylobaeteriosis in human. This 
thesis will explore a novel antibacterial property that has been found in honey after it 
is exposed to high temperatures.
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A im s
This study was designed to explore a novel antibacterial property 
found in diluted honey (after it has been exposed to high temperatures) and to 
expand upon preliminary findings made with Vibrio species that showed that 
honey was inhibitory, by extending the study to include Campylobacters for 
the first time. The specific objectives of this thesis are:
-To determine the susceptibility of Campylobacter jejuni to the antibacterial activity 
of different types of honey.
-To study factors that influence the production of the antimicrobial activity of heat 
treated honey.
- To characterize the interaction between honey and media components.
-To investigate whether using the agar-honey incorporation technique, (Dr Park 
personal comm.), generates a greater antibacterial efficacy of honey 
-To generate useful information to help identify the nature of these novel 
antimicrobial agents.
-To attempt to uncover the mode of action for these honey related antibacterial agents 
in Campylobacter jejuni.
- To examine the effect of these antibacterial agents in Campylobacter jejuni 
virulence.
-To determine the sensitivity of other pathogens including E. coli, Salmonella, L. 
monocytogenes, S. aureus and H. pylori to the same honey preparations.
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2.1 Bacteria
2.1.1 Bacterial strains
All bacterial strains used in the studies performed in this thesis are listed in the 
table below (Table 2.1). All baeterial strains were stored in the lyophilized state at - 
80 °C in Microbank® storage vials (Pro-Lab Diagnostics, Neston, U.K) until 
required. A number of different strains of Campylobacter {C.jejuni and C.coli) were 
used in the work described. However, for simplicity C. jejuni in this thesis always 
refers to C.yc/wm NCTC 11168 unless otherwise stated.
2.1.2 Microbiological media
Mueller-Hinton agar (MHA) and Mueller-Hinton broth (MHB) were 
purchased from Oxoid (Basingstoke, Hampshire, UK). Campylobacter Charcoal 
Differential Agar (CCDA) was used as the selective medium for growing 
Campylobacter species (Oxoid, Basingstoke, and Hampshire, UK). To support 
injured eells to recover after treatment Mueller-Hinton agar was supplemented with 5 
% sheep blood (TCS Bioseienee Ltd, Buckingham, UK). For baeterial selection, 
when it was considered necessary, the antibiotic was added to the media (kanamycin, 
50 pg ml'^). The maximum-reeovery diluent (MRD) was prepared using 0.1 % (w/v) 
bacteriological peptone (Oxoid) and 0.85 % (w/v) sodium chloride (Fisher Scientific 
Ltd, Leicestershire, UK).
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Bacteria Strain Source and references
Campylobacter jejuni 11168 NCTC
Campylobacter jejuni 11351 NCTC
Campylobacter jejuni 480 NCTC
Campylobacter coli 1 2 1 1 0 NCTC
Campylobacter coli 11437 NCTC
Campylobacter coli 11350 NCTC
tskatA mutant of 
Campylobacter jejuni
àkatA
Cjejuni
University of Surrey culture, laboratory 
stock (Grant and Park, 1995)
Escherichia coli (E.coli) 0157:H7
University of Surrey culture, laboratory 
stock
Salmonella typhimuriiim
USCC 2004 
Wild type
University of Surrey culture, laboratory 
stock
Listeria monocytogenes
5105 
Wild type
NCTC
Helicobacter pylori 11637 NCTC
Staphylococcus aureus Wild type
University of Surrey culture, laboratory 
stock
Methicillin-resistant 
Staphylococcus aureus
42517 Frimley Park Hospital
*NCTC: National collection o f  type cultures, Colindale, UK
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For the growth of the other aerobic microorganisms used in this thesis, (e.g. E. coli, 
S. typhimurium, L. monocytogenes and S. aureus) nutrient broth and nutrient agar 
(Oxoid, Basingstoke, and Hampshire, UK) were used. For growing H. pylori brain 
heart infusion agar and broth supplemented with 5 % foetal bovine serum (FBS) 
(Invitrogen Life Technologies Ltd, Paisley, UK) were used. All media used were 
prepared according to the manufacturer’s instructions Media were dissolved in 
Reverse Osmosis (RO) water and sterilized by autoelaving (Series 300, LTE 
Scientific Ltd, Greenfield, United Kingdom) at 121 °C for 15 minutes (refer to 
Appendices for further details on media used in this study).
2.1.3 Bacterial culture preparation
Campylobacter jejuni was routinely grown from frozen baeterial stock and grown on 
Mueller-Hinton (MH) (Oxoid) agar plates at 37 °C in a microaerophilie atmosphere 
containing 5 % O2 , 10 % CO2 , and 85 % N2 generated by the CampyGen gas 
generating system (Oxoid Ltd., UK) (standard conditions were used). Both growth 
curves and survival curves for C. jejuni NCTC 11168 were determined in Mueller- 
Hinton broth. In order to perform these experiments, one bead of C. jejuni was 
streaked onto MH agar plate then forty eight hour cultures of C. jejuni were sub­
cultured onto an MH agar plate and incubated microaerophilieally for another 48 
hours at 37 °C. Microorganisms were harvested by taking a full loop and transferred 
it to 25 ml of Mueller-Hinton broth and incubated at 37 °C under microaerophilie 
conditions with shaking at 120 rpm (InNova 2100 Orbital Platform Shaker, New 
Brunswick Scientific Co. Inc., USA). The optical density for this suspension was 
adjusted to 0.6 at 600 nm (ODeoo = 0.6 equivalent to 1 0  ^ CFU/ml confirmed by 
plating serial dilution on Mueller-Hinton agar). This suspension was used as the
49
Chapter 2: Materials and methods
inoculum to inoculate the growth medium in all growth and survival experiments. 
One milliliter of the adjusted suspension was then transferred to 99 ml of MH broth 
for the C. jejuni growth curve and survival experiment media. Plastic tissue culture 
flasks of 200 ml with screw-caps and ventilation (Sterile Nunclon surface. Thermo 
Scientific Ltd) were used in all experiments.
E. coli, S. typhimurium and L. monocytogenes were grown on nutrient agar 
(Oxoid) at 37 °C aerobically. After 24 hours, they were sub-cultured on nutrient agar 
plates then grown over night in nutrient broth and incubated aerobically at 37 °C for 
24 hours to reach 1*10^ CFU/ml (equivalent to ODaoo = 0.1). H. pylori was grown on 
brain heart infusion agar or broth both supplemented with 5 % foetal bovine serum 
(FBS) (Invitrogen Life Technologies Ltd, Paisley, UK) and incubated at 37 °C 
microaerophieally (5 % O2 , 10 % CO2 , and 85 % N2 generated by the CampyGen, 
Oxoid Ltd, UK). Suspensions of each bacterial culture were prepared as mentioned 
above to inoculate the medium. Mueller-Hinton agar and broth (MHA and MHB, 
respectively) were used to test the susceptibility of all baeterial strains to honey.
2.2 H oney sam ples and their preparation
All of the different samples of honey, whieh were used in this study, are 
presented in Table 2.2. For the series of experiments that were conducted honey 
samples were taken from the main honey container under aseptic conditions using a 
sterile syringe to minimise contamination. In discussing the experiments completed 
in this study, ‘honey’ always refers to honey (A) unless otherwise noted.
Honey samples were purchased from a local supermarket and stored at room 
temperature. According to the information provided by the suppliers of the honey (A) 
it was a pure and natural product derived from bees which complies fully with the 
Honey (England) Regulations 2003. As part of its processing, this particular honey
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type was strained using a 1 0 0 0  micron filter by the manufacturer to remove any bee 
parts such as wings or small particles of hive. The straining process retained all the 
natural components within the honey including pollen that the bees collect when 
feeding on nectar. Part of the processing of this type of honey was a heating step 
carried out at approximately 55 °C before packaging.
The honey was sterilised in different ways prior to testing. In the preliminary 
studies honey was diluted in MH broth then filtered using a 0.22 pm filter unit 
(Millex®-GP, Millipore crop, Ireland). Honey was also autoclaved before being 
added to the pre-autoclaved Mueller-Hinton (MH) medium. In a number of 
experiments honey was added to Mueller Hinton medium and then the complete 
medium (with honey included) was autoclaved.
Table 2.2: Honey samples.
Sample Honey Sources
A Clear honey
Low cost honey, approximately 20 p/100 ml, 
supermarket brand honey, UK
B Pure natural honey
Low cost honey, approximately 90p/100 ml, 
commercial brand honey, UK
C Clear honey
Low cost honey, approximately 60p/100ml 
commercial brand honey, Saudi Arabia
D Pure natural honey Low cost honey, approximately 90p/100ml 
commercial brand honey, Saudi Arabia
E Manuka honey(Active 
15+)
High cost honey, approximately £3.91/100ml, 
commercial brand honey, New Zealand
F
Manuka and Re ware wa 
(50:50) MGO 30+
High cost honey, approximately £2/100ml, 
commercial brand honey. New Zealand
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2.3 A rtificial honey preparation
Artificial honey was prepared as described in White (1979). The artificial honey or 
carbohydrate solution contained 40 % (w/v) D-fructose, 30 % (w/v) D-glucose, 8  % 
(w/v) maltose, 2 % (w/v) sucrose (laboratory grade, all supplied by Sigma-Aldrieh 
with purity >99 %) and 20 % (w/v) water were mixed for one hour at 80 °C in a 
water bath to aid dissolving.
2.4 D eterm ination o f  M inim um  Inhibitory C oncentrations (M IC s) o f  
honey
The minimum inhibitory concentrations (MICs) of honey were determined 
using the agar dilution method. Honey samples were diluted in distilled water across 
a final concentration range of 0.1 % to 10 % then added to Mueller Hinton agar. The 
MH-honey agar plates were inoculated with C. jejuni and incubated in a 
microaerophilie atmosphere for 48 hours then visually examined for evidence of 
growth (colonies). MICs were recorded as the lowest concentration inhibiting visible 
growth of the microorganism.
MICs were also determined by using broth dilution methods. Honey was added 
to Mueller Hinton broth in the same range as previously indicated then the broth was 
incubated at 37 °C in a microaerophilie atmosphere generated by CampyGen (5 % 
O2 , 10 % CO2 , and 85 % N2) with shaking at 1 2 0  rpm. (InNova 2100 Orbital 
Platform Shaker, New Brunswick Scientific Co. Inc., USA). After 48 hours of 
incubation the visual appearance and optical density (CD) was observed. CD was 
measured using spectrophotometry (Helios Alpha, Thermo Fisher Scientific Ltd, UK) 
at a wavelength of 600 nm. Before inoculating with the bacteria, the whole media
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(including honey) was used as a blank to minimise the effect of honey colour on 
absorption. All experiments were done in triplicate.
2.5 G row th and survival o f  Campylobacter jejuni in the presence o f  
honey
The growth of C. jejuni in the presence of honey was measured by adding 1% 
and 2 % (v/v) of honey prepared in a number of ways (Filtered honey, autoclaved 
honey with MH broth and autoclaved honey alone) to the growth medium under 
standard conditions. Ninety-nine milliliters of MH broth placed in a tissue culture 
flasks with a vented cap, and containing 1 % or 2  % of honey, was inoculated with 1 
ml of C. jejuni suspension (ODôoo =  0.6). The growth culture was then incubated at 
37 °C on a shaking platform at 120 rpm for 102 hours under microaerophilie 
conditions (5 % O2 , 10 % CO2 , and 85 % N2 ). Samples of one milliliter were taken 
regularly over a period of five days at the zero time, after 3 and after 6  hours of each 
day to measure the growth of C. jejuni directly by measuring the optical density 
(OD) or by viable-cell counting.
Similar method to the mentioned above was used to establish the rate of 
survival of C. jejuni in the presence of 1% and 2% of honey except that the cultures 
were incubated under normal conditions, that is at room temperature (25 °C) and in 
an aerobic atmosphere, and then this growth was followed using counting colony- 
forming unit (CFU).
2.5.1 Optical density (OD) determination
The growth rates of C. jejuni were determined spectrophotometrically by measuring 
the change in OD at 600 nm of cell suspensions (Spectrophotometer Helios Alpha, 
Thermo Fisher Scientific, UK). One milliliter of each sample was taken regularly and
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the OD was measured against the same medium before baeterial inoculation.
2.5.2 Viable-cell counts
The growth of C. jejuni was determined by measuring the number of eolony 
forming units (CFU). Samples of 1 ml aliquots were taken and serial dilutions were 
prepared in maximum-reeovery diluent (MRD) then 100 pi (20 pi x 5 ) volumes were 
pipetted onto MHA plates (using the Miles and Misra technique). The plates were 
then incubated mieroaerophilically for 48 hours. After the incubation time countable 
plates with 30 - 300 CFU per/plate were all counted. Each plate's CFU count was 
used to estimate the original number of bacteria and each dilution was plated in 
triplicate.
2.6 M easurem ent o f pH
A pH meter (Thermo Orion, model 410A, Cole-Parmer Instrument Co. Ltd. 
UK) was used to measure the pH values at room temperature. Calibration buffers in 
the range 4-7 were used. However, the desired pH of the medium for C. jejuni 
growth was adjusted by adding hydrochloric acid ( IN  HCl) or sodium hydroxide (1 
N NaOH) to the media.
2.7 M easurem ent o f  the brow n pigm ents and absorbance o f  honey  
sam ples
The absorbance of the solutions was measured as described by Jing and Kitts, 
(2004) with some modifications using a spectrophotometer (Spectrophotometer 
Helios Alpha, Thermo). Samples with honey were diluted (1:100 v/v) with distilled 
water and then, measured for absorbance value at 420 nm. The change in the colour 
of the media (MH broth) after adding different concentrations of honey was also 
measured directly without dilution.
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2.8 H oney-casein M aillard reaction products (M R Ps)
2.8.1 Preparation of Maillard reaction products (honey-casein MRPs)
The honey-easein model system was prepared as reported by Jing and Kitts 
(2002) with some modifications. Casein hydrolysate 2.0 g (Oxoid, Basingstoke, 
Hampshire, UK) and 2.0g of honey A were dissolved in distilled water (dH2 0 ) and 
adjusted to pH 7 with 1.0 M NaOH and 1.0 M HCl solution. The solution was heated 
at 121 °C for 15 minutes in an autoclave (Series 300, LTE Scientific, UK). This 
autoclaved honey-easein mixture was termed as Maillard reaction products (MRPs) 
and used in all experiments. All samples were stored at 4 °C prior to use. For some 
experiments (using cell culture), the samples were freeze-dried so that they could be 
dissolved at an appropriate concentration when needed and were stored at -20 °C.
2.8.2 Comparison of the growth and the survival of Campylobacter jejuni 
in the presence of honey-MH broth and honey-casein MRPs
C. jejuni growth was assessed in the presence of honey-MH broth and honey- 
casein MRPs. Ninety-nine millilitres of MH broth, MH broth with 2 % (v/v) honey 
(autoclaved together) or MH broth with 2% honey-casein MRPs were each 
inoculated with 1 ml of C. jejuni suspension (ODeoo^ 0.6). The growth culture was 
then incubated at 37 °C on a shaking platform at 120 rpm (InNova 2100 Orbital 
Platform Shaker, New Brunswick Scientific Co,Inc, USA) for 102 hours under 
microaerophilie conditions as mentioned before (see section 2.1.3). Samples ofl ml 
were taken regularly to measure the growth of C. jejuni by measuring the optical 
density (OD) and eolony forming units (CFU) as mentioned in section 2.5.1 and 
2.5.2. In the C. jejuni survival experiments, flasks were prepared as detailed above, 
however, aerobic conditions and room temperature (25 °C) were used for incubation.
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2.8.3 Effect of different temperatures on the production of the 
antibacterial agents present in honey-casein MRPs
To study the effect of heating temperature, honey-casein samples were 
prepared in triplicate as mentioned in section 2.9.1 (casein-honey, at a ratio 1:1) then 
placed in a water bath (Grant instruments, Cambridge, UK) for the similar length of 
time, approximately 15 minutes as that used in the autoelaving process. The 
antibacterial activity of the heated samples, at 80°C, 100°C (water bath) and 121 °C 
(autoclave) were tested against C. jejuni.
2.8.4 Effect of time on the production of antibacterial agents
For prolonged heating at a lower temperature the casein honey mixture was 
placed in a water bath at 55 °C for five days according to the method used by Jing 
and Kitts (2002). Three samples were taken at intervals (each 24 hours) and placed in 
an ice bath to stop further reaction and were then stored at 4 °C prior to antibacterial 
testing and HPLC analysis.
2.8.5 Effect of the type of sugar on the production of the antibacterial 
agents
The mixture was prepared (as in section 2.9.1) the honey was replaced with 
glucose, fructose or artificial honey as prepared in section 2.3 to test the effect of the 
types of sugar on the production of sugar-easein MRPs antibacterial activity.
2.8.6 Effect of amino acid on the production of the antibacterial agents
To assess the effect of different single amino acids on the production of 
antibacterial agents, honey was mixed with one casein amino acid individually (see
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Table 2.3) in two different approaches. These were:
1) At a concentration that related to their relative percentage in casein
2) At a concentration that was the same for each amino acid in terms of weight.
2.8.7 Ultrafiltration of the honey-easein MRPs
According to the method described by Gu et al, (2009) water-soluble MRPs 
could be separated by molecular weights cut off membrane (size <2000 and <5000) 
(Vivaspin, Satorius stedim, UK) and divided into three fractions:
1- Low molecular weight fraction of <2000 Da (LMW)
2- Intermediate molecular weight fraction (IMW) of between 2000 -5000 Da
3- High molecular weights fraction (HMW) of 5000 Da and higher.
The filtration apparatus was filled with 10 ml of the mixture then centrifuged 
at 10000 g  for 30 minutes, and the resulting supernatants were transferred to another 
filter with a higher molecular weight cut off membrane. Each fraction was collected 
and freeze-dried and then stored at 4 °C until used.
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Table 2.3: Amino acid composition of casein
No Amino acid Abbreviations
Ratio in casein
% w/w*
Supplier
1 Alanine (>98%) Ala 1.73 Sigma
2 Arginine (>98%) Arg 1 . 6 6 Sigma
3 Aspartie aeid (>98%) Asp 4.06 Sigma
4 Cysetine (>98%) Cys 0.9 Sigma
5 Glutamic acid (>98%) Glu 13.34 Sigma
6 Glycine (>98%) Gly 1.14 Sigma
7 Isoleueine (>98%) He 1.84 Sigma
8 Leueine (>98%) Leu 3.33 Sigma
9 Lysine (>98%) Lys 3.72 Sigma
1 0 Methionine (>98%) Met 1.37 Sigma
1 1 Phenylalanine (>98%) Phe 2.28 Sigma
1 2 Proline (>99%) Pro 5.56 Sigma
13 Serine (>99%) Ser 1.03 Sigma
14 Threonine (>98%) Thr 1.44 Sigma
15 Tryptophan (>98%) Try 0 . 1 Sigma
16 Tyrosine (>98%) Tys 1.57 Sigma
17 Valine (>98%) Val 3.38 Sigma
* From casein hydrolysate manufacture table of ana ysis (Oxoid Limited, Basingstoke,
Hampshire, UK)).
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2.8.8 Effect of the eatalase removal of H 2O2 on the antibacterial activity of 
honey-casein MRPs
To determine whether hydrogen peroxide (H2 O2) eontributed to the 
antibaeterial agents in MRPs, a stoek solution of eatalase was made by dissolving 
eatalase from bovine liver (Sigma) in water to a concentration of 10000 units/ ml. 
This was sterilised using 0.22 pm filter unit (Millex®-GP, Millipore crop, Ireland) 
and added to the MRPs at a final eoneentration 5000 units/ml then ineubated at 37 °C 
for 24 hours. The mixture was then added to MH broth and tested against Cjejuni.
2.8.9 Determination of reducing sugar (Glucose) in honey and honey- 
casein MRPs
Glucose in the samples was determined by enzymatie Assay using ILab 650 
(Instrumentation Laboratory, UK). A 1 ml aliquot was added from each sample and 
the absorbance was measured at 510 nm. The assay used is based on a eolourimetric 
measurement aceording to the reactions below. The first step was to oxidise the 
glueose using glucose oxidase and produee hydrogen peroxide (H2 O2). This H2O2  
then produces Quinoneimine dye (red dye) when it reacts with 4-Aminoantipyrine in 
the seeond step of the reaction. The resulting dye was measured eolorimetrieally. The 
absorbance measurements were taken at a primary wavelength of 510 nm and a 
blanking wavelength of 600 nm.
Glucose oxidase
Glucose + O2 + H2O I — glueonic acid + H2O2
2 H2 O2 + 4 amino antipyrine + phenol quinoneimine dye (red) +4 H2 O
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2.9 D eterm ination o f honey-casein M R Ps antibacterial activity
2.9.1 Assessing the antibacterial activity of honey-casein MRPs against 
Campylobacter jejuni in vitro
2.9.1.1 Disc diffusion method
Disc diffusion is one of the most widely used methods to test antimicrobial 
susceptibility. In the current study discs were used to determine the antibacterial 
activity of honey-casein MRPs. Also, more samples were prepared to test the effect 
of a single amino aeid on the production of antibaeterial agents. All samples were 
prepared using the same amount of honey ( 2  % v/v) and amino acids were added in 
two different amounts. The first experiment was carried out by mixing honey with 
amino acids according to their ratio in casein in water and autoclaved. The other 
experiment used involved mixing honey and equal amounts, 65mg, of each amino 
aeid. Whatman blank 6 mm susceptibility filter discs (Whatman, Maidstone, U.K.) 
were impregnated with 30 pi of each mixture and left to dry forlO minutes at room 
temperature. A growth suspension of Campylobacter jejuni was prepared from an 
overnight culture as mention in section 2.1.3. Dried MH agar plates were inoculated 
with C. jejuni by swabbing and then the discs were applied to the plates. The plates 
were ineubated microaerophilieally for 48 hours then the diameters of zones of 
inhibition were measured. The experiment was repeated three times on different 
occasions.
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2.9.1.2 The effect of honey-casein MRPs on the growth and survival of 
Campylobacter jejuni in milk
Milk was used to test the activity of the MRPs in food against Campylobacter 
jejuni. Two milk samples, A and B, were purchased from a local supermarket. Both A 
and B were low fat and ultra-high-temperature (UHT) treated samples of milk. An 
overnight culture of Campylobacter jejuni was prepared as in the previous 
experiments (see section 2.1.3). Samples of 99ml of milk with or without 2 % (v/v) 
honey-casein MRPs was inoculated with 1 ml of a Campylobacter jejuni suspension 
(OD6oo=0.6). The samples were incubated microaerophilically in shaking platform at 
120 rpm for 102 hours at 37 °C to study the effect on growth. For the survival studies 
samples were incubated aerobically at 25 °C for the same duration of time. C.jejuni 
growth and survival were assessed by taking samples at regular time and measuring 
the number of colony forming units (CPU) on MH agar supplemented with 5 % (v/v) 
sheep blood (TCS Bioscience Ltd, Buckingham, UK) as mention in section 2.5.2.
2.9.1.3 Eclipse-100 Antimicrobial assay
An antimicrobial assay was also performed using ready-to-use test 
(Eclipse®-100, Trafalgar Scientific, UK) as described by Rufian-Henares and 
Morales, (2006). The test is performed in a 96-well plate. Each well contains agar 
medium spread with Geobacillus stearothermophilus. The incubation at 65 °C helps 
the spores germinate and the cells grow and produce acid which changes the pH and 
the colour of the agar from blue (purple) to yellowish. When the milk samples 
contain inhibitors at higher concentrations than the detection limit, microorganisms 
will not grow and no change in colour is observed. Honey-casein MRPs were 
reconstituted with distilled water at concentrations of 2%, 5% and 10 %. Samples of
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100 |xl were added to each well and they were allowed to diffuse for one hour. The 
wells were washed four times with distilled water. The plate was incubated for 2.5 
hours at 65 °C in a water bath (Grant Instruments, Cambridge, UK) and the final 
absorbance of each well was read at 600 nm. Distilled water and penicillin (3 pg/1) 
was used as a negative control and a positive control, respectively.
2.9.2 Assessing the antibacterial activity of honey-casein MRPs against 
Campylobacter jejuni in vivo (Galleria mellonella killing assays)
Recently, animal models have been used to evaluate the effect of new 
antimicrobial agents in vivo. The animal models have a similar immune system to a 
mammal’s innate immune system. Moreover, microbes often use factors relating to 
virulence and pathogenicity that are identical to those used in human infection 
(Desbois & Coote, 2012). Wax Moth larva {Galleria mellonella) is one of the widely 
used animal models. It is susceptible to pathogenic infection and has been used as an 
alternative infection model to human beings over a range of different bacterial 
pathogens including Campylobacter (Champion, et al, 2010). In this experiment we 
assessed the antibacterial effect of honey-casein MRPs in vivo using Wax Moth larva 
{Galleria mellonella). The C. jejuni NCTCI1168 inoculum, which was used in the 
infection, was prepared in the same way as mentioned previously. Bacteria were 
cultured on Mueller-Hinton (MH) agar under microaerophilic conditions (5% 
oxygen, 10 % carbon dioxide and 85 % nitrogen) at 37 °C for a period of 48 hours. 
Then bacteria were then harvested from the plates into I ml of phosphate-buffered 
saline (PBS) and optical density (OD) was adjusted at 590 nm to an OD590 of 1.0. 
The dose (1x10^ CPU) was confirmed by serially diluting and plating onto MH agar. 
G. mellonella larvae (Wiggly Wigglers, Herefordshire, UK) were maintained on
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wood chips at 15 °C prior to the experiment. G. mellonella larvae were randomly 
assigned and grouped then infected with C. jejuni in the absence and the presence of 
2% and 5 % honey-casein MRPs in a 10 pi inoculum base using Hamilton 
microinjection syringe (Hamilton, US) in the upper right foreleg. The larvae were 
incubated at 37 °C and survival and appearance were recorded after 24 hours. Ten G. 
mellonella larvae were infected in each group and both PBS and uninjected larvae 
were used as controls.
2.10 BacWghi staining for bacterial viability
The RacLight staining methods (LIVE/DEAD RrrcLight viability kit for 
microscopy (Invitrogen Ltd, UK) was used according to the kit protocol. Syto 9 was 
mixed with propidium iodide at a ratio of 1:2 then 3 pi of the mixture was added to 1 
ml of the bacterial culture, and was incubated for 15 minutes in the dark at room 
temperature. Five microliters of jBacLight-stained C. jejuni cells were immobilized 
and applied to the microscope glass slide then a coverslip was placed over the 
suspension. The slides were examined by fluorescence microscope.
2.11 Transm ission electron m icroscope (TEM ) culture preparation
C. jejuni cultures in 25ml of MH broth, both control and treated samples were 
centrifuged at 4000 rpm (Allegra X-12 Centrifuge, Beckman Coulter) for 10 minutes 
to separate the cells pellets. The pellets were resuspended in 500 pi PBS. A drop of 
the suspension was placed on a wax sheet. Formvar/Carbon Coated - Copper 200 
mesh grids were used and C.jejuni were absorbed onto the grid for 10 minutes and 
then allowed to air dry. Grids were then blotted dry and placed onto a drop of 2 %
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(v/v) phosphotungstic acid negative stain for 15 seconds. Grids were carefully 
blotted dry and viewed using the normal magnification (800X) at a Philips CM 10 
Transmission Electron Microscope and photos were taken in one or two seconds.
2.12 C onfirm ation o f  loss o f  Campylobacter jejuni culturability
To assess whether the non-culturable forms of C. jejuni generated after 
treating C. jejuni with honey-casein MRPs were reversible or not, the treated culture 
was centrifuged at 37 °C and 1000 rpm (Allegra X-12 Centrifiige, Beckman Coulter) 
and the bacterial pellet was transfered to new MH broth supplemented with 5 % (v/v) 
sheep blood (TCS Bioscience Ltd, Buckingham, UK). The culture was then 
incubated at 37 °C in a microaerophilic atmosphere for five days. The viable count of 
the samples was recorded regularly (every 24 hours). Samples were also plated on 
MH agar supplemented with 5 % (v/v) sheep blood (BMHA) and the CPU was 
determined as previously mention in section 2.5.2. The experiment was done in 
duplicate.
2.13 A ssessing the growth o f  other pathogens in the presence o f  
honey-casein M RPs
The growth of other pathogens was assessed in comparison with 
Campylobacter. This included E. coli. Salmonella typhimurium, Listeria 
monocytogenes, Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus 
(MRSA) and Helicobacter pylori. All bacterial inoculum were prepared from 
overnight cultures as mentioned in section 2.1.3. The antibacterial activity of honey 
mixture was assessed in MH broth. A 99 ml sample of MH broth with 2%, 5% or 10 
% (v/v) honey or honey-casein MRPs was inoculated with 1 ml of bacterial 
suspension. The growth culture was then incubated at 37 °C under aerobic conditions
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for 24 hours. Samples of 1 ml were taken regularly to measure the growth by 
measuring the optical density (OD) and colony forming units (CPU) as mentioned in 
section 2.5.1 and 2.5.2 respectively. For growing Helicobacter pylori, which showed 
poor growth in MH broth, the MH broth was supplemented with 5% foetal bovine 
serum (PBS) to support the growth and incubated at 37 °C for 72 hours under 
microaerophilic conditions generated by CampyGen (5 % O2 , 10 % CO2 , and 85 % 
N2) with shaking at 120 rpm(lnNova 2100 Orbital Platform Shaker, New Brunswick 
Scientific Co.lnc., USA).
2.14 H oney-casein M R Ps toxicity tests
The toxicity of honey-casein MRPs was determined by two methods. These 
are described in the sections below.
2.14.1 Cell growth inhibition assay
Human colonic carcinoma cell line (Caco-2) cells were purchased from 
Sigma-Aldrich, (Poole, UK). Cells were grown in Dulbecco's Modified Eagle’s 
Medium (DMEM) (Sigma-Aldrich, UK) supplemented with 10 % heat inactivated 
foetal bovine serum (PBS) (Invitrogen Life Technologies Ltd, Paisley, UK), 1 % 
(w/v) L-glutamine (Gibco Life Technologies), 1 % (w/v) non-essential amino acids 
(NEAA) and 1 % (w/v) Pen-Strep (5000 units/ml Penicillin +5000ug/ml 
Streptomycin) (Gibco Life Technologies). The cells were maintained at 37 °C in a 5 
% CO2 and 90 % humidity incubator. All experiments were performed with cells 
between passage 43 and 50. When flasks (Cell Culture Flask, 75 cm^. Vent Cap, 
Thomas Scientific. UK) reached confluence then the cells were released from the 
flask by trypsin (Trypsin-EDTA 0.5%, Sigma-Aldrich, UK) and plated in 96-well 
plates at a density of 7.5 x 1 0  ^with the DMEM 10 and maintained for 24 hours to 
allow cell attachment. The cell culture medium was then changed and replaced with
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DMEM 10 medium with different concentration of MRPs, namely 0%, 1%, 2% and 
5% (w/v). The cells were incubated with treatment for three hours. After that, the 
culture medium was replaced with DMEM 10, and the cells were incubated for a 
further three days before cells viability was assessed used an MTT test according to 
Mosmann (1983) method. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyltetrazolium bromide) (Sigma-Aldrich, UK) is a yellow tetrazole which is 
converted to an insoluble purple formazan dye by living cells. MTT solution was 
added to each well at a concentration of 0.5 mg/ml in DMEM and incubated for four 
hours at 37 °C. The media were then replaced with dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich, UK) as a solubilisation solution to dissolve the insoluble purple 
formazan. The absorbance of the solution was measured at 590 nm by a 
spectrophotometer (VICTOR 3 Multi label Plate Reader, PerkinElmer, UK) and the 
cells MTT response (% control) was calculated using this equation:
% Control = (absorbance treatment / absorbance control) ^ 100%
2.14.2 .Galleria mellonella killing assays.
G.mellonella also been used to test the toxicity of new drugs (Desbois & 
Coote, 2012). Different concentrations of the MRPs mixture at 0%, 1%, 2% and 5 % 
w/v were prepared in phosphate-buffered saline (PBS). G. mellonella larvae (Wiggly 
Wigglers, Herefordshire, UK) were maintained on wood chips at 15 °C until 
treatment. G. mellonella larvae were injected with 10 pi of each concentration by 
Hamilton microinjection in the upper right foreleg. The larvae were incubated at 
37°C and survival and appearance were recorded after 24 hours. There were ten G. 
mellonella larvae in each group and both PBS and uninjected samples were used as 
controls.
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2.15 Campylobacter jejuni adhesion assays
To determine whether honey-casein MRPs can also affect the ability of 
Campylobacter jejuni to adhere to the epithelium cells, binding assay was performed 
using Human colonic carcinoma (Caco-2) according to the following method:
2.15.1 Bacterial culture
Campylobacter jejuni NCTC 11168 were grown on Mueller Hinton agar for 
48 hours under microaerophilic conditions and then harvested in Mueller Hinton 
broth and incubated overnight. The suspension was centrifuged then the pellet was 
re-suspended in phosphate buffered saline (PBS) with a density of 1x10^ bacteria per 
ml. The number of bacteria was further confirmed by viability counts and PBS serial 
dilution on MHA and Colombia blood agar (CBA) plates before and after incubation.
2-15.2 Cell line
Human colonic carcinoma (Caco-2) cells were obtained from Sigma Aldrich, 
U.K. (Passage 43-50). Dulbecco's minimum essential medium (DMEM)(Sigma)were 
used to grow and maintain the Cells supplemented with 10 % foetal bovine serum, 5 
% L-glutamine and 5 % non-essential amino acids. The cells were seeded into 24- 
well tissue culture plates (Thermo Fisher Scientific) at a density of 7 x 10  ^cells per 
well and incubated at 37°C with 5% CO2 for 72 hours until becoming confluent as 
monolayers. The cells were then washed twice with Hanks-HEPES buffer. Cells 
were infected with bacteria at 100 pi bacterial inoculum to 900 pi of DMEM culture 
medium per well in the presence and absence of 2% honey-casein MRPs. The 
DMEM media with 2 % honey-casein MRPs was added at the same time as the 
infection or one hour after the cells were infected with Campylobacter jejuni. After 
three hours of incubation the cells were washed twice with PBS then the bacteria 
were then released from the cells by 100 pi of 1 % (v/v) Triton X-100 in PBS with
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magnetic follower stirring at 60 rpm. The suspensions were then serially diluted with 
PBS and plated on Colombia blood agar (CBA)(Oxoid) supplemented with 5% sheep 
blood (TCS Bioscience Ltd, Buckingham, UK). The plates were incubated at 37 °C 
for 48 hours in a microaerophilic atmosphere containing 5 % O2 , 1 0  % CO2 , and 85 
% N2 generated by the CampyGen (Oxoid Ltd, UK) then the number of colony 
forming units (CPU) were measured as mentioned in section 2.5.2 .
2.16 G entam icin killing assay
Gentamicin killing assay was used to measure the effect of the presence of 
honey-casein MRPs in the number of intracellular bacteria. The antibiotic can kill the 
extracellular bacteria without affecting the bacteria which has already penetrated the 
eukaryotic cells (Elsighorst, 1994). Campylobacter jejuni inoculum was prepared and 
the cells were infected as mention in the adhesion assays (section 2.16.1 and 2.16.2). 
After the three hours of incubation with and without 2 % honey-casein MRPs, the 
cells were washed twice with PBS to remove non-adherent bacteria. Gentamicin (100 
pg/ml) was added with the media to the infected cells. The cells were incubated 
further for three hours then washed in PBS. To release the intracellular bacteria, 100 
pi PBS with 0.1 % Triton X-100 was added to the cells and incubated for 15 minutes 
at 37°C in a shaking station at 40 rpm. Dilutions were prepared from each well in 
PBS (up to 10"^ ) then plated on CBA plates and incubated at 37°C for 48 hours in a 
microaerophilic atmosphere. The recovered cells were counted and expressed as a 
percentage of the inoculum.
2.17 H igh-perform ance liquid chrom atography (H PLC) analysis
The separations of MRPs using HPLC follow Ames et al, (1997) method
with some modification. Ten microliters of MRPs or other samples were added to
990 pi of water at ratio of 1:100 pf MRPs to water; (v/v) then all samples were
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filtered through a syringe filter (0.45 pm) before analysis. HPLC analysis was 
performed using an UltiMate® 3000 system, Dionex (Thermo Scientific, UK). The 
column used in the separations was an Ultracarb 5 pm ODS (30) high carbon loaded 
reverse-phase column (150 mm x 4.6 mm) (Phenomenex, USA) fitted with a guard 
column packed with the same phase heatedat 30 °C. Solvent A was water which was 
purified using a Milli-Q water purification system (Millipore, Billerica, MA). 
Solvent B was acetonitrile (HPLC grade, 99.93 %, Sigma-Aldrich). The column was 
equilibrated in 100 % water and 0 % acetonitrile. The gradient profile was obtained 
by increasing a linear gradient up to 30 % acetonitrile over45 minutes in a flow rate 
of 0.5 ml/min with a 20pl injection volume. The analysis was monitored at 280nm 
and 420 nm.
2.18 D etection o f  a-d icarbonyl com pounds (m ethylglyoxal)
To confirm the presence of a-dicarbonyl compounds such as methylglyoxal, 
orthophenylendiamin (OPD) method was used according to Mavric et al, 2008. The 
compounds were identified as the quinoxalines generated after derivatization with 
orthophenylendiamin (OPD). Methylglyoxal (40% in water, Sigma-Aldrich) was 
used as standard. One milliliter of honey-casein MRPs (15% in 0.5 M sodium 
phosphate) was mixed with 0.6 milliliter Of orthophenylendiamin(OPD) (1% in 0.5 
M sodium phosphate). The mixture was incubated in the dark for twelve hours then 
filtered through 0.45pl filter (Millex®-GP, Millipore crop, Ireland) and 20 pi were 
used in the analysis. HPLC was used with column C l 8  (250mm x 4 . 6  mm x 5  pm), 
solvent A was 0.15% acetic acid (Sigma-Aldrich) in water and solvent B was 80% 
methanol and 20% solvent A. the analysis started with 20% solvent B over two 
minutes then followed by linear increase to 40% over 20 minutes then to 100% over
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15 minutes. This followed with an elution with solvent B (100%) for five minutes 
then 2 0 % for seven minutes, the peak was detected at 312 nm.
2.19 Statistical analysis
All the results are expressed as the mean of triplicate independent experiments ± the 
standard deviation. In comparison study, the significant differences (p <0.05) were 
calculated using one-way analysis of variance (ANOVA), Dunnett's test or /-test by 
GraphPad prism Software.
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3.1 The effect o f  honey on Campylobacter jejuni
3.1.1 Determining the minimum inhibitory concentration (MIC)
The initial experiment in this study was conducted to determine the minimum 
inhibitory concentrations (MICs) of honey samples against Campylobacter jejuni 
NCTC 11168. Visible growth was observed after incubation on either MH agar or in 
MH broth after incubation for 48 hours in a microaerophilic atmosphere at 37 °C. A 
control with MH agar or broth with no honey was used in each experiment to 
confirm the normal viability and growth of the C. jejuni culture. When the honey was 
sterilized by filtration and then added to the sterilized MH agar the MICs ranged 
from 2 % up to 10 % for the five varieties of honey used. Manuka and Rewarewa 
50:50 (honey F) showed the greatest activity with a MIC of 2 % (v/v) followed by 
Manuka (honey E) and pure honey (honey B) with a MIC 4 % (v/v).The MIC for 
clear honey (honey A) was 5 % and the lowest activity was clear honey (C) with 
MIC 10 % (Table 3.1).
When the honey was sterilized by autoclaving it separately from MH 
medium, and then subsequently adding it to the medium, the antibacterial activity of 
most of the honey varieties increased slightly except for honey B and C (clear honey) 
which remained unchanged, and for honey F (manuka and rewarewa 50:50) in which 
case the activity was sensitive to heat (Table 3.2). When honey was present in the 
medium during the autoclaving process the inhibitory effect increased dramatically 
for all samples and the MIC decreased to 2 % regardless of the honey type (Table 
3.3). To determine whether this generation of antibacterial activity extended to other 
strains of Campylobacter these experiments were repeated using a panel of
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representative strains (Table 3.5). The growth of all strains was prevented by 2 % 
(v/v) honey when the honey was autoclaved with MH agar but not when it was 
autoclaved separately or filter sterilised. MICs were also determined by broth 
dilution. The visual inspection and spectrophotometric measurement of growth using 
the optical density at 600 nm gave similar results. The concentrations of each honey 
which inhibited the visible growth of C.jejuni are presented in Table 3.4. Moreover, 
more Campylobacter strains were examined and this confirmed the antibacterial 
activity (Table 3.5).
Table 3.1: Minimum inhibitory concentrations (MICs) of different honeys when they 
were sterilized by filtration.
Honey
Honey concentration (v/v)
0% 0.1 % 1 % 2% 3% 4% 5% 10%
A +++ +++ +++ ++ ++ +
B +++ +++ +++ ++ +
C +++ +++ +++ +++ +++ +++ +++
D +++ +++ +++ +++ ++ +
E +++ +++ ++ ++ +
F +++ ++ +
— — — — —
Mueller-Hinton Agar plates were prepared with different concentrations of honey 
and were incubated for 48 hours at 37°C in a microaerobic atmosphere then the 
colony growth assessed: (+++) Excellent growth; (++) good growth; (+) poor 
growth; (-) no growth. The honeys used were A, Clear honey , B, pure natural honey, 
C, clear honey, D, pure natural honey, E, Manuka honey and F, Manuka active 15+ 
and Rewarewa honey (50:50).
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Table 3.2: Minimum inhibitory concentrations (MICs) of varieties of honey when 
they were sterilized by autoclaving separately from the medium.
Honey
? Honey concentration (v/v)
0% 0.1 % 1 % 2% 3% 4% 5% 10%
A +++ +++ +++ ++ ++
B +++ +++ +++ ++ +
C +++ +++ +++ +++ +++ +++ +++
D +++ +++ +++ +++ ++
E +++ +++ ++ ++ +
F + ^ ++ ++ ++ + _
Mueller-Hinton Agar plates were prepared with different concentrations of 
autoclaved honey and incubated for 48 hours at 37°C in a microaerobic atmosphere 
then colony growth assessed: (+++) Excellent growth; (++) good growth; (+) poor 
growth; (-) no growth. The honeys used were A, Clear honey, B, pure natural honey, 
C, clear honey, D, pure natural honey, E, Manuka honey and F, Manuka active 15+ 
and Rewarewa honey (50:50).
Table 3.3: Minimum inhibitory concentrations (MICs) of different varieties of honey
Honeys
Honey concentration (volume per volume) *
0% 0.1% 1 % 2% 3% 4% 5% 10%
A +++ +++ +
B +++ +++ + — — — _
C +++ +++ + — — _ __
D +++ +++ + — _ __ __
E +++ +++ +
F +++ +++ + _
Mueller-Hinton Agar plates were prepared with different concentrations of honey 
autoclaved with MH growth medium and were incubated for 48 hours at 37°C in a 
microaerobic atmosphere then colony growth assessed: (+++) Excellent growth; (++) 
good growth; (+) poor growth; (-) no growth. The honeys used were A, Clear honey , 
B, pure natural honey, C, clear honey, D, pure natural honey, E, Manuka honey and 
F, Manuka active 15+ and Rewarewa honey (50:50).
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Table 3.4: MIC values (%) determined by visual inspection and spectrophotometric 
measurement
Sample MIC (%) - Visual MIC (%) - OD
Filtered Honey
A 5 5
B 4 4
C 10 10
D 5 5
E 4 4
F 2 2
Autoclaved Honey
A 4 4
B 4 4
C 10 10
D 4 4
E 4 4
F 4 4
Autoclaved with MHB
A 2 2
B 2 2
C 2 2
D 2 2
E 2 2
F 2 2
Mueller-Hinton broth was prepared with different concentrations of honey and 
cultures were incubated for 48 hours at 37°C in a microaerobic atmosphere then 
growth of C. jejuni assessed by visual inspection and spectrophotometric 
measurement for the optical density (OD) at 600 nm. The varieties of honey used 
were A, Clear honey , B, pure natural honey, C, clear honey, D, pure natural honey, 
E, Manuka honey and F, Manuka active 15+ and Rewarewa honey (50:50)
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Table 3.5: The effect of 2 % (v/v) honey sterilized using different protocols on the 
growth of a range of strains of Campylobacter jejuni and Campylobacter coli.
Campylobacter strain Control
Filtered 
honey 2 % 
(v/v)
Autoclaved 
honey 2 % 
(v/v)
Autoclaved 
honey with 
MHA 2 % 
(v/v)
C.jejuni 11168 +++ ++ ++ -
C.jejuni 480 +++ +++ +++ -
C.jejuni 11351 +++ ++ +++ -
C. coli 12110 +++ +++ +++ -
C.coli\\A31 +++ + ++ -
C.coli 11350 +++ +++ +++ -
Mueller-Hinton Agar plates were prepared with and without 2% honey and incubated 
for 48 hours at 31°C in a microaerobic atmosphere then colony growth assessed: 
(+++) Excellent growth; (++) good growth; (+) poor growth; (-) no growth
76
Chapter 3: Results
3.2 Media conditions
3.2.1 Measurement of medium pH
The acidic pH of honey must be considered as a potential antibacterial 
property when added to microbiological media. It may alter the pH of the media and 
change it from neutral towards acidic pH which may affect the growth of 
microorganisms. Therefore, the pH of MH broth was measured before and after 
adding honey. The initial pH value for MH broth was 7.09. All honey samples were 
found to have an acidic influence on the media pH (Table 3.6 and Figure 3.1) and it 
was evident that the pH of the medium decreased gradually as the honey 
concentration increased. The pH ranged from between 7.13 and 5.84 for filtered 
honey and between 7.00 and 5.73 for autoclaved honey. Amongst the samples, the 
maximal observed decrease was at the highest concentration of autoclaved honey 
with MH broth (10 %) where the pH decreased markedly to the range ft"om 5.84 to 
5.35 and the lowest pH observed in the media with honey C although it showed the 
lowest antibacterial activity. However, when the pH of the medium was adjusted to 
the normal range, suitable for C. jejuni growth (i.e. pH 6.5-1.5), by adding sodium 
hydroxide, the antimicrobial affects were still observed (data not shown) ruling out 
the possibility that the antimicrobial activity was due to pH.
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Figure 3.1: The ehange in pH values for MH broth after adding 0 to 10 % (v/v) honey and 
when it was au toe laved together with the MH medium (Mean of 3 ± SD) The honeys used 
were A, Clear honey, B, pure natural honey, C, elear honey, D, pure natural honey, E, 
Manuka honey active 15+ and F, Manuka and Rewarewa honey (50:50)
3.2.2 Measurement of absorbance and the browning intensity
When MH broth was autoclaved with honey present at the same time it was noticed 
that it became darker in colour (browner). To quantify this phenomenon, the absorbance at 
420 nm was used to examine the formation of brown pigments in MH broth with different 
honey concentrations (Table 3.8). Autoclaving honey with MH broth generated brown 
pigments and this was proportional to the concentration of honey used. When the honey was 
autoclaved separately only a modest darkening of the media occurred and this was even less 
apparent when the honey had been sterilized by filtration (Figure 3.2).
79
Chapter 3: Results
2.0-1
§
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Honey concentration%
Figure 3.2: Colour absorbance at 420 nm (^4 2 0) for MH broth with 0 to 10 %(v/v) honey A. 
MH broth with filtered honey MH broth with autoclaved honey (autoclaved separately) ■ 
and MH broth and honey autoclaved together A (Mean of three readings^ SD).
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The formation of brown pigments in the broth autoclaved with honey 
suggests that a type of browning reaction could be happening during the heating 
process. MH-broth contains amino acids and peptides and honey contains reducing 
sugars, and as both of these are reactants in the well-known browning reaction, the 
Maillard reaction (Clark and Tannenbaum, 1970) may be occurring. It was 
considered that the formation of the brown pigments and perhaps the antimicrobial 
activity might be due to this reaction.
3.3 A ssessing the grow th and the survival o f  Campylobacter jejuni in  
liquid m edia in the presence o f honey
3.3.1 The growth of Campylobacter jejuni in the presence of honey
The results presented in the previous section suggest that autoclaving honey with 
growth media might generate potent antimicrobial compounds that are not present in 
the original medium regardless of the kind of honey used. Consequently, the growth 
of C. jejuni was monitored in the medium described above but in more detail by 
measuring the optical density (OD) of the culture and by the viable counting method. 
Since there was good similarity in the antibacterial effects of all the honey samples 
when they were autoclaved with the media, honey A was chosen for further 
investigations. The OD of the liquid culture was measured by spectrophotometry at a 
wavelength of 600 nm. Growth occurred in all the media except that in which 2 % 
(v/v) honey had been autoclaved with MH medium (Fig. 3.3).
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Figure 3.3: The growth of C. jejuni in MH broth with no honey ( • ) ,  media 
containing 1 % (v/v) (A) and 2 % (v/v) (T) honey which had been filter sterilized 
and added to the media after autoclaving and 1 % (v/v) (□  ), 2 % (v/v) ( ■  ) honey 
which had been autoclaved separately and added to media after autoclaving and 
media which had been autoclaved with 1 % (v/v) (<^), 2 % (v/v) (♦ )  honey. The 
cultures were grown at 37 ”C in a microaerobic atmosphere and regular samples were 
taken for optical density measurements at 600 nm. Data are the mean of three 
determinations ± SD.
Viability was also assessed by plate counting and this gave rise to similar 
patterns of inhibition and also demonstrated that the effect was bactericidal (Figure 
3.4). The addition of filter sterilized honey had little impact on survival. However, 
the inclusion of 1 % (v/v) honey in media during autoclaving led to a loss of viability 
by 1-log after 25 hours of incubation whilst the presence of 2 % (v/v) honey led to 
loss in cell number of 6-logs in just 6 hours.
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Figure 3.4: The growth of C.jejuni in the presenee of honey which had been filter 
sterilized and added after autoclaving to MHB, autoclaved separately, autoclaved 
together with the media. C. jejuni was inoculated into MHB with no honey ( • ) ,  
media containing 1 % (v/v) (A) and 2 % (v/v) (T) honey which had been filter 
sterilized and added to the media after autoclaving, and 1 % (v/v) (□  ), 2 % (v/v) 
(■ ) honey which had been autoclaved separately and added to media after 
autoclaving and media which had been autoclaved with 1 % (v/v) (<$>), 2 % (v/v) (♦ )  
honey. The cultures were grown at 37 °C in a microaerobic atmosphere and regular 
samples taken for plate culturing and measuring the colony forming unit (CFU/ml). 
Data are the mean of triplicates.
3.3.2 The survival of Campylobacter jejuni in the presence of honey (by 
viable count)
The next study sought to investigate in detail how C. jejuni survival was 
influenced by honey. In the cultures to which honey had been added after 
autoclaving, the presence of 1 % (v/v) honey had little influence on survival 
compared to the control whilst the incorporation of 2 % (v/v) honey led to a rapid 
decline in viability after 24 hours. Honey, which had been autoclaved in the presenee 
of media though, produced the most dramatic antimicrobial activity with counts 
falling to undetectable levels in 6 and 72 hours with 2 % (v/v) and 1 % (v/v) honey, 
respectively (Figure 3.5)
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Figure 3.5: The survival of C. jejuni in the presence of honey which had been filter 
sterilized and added after autoclaving to MHB, autoclaved separately, autoclaved 
together with the media. C. jejuni was inoculated into MHB with no honey ( • ) ,  
media containing 1 % (v/v) (A) and 2 % (v/v) (T) honey which had been filter 
sterilized and added to the media after autoclaving, and 1 % (v/v) (□  ), 2 % (v/v) ( ■  
) honey which had been autoclaved separately and added to media after autoclaving 
and media which had been autoclaved with 1 % (v/v) (<^), 2 % (v/v) (♦ )  honey. The 
cultures were grown at 25 °C and under aerobic conditions. Data are the mean of 
three determinations. Data are mean of duplicates ± SD.
3.4 Com parison o f the effect o f honey w ith sugar solutions o f  
equivalent osm olarity m ade from fructose and glucose on the growth  
o f C. jejuni
To determine whether a saturated solution of sugar which had similar 
osmolarity to honey, but lacked other components, had a similar antibacterial activity 
or not, the growth of C jejuni was assessed in a liquid culture containing 2 % (v/v) 
of either honey, 2 % (v/v) artificial honey (containing 40 % (w/v) D-fructose, 3 % 
(w/v) D-glueose, 8 % (w/v) maltose, 2 % (w/v) sucrose and 20% water- see section 
2.3), 2 % (w/v) fructose or 2 % (w/v) glucose. It is clear from Figures 3.6 and 3.7
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that only 2 % (v/v) honey and not 2 % (w/v) fructose or 2 % (w/v) glucose or 
artificial honey were able to generate the compounds that had antimicrobial activity 
against C. jejuni.
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Figure 3.6: The growth of C. jejuni in MHB in the presence of 2 % honey, fructose, 
glucose and artificial honey or MHB only (OD). MHB with no honey ( • )  and in the 
presence of 2 % (v/v) honey that had been autoclaved with MHB (♦ ), 2 % (w/v) 
fructose that had been autoclaved with MHB (T), 2 % (w/v) glucose that had been 
autoclaved with MHB (■ ) and 2 % (v/v) artificial honey that had been autoclaved 
with MHB (O) The cultures were grown at 37 in a microaerobie atmosphere and 
regular samples were taken for optical density measurements at 600 nm .Data are the 
mean of three determinations ± SD.
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Figure 3.7: The growth of C  jejuni in MHB in the presence of 2 % (v/v) honey, 
fructose, glucose and artificial honey. MHB with no honey ( • ) ,  2 % (v/v) honey had 
been autoclaved with MHB (♦ ), 2 % (w/v) fructose had been autoclaved with MHB 
(T), 2 % (w/v) glucose had been autoclaved with MHB (■) and 2 % (v/v) artificial 
honey had been autoclaved with MHB (□). The cultures were grown at 37 °C in a 
microaerobie atmosphere and regular samples were taken for plate counting using 
MH agar incubated under microaerophilic condition at 37 for 48 hours. Data shown 
are mean of triplicate experiments ± SD.
3.5 A ssessing the production o f  antibacterial agents in honey-M H  
broth autoclaved m edium .
3.5.1 Comparison of the effect of honey-MH broth and honey-casein 
mixture on the growth and survival of Campylobacter jejuni
From the previous results it was evident that when honey is autoclaved in the
presence of MH broth, a potent antimicrobial agent (or agents) is generated. The fact 
that honey contains reducing sugars (glucose) and MH-broth contains amino acids, 
together with the formation of a brown pigment suggests that the antibacterial 
activity could be a product of the Maillard Reaction (Clark and Tannenbaum, 1970). 
To determine if this reaction was responsible for the production of antibacterial 
agents and which components of MHB were important for the reaction, a mixture of
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honey and casein hydrolysate (MH broth main content, 17.5g/L) was investigated. 
The autoclaved mixture (named honey-easein MRPs [Maillard Reaction Products]) 
was tested against C. jejuni. The results observed (Figure 3.8) were very similar to 
those seen with Honey and MHB with a 6-log decrease in viability occurring in 6 
hours in the presence of the autoclaved honey-easein mixture (honey-easein MRPs). 
Therefore, more experiments were conducted to examine and potentially identify the 
active antibacterial compounds in this mixture.
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Figure 3.8: The growth of C. jejuni in MHB in the presence of 2 % (v/v) honey. 
MHB with no honey (# ), 2 % (v/v) honey that had been autoclaved with MHB (♦ ), 
2 % (v/v) honey that had been autoclaved with casein (■). The cultures were grown 
at 37 in a microaerobie atmosphere and regular samples were taken for plate 
counting using MH agar incubated under microaerophilic condition at 37°C for 48 
hours. Data shown are mean of triplicate experiments ± SD.
3.5.2 The effect of heating temperature on the production of honey-easein 
MRPs antibacterial agents
This experiment was carried out to assess the effect of the heating temperature on 
the ability of honey-casein MRPs to inhibit C. jejuni growth as the rate of the 
Maillard reaction is known to be influenced by temperature. Autoelaving involves
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the exposure of the mixture to a temperature of 121° C for 20 min and consequently 
to assess the effects at lower temperatures, honey-casein MRPs were exposed to 
temperatures of 80 and 100° C for the same period of time. As can be seen in Figure 
3.9, the only heating regime that induced the antibacterial activity was 121 °C, which 
suggests that the formation of the antimicrobial agents is strongly dependent on 
temperature and again suggesting that these may be generated by the Maillard 
reaction.
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Figure 3.9: The effect of heating temperature on the production of antibacterial 
agents. MHB only (# ), Honey-casein MRPs mixture which had been heated at 121 
°C (♦ ), or heated at 100 °C (■), or heated at 80 °C (T).The cultures were grown at 
37 °C and under microaerophilic conditions and regular samples taken for plate 
culturing and measuring the colony forming unit (CFU/ml). Data are the mean of 
three determinations ±SD.
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3.5.3 Effect of heating time on the production of honey-casein MRPs 
antibacterial agents
The previous experiment (Figure 3.9) showed that only high temperature was able 
to generate the antibacterial agents. However, it has been reported that prolonged 
heating of casein/sugar mixture at 55 °C generates similar Maillard compounds to 
those generated by autoelaving (heated at 121°C) (Jing and Kitts, 2002). To examine 
this flirther, in this experiment honey-casein samples were heated at 55 °C in a water 
bath for 24, 48, 72 hours and then tested against C. jejuni. From the results shown in 
Figure 3.10, heating for 24 and 48 hours produced compounds that had some 
inhibitory effect on C. jejuni growth. However, only heating for 72 hours at 55 °C 
produced the same antibacterial activity as that seen for autoelaving.
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Figure 3.10: The effect of heating time on the production of antibacterial agents. 
MHB only ( • ) ,  heated at 55 °C for 24 hours (■), heated at 55 °C for 48 hours (A), 
heated at 55 °C for 72 hours (▼) and heated at 121°C for 20 min (♦ ). The cultures 
were grown at 37 °C and under microaerophilic conditions and regular samples were 
taken for plate culturing and measuring the colony forming unit (CFU/ml). Data are 
the mean of three determinations ±SD.
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3.5.4 Effect of amino acids in the production of honey-casein MRPs 
antibacterial agents
Casein hydrolysate is essentially a mixture of small peptides and amino acids 
which would be the potential reactants in the Maillard reaction. To further confirm 
that the generation of the antibacterial compound (or compounds) was due to the 
Maillard reaction, and to determine which particular amino acids were important, 
honey was autoclaved in the presence of individual amino acids and the resulting 
antibacterial activities were assessed using the disc diffusion method (Tables 3.8 & 
3.9 and Figure 3.11). The result in Table 3.8 shows the zones of inhibition generated 
by autoelaving different honey-amino acid mixtures and the ratio of amino acids in 
casein whereas in Table 3.9 the amount of amino acid added to mixture equivalent to 
the amount of Lysine = 65 mg. Heated mixtures of honey and most of the individual 
amino acids (78.5 %) did not produce any clear zones of inhibition around the disc. 
However, three amino acids did give rise to active compounds and showed clear 
antibacterial effects. No one single amino acid-honey mixture gave rise to the level 
of activity seen with honey-casein MRPs mixture. Honey-lysine produced the most 
effective activity with a zone of inhibition of approximately 12 mm. This was 
followed by phenylalanine, tyrosine and aspartic acid with zones of inhibition of 10, 
8, and 7.33 mm, respectively. From this experiment, lysine was shown to be the most 
effective amino acid in generating the antibacterial agents and therefore, its ratio in 
casein was used to prepare honey-amino acid mixtures with the same quantity (lysine 
ratio in casein = 3.72% = 65 mg/L) so the same amount (65 mg) of each amino acids 
was used in the subsequent experiment. The results in Table 3.9 confirmed that only 
specific amino acids are involved in the generation of honey-casein MRPs 
antibacterial activity.
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Table 3.8: Zones of inhibition generated by autoelaving different honey-amino 
acid mixtures and the ratio of amino acids in casein
Amino acid
Colour 
(autoclaved 
mixture with 
honey)
Ratio in 
casein % (mg/1)
Zone of inhibition 
(mm)
(6mm disc)*
Casein Brown 100% 18±2
Alanine Yellow 1.73% = 30mg 0
Arginine Brown 1.66% = 29mg 0
Aspartic acid Yellow 4.06% = 71 mg 7.33±0.8
Glutamic acid Yellow 13.34% = 233mg 0
Glycine Yellow 1.14% = 19mg 0
Leucine Yellow 3.33% = 58mg 0
Lysine Dark brown 3.72% = 65mg 12±1.2
Methionine Yellow 1.37% = 24mg 0
Phenylalanine Light Brown 2.28% = 39mg lO il.l
Proline Yellow 5.56% = 97mg 0
Serine Yellow 1.03% = 18mg 0
Threonine Yellow 1.44% = 25mg 0
Tyrosine Yellow 1.57% = 27mg 8±1
Valine Yellow 3.38% = 60mg 0
*Mean±SD
92
Chapter 3: Results
Table 3.9: Zone of inhibition of honey-amino acid autoclaved mixture 
(equivalent to the amount of Lysine = 65 mg)
Amino acid
=Lysine % in 
casein= 3.72 % 
= 65 mg
= mM Zone of inhibition (by 6 mm disc)*
Honey-casein
MRPs - - 18±2
Alanine 65mg 73.00mM 0
Arginine 65mg 37.00 mM 0
Aspartic acid 65mg 48.8 mM 6.2±0.5
Glutamic acid 65mg 44.00 mM 0
Glycine 65mg 86.59 mM 0
Leucine 65mg 49.5 mM 0
Lysine 65mg 44.4 mM 12.333=0.5
Methionine 65mg 43.56 mM 0
Phenylalanine 65mg 40.00 mM lO il.l
Proline 65mg 56.46 mM 0
Serine 65mg 61.85 mM 0
Threonine 65mg 54.57 mM 0
Tyrosine 65mg 35.87 mM 8.33=tl
Valine 65mg 55.49 mM 0
* Figures are mean ±SD
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3
dgure 3.11: Examples of the disc diffusion technique used for assessing the 
antibacterial activity of the autoclaved honey amino acid mixtures. Zones of 
inhibition produced by honey amino acids against Campylobacter jejuni (A) honey- 
alanine MRPs (B) honey-lysine MRPs. Upper disc: control: positive control 1% 
H2 O2 upper left, negative control H2O upper right and lower discs: MRPs
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3.5.5 Effect of the catalase on the antibacterial activity of honey-casein 
MRPs
To investigate whether the activity of honey-casein MRPs was due to the 
production of reactive oxygen species (ROS) and specifically hydrogen peroxide, 
experiments were repeated in the presence and absence of the enzyme catalase which 
destroys hydrogen peroxide. Catalase was added to the autoclaved honey-casein 
MRPs mixture which was then incubated for 24 hours at 37 °C in the dark. The 
results (Figure 3.12) show that catalase provided some protection against the 
antibacterial activity since in the absence of this enzyme viability decreased by six 
logs in 6 hours whereas in its presence it took 9 hours to generate the same effect.
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Figure 3.12: The effect of catalase enzyme on the antibacterial activity of honey- 
casein MRPs against C. jejuni. MH broth only (# ), MH broth + 2 % (v/v) honey- 
easein MRPs (▼) and MH broth + 2 % (v/v) honey-casein MRPs+ catalase (A).The 
cultures were grown at 37 °C in a microaerobie atmosphere and regular samples were 
taken for plate culturing and measuring the colony forming unit (CFU/ml) on MH 
agar (Mean of three determinations ± SD).
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3.5.6 Effect of the catalase enzyme on the susceptibility of C. jejuni to 
honey-casein MRPs
Another experiment was condueted to determine the eontribution of the 
endogenous C  jejuni catalase to the resistance to honey-casein MRPs antibacterial 
effects. In this experiment a Cjejuni mutant deficient in catalase (katA) (Grant and 
Park, 1995) was tested. The results demonstrated that both C. jejuni wild-type and 
katA mutant were sensitive to honey-casein MRPs but the katA mutant was more 
sensitive than the wild type, with its viability falling to undetectable levels in only 4 
hours compared to 6 hours for the wild type (Figure 3.13).
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Figure 3.13: The effect of a katA mutation on the susceptibility of C. jejuni to honey- 
easein MRPs, C. jejuni (wt) MH alone (# ), C. jejuni in the presence of 2 % honey- 
casein MRPs (T ), C. jejuni {katA) MH alone (■ ) and C. jejuni {katA) in the 
presence of 2 % honey-easein MRPs (A). The cultures were grown in MHB 
mieroaerophilically at 37°C and samples were taken for plate culturing and 
measuring the colony forming unit (CFU/ml). Data presented are the mean of three 
experiments ±SD.
96
Chapter 3: Results
3.5.6 The effect of storage on the antibacterial activity of honey-casein 
MRPs
To determine whether the antimicrobial agents were stable, the effect of 
storage on the antibacterial activity of honey-casein MRPs was assessed. After 
autoelaving, honey-casein MRPs were used immediately or stored for 48 hours in the 
light at room temperature. In Figure 3.14 it can be seen that there is some loss of 
antibacterial activity during the 48 hour storage.
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Figure 3.14: The effect of storage on the antibacterial activity of honey-easein MRPs 
against C. jejuni. MHB only ( • ) ,  MHB with honey-casein MRPs used direct after 
autoelaving (♦ ) and MHB with honey-casein MRPs autoclaved then stored at room 
temperature for 48 h before using (A) The cultures were grown at 37 °C in a 
microaerobie atmosphere and regular samples taken for plate culturing and 
measuring the colony forming unit (CFU/ml). Data are the mean of three 
determinations.
3.5.7 Determination of reducing sugar in honey and honey-easein MRPs
It was considered that if the antimicrobial compounds generated by 
autoelaving honey and the amino acid containing mixtures were generated by the 
Maillard Reaction, then the level of glucose in honey would be expected to decrease 
after autoelaving as this is a reducing sugar and thus a Maillard reactant. An
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enzymatic assay was used to determine the amount of glucose in honey before and 
after autoelaving in comparison with just glucose alone. The results in Table 3.11 
showed slight decreases in the glucose level after autoelaving the honey mixture 
eompared to the glucose. Moreover, it is obvious that honey (A) has high content of 
glucose which is approximately 50 % of the sugars present. The result in Figure 3.16 
illustrates that there was an increase in glucose level after autoelaving honey with 
casein which was not expected.
6 0 n
Y = 0.05550*X-2.211e-007
4 0  -
S
s
2 0 00 4 0 0 6 0 0 800 1000
m g / d l
Figure 3.15: Determination of glucose concentration in 1 g honey/d 1 water (♦ )  
Table 3.10 Honey content of glucose content
Sample (g/ dl H2 O) Glucose content (mmol/1)
0.3 g Glucose/casein 20.95±0.21
0.3 g Glucose/casein (autoclaved) 13.36±0.05
1 g Honey/casein 31.73 ±0.57
1 g Honey/casein (autoclaved) 35.06 ±0.77
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Figures.!6 : Determination of glueose in honey and honey-easein MRPs.
3.6 D eterm ination o f  the m olecular w eight o f the antim icrobial 
com pounds in the honey-casein M R P m ixtures
As a preliminary step to isolating the actual antimicrobial compounds present 
in the honey-casein MRP mixtures, the mixture was separated by using ultrafiltration 
(using molecular weight cut off (MWCO) membranes) into three fractions: a low 
molecular weight fraction <2000 Da, an intermediate molecular weight fraction 
between 2000 and 5000 Da and a high molecular weight fraction of 5000 Da and 
higher. Around 10 % of the honey-casein MRPs were <2000Da, 40 % between 2000 
and 5000Da and the rest of the sample was > 5000 Da. The antibacterial activity of 
each fraction was tested by using the disc diffusion method. The zones of inhibition 
generated by each molecular weight fraction are shown in the table below (Table
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3.12). Only the fraction with a molecular weight greater than 5000 Da gave rise to 
any significant antibacterial activity against C. jejuni.
Table 3.11; Antibacterial activity of honey-casein MRPs fractions (by molecular 
weight) against C. jejuni as determined by disc diffusion
Zone of inhibition (mm)
Sample LMW
<2000
IMW 
2000 < - <5000
BMW
>5000
Honey-casein MRPs 20±2mm
3.7 A ssessing the activity o f honey-casein M RPs against 
Campylobacter jejuni
3.7.1 Assessing the activity of honey-casein MRPs against Campylobacter 
jejuni in milk
To confirm whether the honey-casein MRPs antibacterial agents are active 
against C. jejuni in real food systems, the honey-casein MRPs mixture was added to 
ultra-high temperature (UHT) milk and the survival of this bacterium studied. In milk 
the antibacterial agents retained their ability to kill Campylobacters bringing about an 
8-log reduction in viability in just 6 hours (figure 3.17).
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Figure 3.17: The survival of C. jejuni in milk with and without honey-casein MRPs. 
Milk A only ( • ) ,  Milk B only (■), milk A + 2 % (v/v) honey-casein MRPs (T ) 
milk B + 2 % (v/v) honey-casein MRPs (A). The cultures were grown at 37 °C and 
under microaerophilic conditions and regular samples were taken for plate culturing 
and measuring the colony forming unit (CFU/ml).Data are the mean of two 
determinations ± SD.
3.7.2 Antibacterial activity of honey casein MRPs by Eclipse(s)-100
Eclipse-100 assay was used as another experiment to confirm that honey- 
casein MRPs have antibacterial activity. This microtiter plate-based assay is designed to 
detect antibiotics or microbial growth inhibitors in raw and thermally treated milk samples at 
low concentrations (as low as 0.003 mg/1 for penicillin). The test is based on the production 
of acid by Geobacillus stearothermophylus var. calidolactis bacteria (a Gram-positive 
thermophilic bacterium that grows at 65 °C) when it grows in the added sample. The 
presence of an antibacterial agent prevents the growth of the G. stearothermophylus spores 
and the colour of the medium (sample) remains blue. Honey-casein MRPs were added to the 
96-well microplate at different concentrations ranging between 2 and 10 %. After one hour, 
to allow diffusion of the MRPs, the plates were incubated in a water bath for 2 hours at 65 
°C. No change in the colour was observed on the wells containing honey-casein MRPs or
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penicillin. However, the colour of the medium in the wells with water (negative control) 
changed to dark yellow which suggests that honey-casein MRPs also demonstrate 
antibacterial activity in this assay.
3.7.3 Galleria mellonella killing assays
Galleria mellonella larvae have been used as a cost effective and ethical 
model for assessing the virulence of C. jejuni (Desbois & Coote, 2012 and 
Champion, et al, 2010). Larva appearance and survival was recorded after 24 hours 
of infection with 1x10^ CFU of C. jejuni resuspended in PBS with and without 
honey-casein MPRs (Figure 3.18 & 3.19). It is obvious that when the group of larvae 
which were not injected or injected with PBS only (which was used as a vehicle to 
suspend C. jejuni) were scored, that larvae were alive with no melanisation or 
changes in colour with no indications of toxicity. In contrast, the infected group 
(injected direct with 10 pi of 1x10^ CFU of C. jejuni) were observed to be mostly 
dead and with distinctive melanisation (~ 90 %). Although the same doses of C. 
jejuni (1x10^ CFU) were used to infect all the groups, the presence of 2 and 5% (v/v) 
honey-casein MDRPs resulted in 93 and 100 % survival, respectively. Moreover, no 
change in the colour or the appearance in melanisation was recorded in these treated 
groups.
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Figures. 18: Ability of C. jejuni to kill Galleria mellonella in the absenee and 
presence of honey-casein MRPs (2 and 5 % (v/v)) after 24 h of incubation at 37 °C. 
No significant decrease between control and C. jejuni with 2 & 5 % (v/v) honey- 
easein MRPs (one-way ANOVA and Dunnett's test) (P < 0.05) (means of triplicate 
experiments ±SD).
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Figure 3.19: Appearance of Galleria mellonella larvae (n= 10/plate) after 24 h of 
incubation at 37 °C injected with (A) 10 pi PBS only (B) 10 pi 1x10^ CFU 
Campylobacter jejuni in PBS (C) 10 pi 1x10^ CFU Campylobacter jejuni + 2 % 
Honey-easein MRPs in PBS (D) 10 pi 1x10^ CFU Campylobacter jejuni + 5 % 
Honey-casein MRPs in PBS.
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3.8 Exam ination o f  Campylobacter jejuni for m orphological 
characteristics after treatm ent w ith  the honey-casein M R Ps by  
transm ission electron m icroscopy (TEM )
The change in C. jejuni morphological characteristics following MRP 
exposure was evaluated by using transmission electron microscopy (TEM). The 
images showed that incubating C. jejuni in a medium containing 2 % (v/v) Honey- 
easein MRPs caused a modification in C. jejuni physiology (Figure 3.20). In the 
control cultures, with no MRP addition, rod shape cells with two bipolar flagella 
were observed (Figure 3.20 A). However, after exposure to the honey-casein MRPs 
(3 hours), cells underwent a degenerative change to coccoid forms. In addition, blebs 
appeared around the cells during this transition process (Figure 3.20 B). The 
complete coccoid shape was detected after 6 hours of treatment (Figure 3.20 C).
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Figure 3.20: Transmission electron micrographs (TEM) of (A) Campylobacter jejuni 
NCTC 111 68 untreated (B) Campylobacter jejuni NCTC 11168 treated with honey- 
casein MRPs for 3 hours (C) Campylobacter jejuni NCTC 11168 treated with honey- 
easein MRPs for 6 hours.
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3.9 LIV E/D EA D  Baclight staining for bacterial viability
As an alternative assessment for viability, a membrane integrity stain 
(LIVE/DEAD BacLight) was used to measure the number of viable cells after 
treating Campylobacter jejuni with the honey-casein MRPs. This stain depends on 
the membrane integrity to distinguish between dead bacterial cells and live ones. 
Fluorescence microscopic examination showed that the green fluorochrome (Syto 9) 
which penetrates all intact membranes stained the cells in control and treated samples. 
However, propidium iodide, the red fluorochrome, which only penetrates the 
compromised membrane. From Figure 3.20 it is evident that C. jejuni remained 
viable (with no damaged membranes) after being treated with honey-casein MRPs. 
In Figure 3.21 it is noticeable that propidium iodide (the red fluorochrome) was not 
able to penetrate the treated cells (with honey-casein MRPs) and only Syto 9 (the 
green fluorochrome) stained them which suggest that they still have intact 
membranes. Moreover, as the images from TEM showed a transition to the coccoid 
form, this result suggests that the transition and morphology changes of C. jejuni 
occurred with the viable cells and intact membranes.
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Figure 3.21. Membrane integrity of Campylobacter jejuni. C. jejuni was incubated 
with honey-casein MRPs for 6 h then stained by the LIVE/DEAD BacEight Bacterial 
Viability kit. Green fluorescent cells = retain membrane integrity and the red cells = 
lost membrane integrity. A, untreated cells, B, treated cells with honey-casein MRPs 
for 6 hours and C, cells thermally treated at 55 °C for 7 min.
3.10 Confirm ation o f loss o f  C.jejuni culturability
After treatment with honey-casein MRPs cells, images obtained with TEM 
confirmed the transition of C  jejuni into the coccoid shape. In addition, the 
LIVE/DEAD BacEight assay seemed to suggest that whilst cells could not be 
recovered on MH-agar that the cells still remained viable as their membranes were 
still intact. This gave rise to the possibility that after treatment with the honey-casein 
MRPs that cells were entering the viable but non-culturable form (VBNC) which 
happens under unfavourable conditions (Rollins and Colwell, 1986; McKay, 1992). 
To determine whether these eells could be reeovered by using a more protective 
media than MHA, blood agar was used for plate counting. Cells were exposed to 
honey-casein MRPs and samples were taken every 24 hours and then plated onto 
media supplemented with blood to support injured cells to recover. It is evident from
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Figure 3.22 that the apparent viable eells eould not be reeovered using this medium 
and that for C. jejuni treated with honey-casein MRPs, the loss of viability might not 
be reversible.
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Figure 3.22: Recovery of C. jejuni after treatment with honey-casein MRPs, control 
untreated ( • ) ,  treated with honey-casein MRPs for 6 hours the transferred to MH 
broth (■) samples were taken every 24 h and plated on MH agar supplemented with 
5 % sheep blood. The plates were incubated for 48 hours at 37°C in a microaerobie 
atmosphere Mean of three experiments ±SD.
3.11 The Effect o f  H oney-casein M R Ps on Campylobacter adhesion.
In this experiment, the ability of C. jejuni to bind to human colon adenocarcinoma 
eells (Caco-2) in the presence of honey-easein MRPs was examined. The cells were 
infected with 1x10^ C. jejuni with or without honey-easein MRPs. Honey-easein 
MRPs were added to the medium in two different stages, at the same time with the C. 
jejuni or after one hour of incubation in the presence of the eells. All bacterial cells, 
the control, bacterial cells exposed to honey-casein MRPs from the beginning and 
bacterial cells exposed to honey-casein MRPs after one hour of incubation showed a 
similar pattern of adhesion and no significant decrease was observed (P > 0.05). In
109
Chapter 5: Results
general, the number of baeterial cells (treated and untreated) which were able to 
adhere to Caeo-2 was around 85 % of the C.jejuni inoculum.
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Figure 3.23: C. jejuni adherence to Caco-2 cells in the presence of honey-easein 
MRPs. The results are presented as loglO CFU. No significant decrease between 
control and treated (one-way ANOVA) (P > 0.05) (means of triplicate ±SD)
3.12 Effect o f H oney-casein M RPs on Campylobacter invasion  
(G entam icin killing assay)
As the honey-easein MRPs gave no effect on the ability of C. jejuni to 
adhere to caco-2 eells, C. jejuni invasion of Caco-2 eells experiment was studied in 
order to determine the amount of cells that were able to invade of Caeo-2 eells. After 
infection and three hours of incubation with honey-casein MRPs, the cells were treated with 
Gentamicin for another three hours to kill extracellular bacteria. C. jejuni invasion of Caco-2 
cells in the presence of honey-casein MRPs was 2 log lower than the control (Figure 3.24). 
This was a significant reduction (P < 0.05) in the number of C.jejuni that invaded the Caco- 
2 cells.
In general, adding honey-casein MRPs only affected the ability of C.jejuni to 
invade Caeo-2 cells and not the adherence. By comparing the results of adhesion and
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invasion (Figure 3.25), there was a significant difference (t-test, P < 0.05) between 
the number of C. jejuni cells which adhered to Caco-2 cells and the number of C. 
jejuni which invaded of Caco-2 cells in the presence of honey-casein MRPs. After 
incubation with honey-casein MRPs, only 59 % of the adhered C. jejuni were 
successfully able to invade Caco-2 cells. As suggested, invasion always happens 
after irreversible adhesion and the rest of the adhered cells (41 %) attached in a 
reversible manner so the bacteria were easily removed by washing the cells.
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Figure 3.24: C. jejuni invasion of Caco-2 cells in the presence of honey-casein MRPs. 
The results are presented as logio CFU. Differences between control and treated was 
significant (f-test) (P < 0.05) (means of triplicate ±SD)
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Figure 3.25: C. jejuni adhesion and invasion of Caco-2 cells in the presence of 
honey-casein MRPs. The results are presented as logio CFU. Difference was 
significant (/-test) (P < 0.05) (means of triplicate ±SD)
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3.13 H oney-casein M R Ps toxicity tests
The toxicity of honey-casein MRPs was determined by two different methods, 
the Cell Growth Inhibition Assay and Galleria mellonella larvae killing assay
3.13.1 Cell Growth Inhibition Assay
The ability of honey-casein MRPs to induce cellular damage was assessed 
using the cell growth inhibition assay (or MTT assay). In this enzyme-based assay 
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tétrazolium bromide (MTT) was used to 
test the cell viability of caco-2 cells after the cells had been exposed to components 
such as MRPs which may have toxic effects. In this test only viable cells (with 
functional mitochondrial enzymes, e.g. dehydrogenases) are able to cleave and 
reduce the tétrazolium ring to form purple formazan crystals which can be measured 
speetrophotometrically. To investigate the possible cytotoxicity effect of honey- 
casein MRPs, Caco-2 cells were used as a representative and appropriate cell type.
The Caco-2 cell line was treated with the honey-casein MRPs mixture at a 
range of concentrations, namely, 0, I, 2, 5 and 10 % (w/v) in DMEM for a period of 
3 hours of incubation. To evaluate the toxic effects of honey-casein MRPs, the cells 
were incubated in DMEM media after the 3 hour treatment. To study these effects, 
the medium containing the honey-casein MRPs treatments was replaced with DMEM 
and cells were incubated for a further 72 hours and then the MTT assay was 
performed.
The results showed that all cells incubated with concentrations up to 5 % 
(w/v) honey-casein MRPs showed no cytotoxic effects in terms of the MTT results. 
Indeed, there was no significant decrease in the cell viability detected compared to 
eontrol (P>0.05) for either 1 %, 2% or 5 % MRPs. However, cell viability dropped to
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79.33 % of the control when cells were incubated with the highest concentration of 
honey-casein MRPs (10 %, w/v) (Figure 3.26). The only significant decrease (P < 
0.05) in cells viability was therefore only exhibited at the highest concentration (10 
%).
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Figure 3.26: Viability of Caco-2 cells after 3 hours of incubation with different 
concentrations of honey-casein MRPs (1. 2. 5 and 10 % w/v) in DMEM media 
assessed by MTT assay. No significant decrease between the control and 1, 2 & 5 % 
honey-casein MRPs. **Significant decrease between the control and 10% honey- 
casein MRPs (one-way ANOVA and Dunnetfs multiple comparisons test) (P < 0.05) 
(means ±SD).
3.13.2 Galleria mellonella killing assay
Galleria mellonella have been recently used as an animal model to examine 
the toxicity of chemical substances (Desbois & Coote, 2012). In this experiment the 
toxicity of honey-casein MRPs was further investigated and the possibility of having 
toxic effect in vivo was evaluated by determining the rate of survival of G. mellonella 
larvae after inoculation with honey-casein MRPs. The range of different 
concentrations of honey-casein MRPs which showed no toxic effect on mammalian 
cells was used. G.mellonella larvae were injected with 10 pi of 1, 2, or 5% (w/v) 
honey-casein MRPs in PBS. After 24 hours of incubation in the dark, mortality was
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checked with no killing effect was observed at any concentration compared to the control 
(Figure 3.27). However, 10 % of the G. mellonella which injected with high concentration 
(5% w/v) appeared to have slower movement and slightly melanised in colour.
m m #
Figure 3.27 Appearance of Galleria mellonella larvae (n= 10/plate) after 24 h of 
incubation at 37 °C injected with (A) 10 pi PBS only (B) 10 pi 1 % Honey-casein 
MRPs in PBS (C) 10 pi 2 % Honey-casein MRPs in PBS (D) 10 pi 5 % Honey- 
casein MRPs in PBS.
3.14 High perform ance liquid chrom atography (H PLC) analysis
3.14.1 Optimization of chromatographic analysis conditions
To identify the active compounds in honey-casein MRPs, analysis was 
performed using high performance liquid chromatography (HPLC) according to the 
method reported by Ames (1998).
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At first the analysis was performed using a linear water/methanol gradient, 0- 
70 % methanol over 35 min. However, it was considered that the separation could be 
improved and by replacing methanol with acetonitrile in the mobile phase this was 
found to improve peaks separation. Further modifications were made to the gradient 
method and it was observed that when the sample was injected onto the column 
using a linear water/acetonitrile gradient, (0-30 % acetonitrile over 45 min) that this 
showed better separation of the constituent peaks. Furthermore, it was observed that 
using different wavelengths and by monitoring the analysis at 280, 360 and 460 nm, 
showed that at 280 nm the peaks were most clearly observed (Figure 3.28A and B).
HPLC chromatograms (Figure 3.28) clearly shown that altering the solvents, 
their percentage and the time of the gradient has had a dramatic effect on the 
observed peaks. It is obvious that more compounds can be separated by changing the 
analysis system. In Figure 3.28 B, the developed method revealed a further 5 peaks 
which is around three times the number of peaks appeared in the chromatogram of 
the original method (Figure 3.28 A). However, the chromatogram still showing large 
humps of unseparated peaks which appeared to be a great deal of work to do to 
elucidate them all.
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Figure 3.28: HPLC chromatograms of honey-casein MRPs reaction mixture. HPLC 
was performed under the following conditions: instrument; UltiMate® 3000, Dionex 
(Thermo Scientific, UK), column; Ultracarb ODS (30) (5 pm, 150 x 4.6 mm, 
Phenomenex, USA), detection wavelength, 272 nm.; The elution, linear 
water/acetonitrile gradient. A) 0-70 % acetonitrile over 35 min (original method) and 
B) 0-30 % acetonitrile over 45 min (developed method)
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3.14.2 Honey-casein MRPs content analysis
The newly developed method was used to assess the effect of heating on the 
honey casein mixture. Chromatograms of honey-casein mixtures analyzed before and 
after heating are illustrated in Figure 3.29.
The application of HPLC analysis of honey-casein mixtures showed clear 
differences between the chromatographic patterns of the sample before (Figure 3.28 
A) and after (Figure 3.29 B) autoclaving. Before autoclaving it was evident that there 
was a clear peak at 10.1 minutes and a very small peak at 14.2 minutes. There was 
also some indistinct material eluted between 15 min and the end of the 
chromatographic run.
After autoclaving the peak at 10.1 minutes remained on the chromatogram 
with a similar peak area but it was clear that the chromatogram had changed 
dramatically with the heating process. Figure 3.29B shows the appearance of two 
main peaks at retention times 16.8 and 20.0 min. The peak at 14.2 minutes was also 
more evident in this sample and there were further peaks at 14.81, 15.20, 20.71 and 
21.55 minutes. These peaks were not identified further due to the lack of Maillard 
reaction products standards. Indeed, this mixture was considered to be too complex 
to be analysed in further detail and no sole compound was isolated as the main one 
responsible for the antibacterial activity of honey-casein MRPs.
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Figure 3.29: HPLC chromatograms of honey-casein MRPs reaetion mixture before 
(A) and after (B) autoelaving. HPLC was performed under the following conditions: 
instrument; UltiMate® 3000, Dionex (Thermo Seientifie, UK), eolumn; Ultraearb 
ODS (30) (5 pm, 150 x 4.6 mm, Phenomenex, USA); solvent A: H2 O, solvent B: 
acetonitrile; flow rate, 0.5 ml/min; elution, gradient from 0 % to 30 % solvent B over 
35 min; deteetion wavelength, 272 nm.
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Furthermore, Prolonged heating of the honey-casein mixture at 55 °C also 
showed an increase in the antibacterial activity of the mixture, therefore, more 
experiments were conducted to investigate whether any compounds increased in 
concentration during this heating process at 55 C. Obvious increases of these peaks 
were observed in the honey-casein MRPs incubated at 55 °C for 24, 48, 72 hours and 
the autoclaved mixture (Figure 3.30). Clearly, the peak at 10.1 min goes down more 
with the more intense heat/duration. Peaks at 14.2 minutes and 16.8 minutes increase 
more with a longer duration at 55 C. Other peaks in between seem to become more 
evident at the longer duration too.
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Figure 3.30: HPLC chromatograms of honey-casein MRPs reaction mixture. Black 
line, autoclaved at 121 C for 15 min; red line, heated at 55 °C for 72 hours; pink line, 
heated at 55 °C for 48 hours and blue line, heated at 55 °C for 24 hours. HPLC was 
performed under the following conditions: instrument; HPLC UltiMate® 3000, 
Dionex (Thermo Scientific, UK), column; Ultracarb ODS (30) (5 pm, 150 x 4.6 mm, 
Phenomenex, USA); solvent A: H2 O, solvent B: acetonitrile; flow rate, 0.5 ml/min; 
elution, gradient from 0 % to 30 % solvent B over 35 min; detection wavelength, 280 
nm.
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3.14.3 Detection of a-dicarbonyl compounds
Alpha-dicarbonyl compounds are common intermediate compounds found in 
many foods as a result of the non-enzymatic browning reactions (Degen et al, 2012). 
The content of these compounds in foods has been recently been found to have a 
strong correlation with antibacterial activity such as honey as well as MRPs (Adams 
et al, 2009, Marvic et al, 2008 and Chen and Kitts 2011). These compounds, mainly 
methylgloxal (MGO), are known to possess antibacterial activity (Adams et al, 
2009). Their antibacterial activity is thought to be caused by their protein damaging 
effects on bacterial cells. The detection of a-dicarbonyl compounds previously has 
been done using analytical methods such as HPLC after derivatization with O- 
phenylenediamine (OPD). In order to assess the contribution of MGO in the 
antibacterial activity of honey-casein MRPs samples, the OPD method was used to 
detect MGO. The method is based on derivatization of the relevant compounds firstly 
with O-phenylenediamine (OPD) and then analysis was performed using HPLC with 
detection at 312 nm. The chromatogram in Figure 3.31 shows that the MGO 
derivatised with OPD had a retention time of 7.4 minutes. The honey-casein sample 
analysed produced 2 peaks with one at the same retention time as that for OPD 
derivatised MGO.
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Figure 3.31: HPLC chromatograms of honey-casein MRPs after derivatization with 
OPD. Black line (—) MGO standard solution in water (15 %, v/v); Blue line (--) 
honey-casein MRPs in water (15 %, v/v).
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To confirm the antibacterial activity of MGO, this compound was tested 
against C. jejuni. MGO obtained from Sigma (40 % (w/v) in water) and used to 
determine the minimum inhibitory concentration (MIC) against C. jejuni. The results 
presented in Table 3.12 show that 1 mM was able to completely prevent the growth 
of C. jejuni in liquid media.
Table 3.12: The minimum inhibitory concentration (MIC) of methylglyoxal (MGO)
Bacteria
MIC (mM)
0.01 0.05 0.5 i l l j | | | l i | 10
C. jejuni 
NCTC 11168 +++ +++ +++ ++ - - -
MH broths were prepared with different concentrations of MGO and colony growth 
assessed after 48 hours of incubation at 37°C for 48 hours in a microaerobic 
atmosphere then : (+++) Excellent growth; (++) good growth; (+) poor growth; (-) no 
growth
The presence of Methylglyoxal, as one of the intermediate compounds, is 
considered to be involved in further reactions with the amino acids. These reactions 
generate more compounds which may enhance the activity of the final mixture. One 
of these compounds is carboxyethyllysine (CML). To investigate wither CML has 
any antibacterial activity against C. jejuni, it was added to the growth medium in 
different concentrations including 0, 5, 10, 15, 20 and 25 mM. The result in Table 
3.13 shows the minimum inhibitory concentration (MIC) with no growth at 
concentration 15 mM and higher.
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Table 3.13: The minimum inhibitory concentration (MIC) of Carboxymethyllysine 
against C.jejuni.
Bacteria
MIC (mM)
0 5 15 25
C. jejuni 
NCTC 11168 +-H- +++
+++ - - -
MH broths were prepared with different concentrations of MGO and colony growth 
assessed after 48 hours of incubation at 37°C in a microaerobic atmosphere then : 
(+++) Excellent growth; (++) good growth; (+) poor growth; (-) no growth
Ë
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Figure 3.32: The survival of C. jejuni in the presence of CML, control (A), 5 
mM(H), 10 mM (V)15 mM (A) 20 mM (<>) and 25mM ( ^ ) .  The cultures were 
grown at 37 °C and under microaerophilic conditions and regular samples were taken 
for plate culturing and measuring the colony forming unit (CFU/ml).Data are the 
mean of two determinations.
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3.15 A ssessing the effect o f  honey on the growth o f  other foodborne  
pathogens
As honey which was autoclaved with media showed such good antibacterial 
activity against C. jejuni 11168, it also was tested against other foodborne pathogens 
including Escherichia coli (non-toxigenic E.coli 0157:H7), Salmonella 
Typhimurium {S. Typhimurium) and Listeria monocytogenes (Z. monocytogenes 
NCTC 5105).
3.15.1 Determination of the minimum inhibitory concentration (MIC)
These studies showed that honey was able to prevent the growth of all three 
bacterial strains that were tested but this occurred at different concentrations when 
honey was autoclaved with MH medium (either broth or agar). From the results 
presented in Table 3.14, it can be seen that the growth of all bacterial strains was 
totally inhibited by 5 % of autoclaved honey with MHA or higher. E.coli and S. 
Typhimurium were not able to grow in the presence of 10%. Furthermore, L. 
monocytogenes was evidently more sensitive that E. coli and S. Typhimurium and 
showed no growth at 5 % autoclaved honey with media.
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Table 3.14; MICs of different honey concentrations (autoclaved with MHB) against 
E. coli, S. Typhimurium and L. monocytogenes
Bacteria
Honey concentration (autoclaved with MH agar) (v/v)
0.1% 1.0% 2.0% 3.0% 4.0 % 5.0 % 10.0%
E. coli 0157 +++ +++ +++ +++ +++ +++ -
Salmonella
Typhimurium +++ +-H- -H-f +++ +++ +-H- -
Listeria 
monocytogenes 
NCTC 5105
+++ +++ +++ +++ ++
- -
MHA plates were préparée with dif brent concentrations of honey A (autoclaved
together) and colony growth was assessed: (+++) Excellent growth; (++) good 
growth; (+) poor growth; (-) no growth. The plates were incubated aerobically at 37 
°C for 24 hours.
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3.15.2 The effect of honey on the growth o îEscherichia coli {E,coli 0157)
Further bacterial growth studies were performed in broth media on E.coli 
cultures. Data in Figure 3.33 shows that 10 % (v/v) of autoclaved honey totally 
inhibited the growth of this strain of E. coli. It was evident, however, from the time- 
course growth curves that some inhibition of growth was also evident after 24 hours 
and the growth was 26% and 45% lower than the control at both 2 and 5 % (v/v/) 
respectively. Indeed, this inhibition was dependent on the percentage of honey 
autoclaved with the medium (a dose-dependent response).
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Figure 3.33: The growth of E. coli in the presence of 2, 5, and 10 % honey. E. coli 
was grown in Muller-Hinton broth and incubated at 37 °C under aerobic conditions. 
MHB with no honey ( • ) ,  2 % (H), 5 % (A ) and 10 % (O) honey that had been 
autoclaved with MHB. The growth was assessed speetrophotometrically at 600 nm 
(OD). Data are the mean of three determinations.
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To determine whether a saturated solution of sugar with a similar osmolarity 
to honey, but lacking other components, had a similar antibacterial activity to honey, 
the growth of E. coli was assessed in a liquid culture containing either 10 % honey, 
or 10 % artificial honey or 10 % fructose or 10% glucose autoclaved with the 
medium. Interestingly, the results from this work revealed that neither fructose nor 
glucose were able to prevent the growth of E. coli as effectively as honey. From the 
information presented in Figure 3.34, it is clear from the increasing absorbance at 
600 nm that the growth of E. coli continued in presence of 10 % (w/v) carbohydrate 
solution. Nevertheless, the growth was less than that observed in control so some 
inhibitory action was observed.
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Figure 3.34: The growth of E.coli in MHB with 10 % honey, artificial honey, 
fructose and glucose. E.coli grown at 37 °C under aerobic conditions in Muller- 
Hinton broth with no additions ( • ) ,  MHB with 10 % honey that had been autoclaved 
together with MHB (^ ) , 10 % honey that had been autoclaved alone then added to 
MHB (A), 10 % artificial honey had been autoclaved with MHB (▼), 10 % fructose 
had been autoclaved with MHB (<$>) and 10 %glucose had been autoclaved with 
MHB ( • ) .  The growth was assessed speetrophotometrically at 600 nm. Data are the 
mean of three determinations.
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3.15.3 The effect of honey in the growth of Salmonella Typhimurium
In this experiment, no evidence of growth inhibition was shown at 
concentrations of up to 5 % (v/v) heat-treated honey. The active concentration 
against S. typhimurium was shown to be 10 % (v/v) with no growth being observed 
at this concentration at all as shown in Figure 3.35.
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Figure 3.35: The growth curve of S. Typhimurium grown in Muller-Hinton broth 
incubated at 37 °C under aerobic conditions with no honey (# )  and in the presence 
of 2 % (H), 5 % (A ) and 10 % (^ )  honey had been autoclaved with MHB. The 
growth was assessed speetrophotometrically at 600 nm. Data are the mean of three 
determinations.
In addition, only honey was able to completely inhibit the growth of S. 
Typhimurium in comparison with the same amount (10 %, v/v) of the other 
carbohydrates tested, i.e. fructose and glucose (Figure 3.36). Clearly, the growth has 
been slowed by the 10 % sugars used and some inhibition is evident. However, 
artificial honey and both glucose and fructose are poorer.
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Figure 3.36: The growth curve of S. Typhimurium in MHB in presence of 10 % 
honey, artificial honey, fructose and glucose. S. Typhimurium was grown at 37 °C 
under aerobic conditions in Muller-Hinton broth with no additions (# ), MHB with 
10 % honey had been autoclaved together (^ ) , 10 % honey had been autoclaved 
alone then added to MHB (A), 10 % artificial honey had been autoclaved with MHB 
(▼), 10 % fructose had been autoclaved with MHB ( ^ )  and 10 % of glucose had 
been autoclaved with MHB ( • ) .  The growth was assessed speetrophotometrically at 
600 nm. Data are the mean of three determinations
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3.15.4 The effect of honey (autoclaved with MHB) in the growth of 
Listeria monocytogenes
The activity of autoclaved honey was also tested against Listeria monocytogenes 
which was more sensitive to 5 % honey in the agar studies. As observed in Figure 
3.37 no complete inhibition was observed in the growth of L. monocytogenes culture 
when in presence of 2 % honey. However, it showed some inhibition impact which 
reduced the growth 40% compared to eontrol Moreover, adding 5 % honey to the 
medium completely inhibited the growth off .  monocytogenes.
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Figure 3.37: The growth curve of L. monocytogenes grown in Muller-Hinton broth 
incubated at 37 °C under aerobic conditions with no honey ( • )  and in the presence 
of 2 % (■) and 5 % (♦ ) honey had been autoclaved with MHB. The growth was 
assessed speetrophotometrically at 600 nm. Data are the mean of three 
determinations.
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3.16 A ssessing the effect o f  honey (autoclaved w ith M H B) on the 
growth o f Staphylococcus aureus and m ethicillin-resistant 
Staphylococcus aureus (M RSA)
These experiments were carried out to assess the activity of honey 
(autoclaved with MHB) against Staphylococcus aureus and methicillin-resistant 
Staphylococcus aureus 42517 (MRSA). Table 3.15 shows that 10 % of honey in agar 
was also able to prevent the growth of both types of bacteria when honey was 
incorporated into the medium during the autoelaving process.
Table 3.15: Minimum inhibitory concentrations (MICs) of honey A sterilized by 
autoclaving together with the MH growth medium against S. aurus and MRSA
Bacteria
Honey concentration (autoclaved with MH agar)(v/v))
0.1% 1.0% 2.0% 3.0% 4.0% 5.0% 10.0%
S. aureus +++ +++ +++ +++ ++ ++ -
MRSA +++ +4-f +++ +++ +++ +++ -
MHA plates were prepared with different concentrations of honey A (autoclaved 
together) and colony growth assessed :(+++) Excellent growth; (++) good growth; 
(+) poor growth; (-) no growth.
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Moreover, S. aureus was seen to be unable to grow in the presenee of 2 % 
honey and the number of bacterial counts was still around 6 logio CFU/ml after 24 
hours of incubation (figure 3.38 and 3.39).
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Figure 3.38: The growth of S. aureus grown in Muller-Hinton broth incubated at 37 
°C under aerobic conditions with no honey ( • )  and in the presenee of 2 % (■ ) and 
10 % (♦ ) honey had been autoclaved with MHB. The growth was assessed 
speetrophotometrically at 600 nm. Data are the mean of two determinations ±SD.
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Figure 3.39: The growth of S.aureus grown in Muller-Hinton broth incubated at 37 
°C under aerobic conditions with no honey ( • )  2% honey had been autoclaved with 
MHB (■) and 10% honey had been autoclaved with MHB (♦ ). The growth was 
assessed by measuring the colony forming unit (CFU/ml) Data are the mean of two 
determinations ±SD.
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A similar pattern was observed for methieillin-resistant Staphylococcus aureus 
(MRSA) with complete inhibition of MRSA was observed at 10 % honey 
concentration (figure 3.40). However, MRSA showed more sensitivity to 2 % honey 
(autoclaved with the medium) and MRSA growth decreased 1 logio after 6 hours of 
incubation (Figure 3.40 and 3.41).
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Figure 3.40: The growth curve of MRSA 42517 grown in Muller-Hinton broth 
incubated at 37 "C under aerobic conditions with no honey (# )  and in the presenee 
of 2% (■) and 10% (♦ ) honey had been autoclaved with MHB. The growth was 
assessed speetrophotometrically at 600 nm. Data are the mean of three 
determinations.
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Figure 3.41: The growth of MRSA grown in Muller-Hinton broth incubated at 37°C 
under aerobic conditions with no honey (# )  2% honey had been autoclaved with 
MHB (■) and 10% honey had been autoclaved with MHB (♦ ). The growth was 
assessed by measuring the colony forming unit (CFU/ml). Data are the mean of two 
determinations ±SD.
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3.17 A ssessing the effect o f  honey (autoclaved w ith  M H B) on the  
growth of Helicobacter pylori ^ C T C  11637
Helicobacter and Campylobacter have some similar properties and they are 
related. This suggests that H. pylori may also be susceptible to honey when it is 
autoclaved with the medium and may offer some potential treatment pathways in the 
eradication of H. pylori infection. This experiment was conducted to assess the 
sensitivity of H. pylori NCTC 11637 to honey when it was autoclaved with the 
medium (MH broth and agar). Surprisingly, and in contrast to C. jejuni, when H. 
pylori exposed to 2 % (v/v) honey autoclaved with MHB its growth was not 
completely inhibited. However a 50% inhibition effect was observed after 24 hours. 
As shown for other bacteria, however, Hpylori was not able to grow at the higher 
concentration (10 %) assessed (Table 3.16 and Figure 3.42). Helicobacter pylori 
showed poor growth in Muller-Hinton broth so the growth media was supplemented 
with foetal bovine serum (FBS) to support the growth.
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Table 3.16: Minimum inhibitory concentration of honey A autoclaved together with 
the MH agar against H. pylori NCTC 11637
Bacteria
Honey concentration (autoclaved with MH agar)(v/v))
0T94 1.0% 2.0% 3.0% 4.0% 5.0% 10.0%
H.pylori 11637 +++ +++ ++ ++ ++ + -
MHA plates were prepared with different concentrations of honey A (autoclaved 
together) and colony growth assessed after 72 hours :(+++) Excellent growth; (++) 
good growth; (+) poor growth; (-) no growth. The plates were incubated at 37°C 
under microaerophilic conditions.
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Figure 3.42: The growth of Helicobacter pylori grown in Muller-Hinton broth (+10 
% v/v PBS) incubated at 37°C under microaerophilic conditions with no honey (# )  2 
% v/v honey that had been autoclaved with MHB (■) and 10 % (v/v) honey that had 
been autoclaved with MHB (♦). Regular samples (3, 6 and 25 hour) were taken for 
plate culturing and the growth was assessed by measuring the colony forming unit 
(CFU/ml). Data are the mean of two determinations ±SD.
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Chapter four
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Chapter 4: Discussion
4.1 M inim um  inhibitory concentration o f honey
The work in this thesis began with an investigation assessing the antibacterial 
potency of a range of different honey samples against C. jejuni and comparing the 
antibacterial efficacy of six different kinds of honey. The types of honey used in the 
experiments ranged in their price per gram quite considerably and included the clear 
and pure type available at most local supermarkets. The study also included 
expensive samples of honey which have been reported as biologically active (i.e. 
Manuka and Manuka & Rewarewa honey).
In order to compare the results with some of the previous reports in the 
literature of the field, the honey samples were introduced to the culture medium by 
three different methods. These were 1) filtered and then added to the media, 2) 
autoclaved separately and then added to the media and 3) autoclaved together with 
the media. The outcome of the study revealed that, regardless of method, that the 
growth of C. jejuni was inhibited by all the honey samples that were tested.
The initial experiments revealed that the minimum inhibitory concentrations 
(MICs) of the honey sample were influenced according to the method used to 
sterilize and to introduce the honey to the culture medium. In general, honey was 
able to totally inhibit the growth of Campylobacter strains in this study even when it 
was diluted 10-20 fold. Campylobacter was inhibited by the presence of honey in the 
medium at a concentration of 10 % (v/v) or lower depending on the way in which 
honey was sterilized/added.
The antibacterial activity of honey has been shown in the literature to vary 
depending on the kind of honey used, the concentration employed and the strain of
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bacteria being tested (Taormina et al., 2001). The results of this study are in 
agreement with the findings of Boom et al, (2010) and Lin et al, (2011) where 
antibacterial activity was discovered to differ in relation to the bacterial strain and 
type of honey employed in their experiments. In contrast, however. Basson and 
Grobler (2008) reported that no honey samples that they selected were able to 
produce complete inhibition of growth of bacteria {Streptococcus, Staphylococcus 
aureus and Escherichia coli) at concentrations up to 25 % (v/v). They also noted that 
the effect of honey appeared to be significant when the concentration was increased 
to 40 % (v/v), although this probably means that the osmotic effect was the primary 
mechanism involved at these much higher concentrations.
Although French et al, (2005) found the MIC for honey ranged between 2 
and 5 % (v/v), the osmotic effect together with the sugar content of the honey 
samples tested, were reported to be responsible for the honey’s antibacterial effects. 
However, the investigation completed in the present work revealed that artificial 
honey showed much less antibacterial activity than the real honey samples which had 
a much greater antibacterial activity. This leads to the suggestion that although 
osmolarity is important it is not the only factor responsible for the antibacterial 
activity in honey as reported in some studies especially at the lower concentrations 
used. These findings are in line with Lin et al, (2009) who found that honey’s 
antibacterial effect cannot be only due to osmolarity, particularly when included at 
lower concentrations (around 2%). Moreover, an equivalent amount of artificial 
honey did not generate the same level of antibacterial activity as real honey, a result 
also obtained by El-Essawy et al, (1984) and Lin et al, (2011).
The results from the study here show that some commercial honey varieties 
have good antibacterial activity and that they could be perceived as being as effective
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as much more expensive varieties of honey. It also emphasizes the small variability 
in antibacterial activity and highlights the minimal difference in antibacterial activity 
against C. jejuni of both non-Manuka and Manuka honey. This similar antimicrobial 
activity was also noted by Lusby et al, (2005) who tested three types of honey that 
were commercially available and three types of therapeutic honey including Manuka 
honey. The activity of the honey samples was assessed at a range of concentrations 
between 0.1 and 20 % (v/v) against 13 bacterial strains using the agar dilution 
method and the antibacterial activity for Campylobacter strains was found to be 
similar with MICs around 5 % (v/v). Indeed, there was less than a 5 % difference in 
MICs between Manuka and the other kinds of honey tested revealing that the 
antibacterial effects of high-end honey are not necessarily better than the inexpensive 
types. The results of Willix et al, (1992), who tested two types of honey, agree with 
these findings. They tested honey with a normal range of antibacterial activity and 
Manuka honey with non-peroxide antibacterial activity and found that both types of 
honey were capable of totally preventing bacterial growth at a concentration of less 
than 11 % (v/v).
The MICs of Manuka and Rewarewa when assessed alone were similar in 
this current study. However, Manuka and Rewarewa honey combined (Honey 
sample F) was shown to be the most effective type tested and possessed the highest 
antibacterial activity with a MIC of 2 % (v/v). This is the first time that the 
effectiveness of this combination against Campylobacter has been reported.
Manuka honey alone gave rise to a lower activity with a MIC of 4 % (v/v) 
compared to Manuka and Rawarewa honey combined. Manuka honey is the type of 
honey that has been the most extensively studied in laboratory studies and has been 
claimed to have a broad-spectrum of antimicrobial activity against many bacteria
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(Allen, 1991). A similar MIC was reported by Cooper et al, (1999) for pasture 
honey against 58 strains of Staphylococcus. This is noteworthy as pasture honey is a 
variety of honey that comes from a similar region to Manuka honey and it may 
therefore have similar properties. A similar investigation was carried out by Lin et 
al, (2011) and the range of MIC values observed for Manuka honey against a 
selection of gastrointestinal pathogens was found to be between 5 and 10 %. 
However, it is evident that the method used to determine the MIC can produce 
different results. For example, using the micro-dilution method by Lin et al, (2009) 
to evaluate the efficacy of Manuka honey against Campylobacter spp. (20 strains of 
C. jejuni and 7 strains C. coli) showed that the bacteria were more sensitive and the 
MIC using this method was around 1 % which is lower than the study here. Support 
for this contention, comes from the study by Luber et al, (2003) who demonstrated 
that the sensitivity of Campylobacter to an antibiotic was dependent on the method 
used to determine the MIC. Here the susceptibility to erythromycin was lower in a 
broth micro-dilution method than the other methods (E test and agar dilution) used in 
the same study. It is therefore evident that this feature needs to be taken into aecount 
when assessing results.
Osmolarity is an important factor in the inhibitory effect of some 
antimicrobials including honey. At high concentrations of honey, the antibacterial 
effect is closely linked to a high osmolarity. However, in this study it is evident that 
honey could be growth-stimulatory when present at low concentrations and sterilized 
by filtration. In this respect, the growth of C. jejuni was observed to be slightly 
higher in culture medium containing 1 % (v/v) filtered honey. This finding is in 
agreement with Reezal et al, (1998) who found that the growth of C. jejuni was
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higher in the medium with a moderate osmolarity (0.5 % NaCl) rather than a very 
low osmolarity growth medium, regardless of the osmolyte used.
In other experiments honey was heat sterilised (at I2I°C) using an autoclave 
and tested for antibacterial activity. By doing this the enzymes in the honey were 
effectively destroyed especially glucose oxidase which is thermally denatured at 
temperatures of around 72 °C (Nokmura et al, 1976). However, it was interesting to 
see, that when honey was autoclaved before it was introduced to the culture medium, 
its antibacterial aetivity was observed to become marginally more pronounced, not 
less effective, against C. jejuni. This is in contrast to the studies of White and Subers 
(1964), and then later by Molan and Allen (1996), which reported that the 
antibacterial activity in honey was heat-labile. Both studies concluded that 
antibacterial activity in honey is easily destroyed by heat and would therefore be 
eradicated when honey had been autoclaved. The results of this present study are 
contrary to this and show that the antibacterial effectiveness of autoclaved honey was 
higher than the activity of un-autoclaved honey. This supports the suggestion, 
reported in other previous studies, that the major antibacterial activity in honey is 
heat stable and comes from a non-hydrogen-peroxide mechanism as explained by 
Molan (1998). Furthermore, the findings of this present study are in agreement with 
Mandai et al, ., (2010) who showed that the process of autoclaving honey enhanced 
its antibacterial activity against Escherichia coli. Pseudomonas aeruginosa and 
Salmonella spp. Moreover, according to Turhan et al, (2008) heating honey at a high 
temperature (up to 90 °C) for 90 minutes did not affect its quality.
One of the crucial findings of this study was the fact that when lower 
concentrations of honey (2 %, v/v) were autoclaved together with MH media, that for 
all honey types, the antibacterial activity was significantly greater against C. jejuni
142
C hapter 4: Discussion
compared to that seen when other methods were used to sterilize/introduce honey 
into the media. This novel finding is in general agreement with Kim and Lee (2003) 
who observed a significant growth inhibition when bacterial growth media contained 
sugar and amino acids. Their explanation for this effect was thought to be due to a 
chemical modification taking place, i.e. the so called Maillard reaction (Kim and 
Lee, 2003). This aspect will be explored further in Section 4.2.
In this study different Campylobacter strains were assessed including C. 
jejuni and C. coli. Although most of the work was conducted with C. jejuni NCTC 
11168, all strains tested showed similar sensitivity which revealed that honey has 
strong antibacterial activity against Campylobacter regardless of the strain type. 
Moreover, some strains showed more sensitivity to the preparations of honey 
autoclaved with media with even 1 % being effective in the case of C. coli 11437. A 
similar difference in sensitivity was also reported in antibiotic sensitivity and Tambur 
et al. (2009) found that C. coli strains were more sensitive to antibiotics than C. 
jejuni.
4.2 Effects o f  honey on the m edium  properties
It is evident that when adding an acidic substance like honey to 
microbiological media the pH of it will be changed. Therefore measuring the pH of 
the medium after adding honey is an important step in assessing the extent of this 
effect. In general, a reduction in pH levels was observed when honey was added to 
the medium. However, this reduction was not considered responsible for the 
antimicrobial activity of honey as when honey was added to media it showed 
significant activity at low concentrations (between 2 and 10 %, v/v) even when the 
pH change was not sufficient to prevent growth. The filtered and autoclaved honey at 
the highest concentration (10 %) lowered the pH value for the media from pH 7.09 to
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5.84 and 5.53, respectively. The acidic nature of honey and the enzymatic generation 
of acids such as gluconic acid when honey is diluted accounts for this reduction and 
this in accordance with what been reported by Wahdan (1998). Moreover, the most 
notable reduction in pH was observed in the media that was thermally treated after 
the addition of honey. For the 10 % honey concentration the pH dropped from pH 
7.09 to pH 5.35. The formation of acids has been reported when a reaction occurs 
between amino acids (present in the medium) and reducing sugars (present in the 
honey) (Clark and Tannenbaum, 1970). The accumulation of products of this 
reaction in the medium results in a reduction in pH as a consequence of the creation 
of acidic compounds, such as organic acids. This result is in agreement with previous 
observations conducted by Morales and Jimenez-Perez (2001), Benjakul et al, (2005) 
and Kim and Lee (2009). These authors have reported that pH levels in the media 
often decline over time as temperature rises as a consequence of the reaction. This 
decline is a result of the creation of organic acids, such as formic and acetic acid 
(Brands and Van Boekel, 2002). These short-chain organic acids (SCA) have been 
proven to have a bactericidal effect on many bacteria. In studies using these acids to 
control Campylobacter transmission in water it was shown that a decrease in the 
number of colonies occurred to below the limit of detection in one hour (Chaveerach 
et al, 2002). According to Van Netten et al, (1994) 2 % of acetic acid was effective 
in controlling Campylobacter in meat. However, it was reported by Chaveerach et al, 
(2002) that the structure of these acids has a more important role in their antibacterial 
activity rather than simply causing a reduction in the pH. Indeed, it was observed that 
formic acid had a stronger impact on Campylobacter culturability than acetic acid at 
a similar pH.
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When the colour of the honey was compared to its antibaeterial activity, there 
appeared to be little correlation. Studies carried out by Frankel et al, (1998) and also 
Taormina et al, (2001) are in contrast to these findings and these suggested a link 
between colour and the antimicrobial activity of honey. Both of these studies 
demonstrated that the darker coloured honeys possessed the higher antimicrobial 
activity. The difference between the current work and that of Frankel et al, (1998) 
and Taormina et al, (2001) may relate to the selection of honey samples used. 
However, it was evident in the current work that the Manuka and Rewarewa honey 
that was used, which had the highest antibacterial activity, had a light colour in 
contrast to the less effective but darker ones.
In terms of the obvious browning that occurred during autoclaving and the 
change in the colour of the media, the data in this thesis demonstrate that an increase 
in the formation of brown pigments occurred in the media supplemented with honey. 
For example, the absorbance measurement at 420 nm showed an increase in the 
brown pigments being generated after adding honey with autoclaving. The browning 
intensity increased as a result of increasing the heating time or increasing the heating 
temperature. A study by Turkmen et al, (2006) using heated honey alone 
demonstrated that that the highest temperature used in their study was more effective 
in generating the brown pigment fi-om honey when it was heated at different 
temperatures (50, 60 and 70 °C), a finding that is confirmed in the current study. In 
our experiments, collectively, the increase in brown colour reached the highest level 
when honey was autoclaved (at 121 °C) with MH media. It is evident that the colour 
formation is almost certainly due to the non-enzymatic browning occurring in the 
presence of amino acids and reducing sugars (present in honey) as explained by 
Fayle et al, (2001). These brown pigments are produced in the final stage of the
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reaction according to Ames (1992). Moreover, a correlation between the increase in 
the browning intensity and antibacterial activity was observed in the honey-casein 
MRPs when exposed to prolonged heating (72 hours) at 55 °C which was generally 
equivalent to the colour change observed when the mixture was heated at 121 °C for 
15 min. This in agreement with other studies which have reported a correlation 
between the increase of a brown colour and the biological and chemical effects of the 
products, including the formation of antioxidants (Brands et ah, 2000; Morales & 
Jimenez-Perez., 2001).
Also, Turkmen et al, (2006) reported a strong correlation between the 
increase in the brown colour in heated honey and its antioxidant aetivity. Their 
results showed a positive correlation between the formation of brown pigments and 
antioxidant activity with temperature. Furthermore, this was more noticeable when 
honey was heated for a longer time or at a high temperature (70 °C). Similarly the 
influence of heat in the colour formation and the antioxidant activity of honey was 
reported by Taormina et al, (2001).
However, the development of the brown colour alone is not an obvious 
feature of the active MRPs and this is not sufficient evidence for the generation of 
bacterial inhibitory agents. Indeed, in the current work the brown colour was also 
observed in both the active (honey-casein) and inactive (sugar-casein) MRPs mixture. 
This finding is in agreement with Jing and Kitts (2002) who emphasized that the 
generation of the brown colour in heated sugar-casein mixtures is not always 
correlated to the generation of biochemically active MRPs.
As the addition of honey to microbiological media followed by heating 
enhanced its antibacterial activity against C  jejuni, it was assumed that a chemical 
reaction occurred between the reducing sugars in the honey (containing carbonyl
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groups) and amino acids in MH media (amino groups). This initial reaction, the 
carbonyl amino reaction, is the first stage of the complex Maillard reaction and this 
pathway was therefore suspected to be responsible for the generation of the 
antibacterial activity. The decrease in the medium pH and the dramatic increase in 
the dark brown colour gave rise to this suggestion. Moreover, there is new interest in 
studies concerned with honey and its content of Maillard reaction like products 
(MRLP) and how this affects the antibacterial action of honey. For example, a strong 
link has been found between these compounds and the antibacterial action of twenty 
samples of Canadian honey when tested against E. coli (Brudzynski and Miotto, 
2011).
Furthermore, Beretta et al, (2005) reported an increase in the amount of a 
similar compound (unidentified, called P) in the brown pigments extracted from 
unprocessed acaeia honey, honey heated alone and honey heated with its main amino 
acid (proline) when they analysed them using liquid chromatography-mass 
spectrometry LC-MS. Moreover, analysing honey samples before and after heating 
by size-exclusion chromatography (SEC) identified an increase in the related 
compounds, namely the melanoidins, which means that heat accelerated the 
formation of MRPs in honey (Brudzynski and Miotto, 2011).
The sequence of reactions in which these products (MRPs) are created occurs 
in three key phases. The initial step involves the reaction between amine groups of 
the amino acids with carbonyl group of the sugar to generate Amadori rearrangement 
products (ARP). Eventually these intermediates products undergo dehydration to 
form reductones that participate in various oxidation-reduction reactions and form 
more complex products which called melanoidins (Hodge, 1953).
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It is during the intermediate phase that the coloured compounds start to 
develop. These compounds, including the a-dicarbonyl compounds, such as 
methylglyoxal, are thought to be some of the active factors in Manuka honey 
(Brudzynski and Miotto, 2010). It is important to note that honey initially contains 
MRPs, as reported by Brudzynski and Miotto (2011), and this can affect the final 
amount of MRPs present after heat treatment. This causes a significant enhancement 
in the formation of MRPs and increases the final concentration of MRPs by up to 
three fold.
The aforementioned work lead to the study of the antibacterial activity of a 
mixture generated by mixing a specific amount of honey (2 g) with the main 
component of MH media (i.e. casein). These results showed that the growth and 
survival of C. jejuni dropped to below the detection limit and non-culturability was 
reached after six hours of incubation with this mixture (honey-casein MRPs). This 
was similar to the activity that was observed by adding honey to the MH media. It 
therefore seems highly likely that the antibacterial agents produced as a consequence 
of the Maillard reaction and that these have a strong influence on the growth and 
survival of C. jejuni.
4.3 Factors affecting the production o f  honey-casein antibacterial 
agents
More studies were carried out to understand what factors affected the 
generation of antibacterial compounds in the honey-casein mixture (termed honey- 
casein MRPs). As it was assumed that the active antimicrobial agents were the result 
of the Maillard reaction, the factors reported previously to be important in generation 
of the biological activity of MRPs, were further studied. For example, according to
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Lanciotti et al, (1999) different compounds with different properties could be 
formed by heating different sugar-amino acids solutions.
Studying the effect of heating temperature on the production of the 
antibacterial compounds showed that only 121 °C was effective and using lower 
temperatures i.e. 100 °C and 80 °C for the same length of time (15 minutes) was not 
sufficient to generate the antibacterial activity. This result in agreement with Wang et 
al, (2011) who highlighted that both the temperature and the duration of the heating 
process were key factors in the generation of biologically active MRPs. However, it 
was evident from the current experiments that a lower temperature can be effective in 
producing these active compounds when it is used for a longer time. Here the 
heating of the honey-casein mixture at 55 °C for a long duration (24, 48 and 72 hours) 
gave rise to an increase in the production of antibacterial agents. Similar results were 
reported by Einarsson (1987) who reported that the maximum antibacterial effect of 
MRPs from a histidine-glucose mixture was reached by increasing the temperature 
from 80 °C to 120 °C or by heating the mixture at 100 °C for a longer time (10 or 20 
hours). Indeed, Antony et al, (2000) reported the generation of other active 
compounds with different properties using a similar type of carbohydrate/amino acid 
mixture. This group mixed 0.3 M dry honey with 0.2 M lysine and heated his for 4, 8, 
12, 16, and 20 hours. The resultant products showed strong antioxidant activity 
which was related to the duration of heating.
In addition to the above results, it is worthwhile noting that the antibacterial 
activity observed in this study was obtained when using honey and no other reducing 
sugar. Indeed, only honey MRPs showed bactericidal action against the range of 
bacteria studied. Jing and Kitts (2004) demonstrated considerable variation in the 
physicochemieal parameters of MRPs as a result of using three kinds of sugar when
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they were mixed with lysine to generate model MRPs. In addition, Hegele et al, ., 
(2009) observed that the biological action of MRPs relies heavily on the kind of 
sugar being used and this was observed in mixtures of sugars (ribose, lactose or 
glucose) and lysine when heated at 120 °C for up to 5 hours. Likewise this present 
study tested other monosaccharides and the result confirmed that no antibacterial 
agents were generated in contrast to what was seen for honey.
The role of different amino acids in the formation of the antibacterial 
compounds was also investigated in the current study. Kim et al, (1991) revealed 
that the type of amino acid used plays a significant role in regards to the biological 
action of MRPs formed. To assist in this proeess the amino acid composition of 
casein was examined and the amino acids present in casein at the highest levels were 
used in a series of experiments. These experiments used each amino acid individually 
in order to elucidate which amino acid may be the most important in terms of 
generating the antibacterial effect when mixed and heated with honey. Interestingly, 
the combination of honey and one individual amino acid did not give rise to the same 
antimicrobial activity seen when the whole casein extract was used. This finding is in 
general agreement with Kim et al, (1991) who reported that the activity of sugar- 
amino acid combinations against S. Typhimurium was higher with amino acid 
combinations (arginine and lysine) when they were mixed together with glucose than 
when each amino acid was used alone. Furthermore, in the present work it was 
observed that among all the amino acids tested, less than 25 % of them (lysine, 
phenylalanine, tyrosine and aspartic acid) were active in terms of generating active 
antibacterial agents with none giving rise to activity as strong as the honey-casein 
MRPs. However, the majority of the amino acids tested (76.5 %) did not show any 
zone of inhibition. This is in general agreement with Field and Lichstein (1958) who
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reported that only three of the nine amino acids tested exhibited good activity when 
autoclaved with glucose in the medium. Einarsson (1987) also investigated the effect 
of different amino acids in the formation of antibacterial compounds against 
Staphylococcus aureus and reported that an arginine containing mixture gave rise to 
a greater inhibitory effect than histidine, when these were mixed with either glucose 
or xylose.
To investigate the Maillard reaction further and to establish what was 
happening to one of the main constituents of honey (as a result of its interaction with 
casein), studies were performed to measure the amount of glucose pre- and post 
autoclaving with honey. The disappearance of glucose in the autoclaved glucose- 
casein mixture was 1-fold higher than honey-casein MRPs which may due to the 
presenee of multiple components in honey that are believed to be involved in the 
Maillard reaction. According to Ajandouz et al, (2008) the loss of glucose in 
Maillard reaction was found to increase with amino group availability and decrease 
with hydroxide ion availability.
4.4 U ltrafiltration o f  the honey-casein M RPs
The formation of compounds in the Maillard reaction is a result of a variety 
of sugars and amino acids reacting and these result in the generation of compounds 
with widely differing molecular-weights (Hoffinann, 1998). These compounds can 
be divided in two groups, namely, a low molecular weight (LMW) fraction and a 
high molecular weight (HMW) fraction (Rufian-Henares and Morales, 2007). Hence 
it was decided to use molecular weight cut-off membranes to create different 
fractions from the honey-casein MRPs. Using this separation technique it is evident 
that the different fractions possessed different activities. This experiment also
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showed that the majority of the honey-casein MRPs (more than 50 %) were of high 
molecular weight (HMW) with a size of greater than 5000 Da. The percentage of the 
mixture with a molecular weight less than 2000 Da was around 20 %. This result is 
in agreement with Wang et ai, (2011) who showed that 59 % of the MRPs are HMW 
with 10000 Da and higher. These HMW compounds were also shown to possess the 
inhibitory activity with no zones of inhibition evident around the discs containing the 
lower MW fractions. Similar results have been reported by Hiramoto et al, (2004). 
The work of Rufian-Henares and Morales (2007) support this finding also, and this 
study also demonstrated that the HMW compounds from food-derived MRPs (by 
mixing sugar, amino acids and other food components) possess higher antimicrobial 
activity compared with those MRPs produced in model systems with low molecular 
weight. The higher activity is thought to be due to the higher complexity of food 
derived MRPs. In this current study, honey was used to generate MRPs and this is a 
simple way to generate more potent antibacterial agents through Maillard reaction.
4.5 The antibacterial activity o f  honey-casein M RPs
The antibacterial activity of honey-casein MRPs was assessed firstly in 
growth medium (MH broth). This experiment showed that there was a rapid decline 
in the number of C  jejuni cells which were able to grow in the presence of honey- 
casein MRPs with a complete loss of viable cells after 6 hours of incubation. For 
further confirmation and to provide a food specific role for the antibacterial activity 
of honey-casein MRPs against C. jejuni, the activity was tested in UHT milk. This 
experiment showed that the addition of honey-casein MRPs had a similar bactericidal 
effect to that observed in MH media and that C. jejuni was not able to survive for 
greater than 6 hours in this system.
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It is interesting to note that little attention has been paid to the antibacterial 
activity of MRPs and this aspect has not been fully studied or reported in the 
literature. Indeed, most research has focused on their effects in the diet (Ames et ah, 
1999, Jing and Kitts, 2002) and their deleterious effects in human systems (Tessier, 
2010). There have also been studies on the undesirable effect on microbiological 
media during autoclaving (Einarsson, 1986) and on their pronounced antioxidant 
activity (Antony et al, 2000). However, according to Einarsson, (1986) the 
production of both antibacterial and antioxidative compounds is favoured by the 
similar reaction conditions including the temperature and reaction time. One of the 
earliest reports on their antibacterial activity was by Jemmali (1969) who studied the 
positive effect of glycine-dextrose MRPs on the intestinal microflora. In the 1980s, 
Einarsson and his colleagues did some studies to investigate the antibacterial activity 
of Maillard reaction products and the effect of temperature, time, pH and reactants on 
the formation of these antibacterial compounds. This current study examined in 
detail the antibacterial activity of these compounds and in particular their striking 
activity against Campylobacter species, which are leading causes of foodbome 
illness.
4.6 The im pact o f  catalase
According to the result of Bang et al, (2003) and Hegele et al, (2009) honey 
dilution and MRPs were both reported to produee hydrogen peroxide. This is an 
effective antibacterial agent and its generation might be a way to explain the effects 
observed with honey. To further understand the role of hydrogen peroxide formation, 
the contribution of hydrogen peroxide in the antibacterial activity was assessed in the 
presence (and absence) of catalase. Honey-casein MRPs were treated with sufficient 
catalase to eliminate the effect of hydrogen peroxide and then tested against C. jejuni.
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It has been reported by Kim et al, (1991) that employing catalase at concentrations 
of 20 pg/10 pi inhibited the activity of MRPs against S. Typhimurium (Kim et al, 
1991). However, the result demonstrated by Kim et al, (1991) is in contrast to the 
efficacy of antibacterial effects observed for honey-casein MRPs in this current work, 
which showed that the aetivity was not completely destroyed by catalase addition. 
Nevertheless, the growth of Campylobacter in catalase-treated honey-casein MRPs 
solutions was retarded and the lag phase was extended (by 3 hours) compared to the 
growth of C. jejuni in the presence of catalase untreated honey-casein MRPs which 
means adding catalase extended the C. jejuni survival time by 50 %
As the exogenously added catalase had little effect on the antibacterial 
properties of the MRPs it was decided to investigate the contribution of endogenous 
C. jejuni catalase, one of its oxidative defence systems. For these experiments a 
catalase-deficient mutant of C. jejuni (katA) was used and this showed that these 
organisms had greater sensitivity to honey-casein MRPs compared to the wild-type. 
Indeed, the mutant killing time was 2 hours shorter compared to the wild type C. 
jejuni. This experiment clearly showed that catalase provides C. jejuni with some 
protection against the antibacterial activity of honey-casein MRPs. This is consistent 
with the work of Grant and Park (1995) who reported that the C. jejuni katA mutant 
is hypersensitive to H2 O2 . It is therefore likely that the slight increase in the 
sensitivity of the C. jejuni katA mutant to MRPs, compared to the wild type strain, 
can be attributed to the generation of H2 O2 in the media.
4.5 M echanism  o f antibacterial action
The TEM images created in this study confirmed the development of 
coccoidal shaped C. jejuni cells after treatment with honey-casein MRPs. The images 
showed that during the shape conversion process the cells became shorter which is
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agreement with the studies of Moran and Upton (1986) and also with the work of 
Rollins and Colwell (1986) that showed that this was due to the loss in cytoplasmic 
components. Moreover, the image of the bacterial cells during the transition process 
(after 3 hours of incubation with honey-casein MRPs) clearly showed the membrane 
with bleb-like features around the cells. Similar images have been observed in C. 
jejuni during starvation by Beatriz Lazaro et al, (1999). The formation of these bleb­
like features is believed to be one of the survival strategies in which C. jejuni adjusts 
the cell volume and reduces the maintenanee requirements according to an 
explanation put forward by Jiang and Chai (Jiang and Chai, 1996).
The LIVE/DEAD staining was used to confirm membrane integrity and the 
results showed that cells after treatment with MRPs retained their membrane with no 
disruption and were still viable. This finding is in agreement with the studies 
reported by Rollins and Colwell (1986), Yiping and Chen (2010) and Cameron et al, 
(2012). Both the TM data and the LIVE/DEAD staining results support the finding 
that Campylobacter enters the viable but non-culturable state (VBNC) under the 
unfavourable conditions as first reported by McKay (1992).
Our results also confirm that the VBNC form of C. jejuni is irreversible and 
that transferring the treated cells to an enriched medium did not support their growth. 
In effect, the recovery fi’om the coccid form was not possible and this result in 
agreement with Beumer et al, (1992) and Yiping and Chen (2010). This rapid 
decline in the cells’ culturability could be due to the loss in cytoplasmic contents as 
reported by Reezal et al, (1998). However, the results presented here are in contrast 
to those reported by McKay (1992) who showed that the VBNC form appeared 
reversible when the conditions changed and the growdh environment was improved.
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The mechanism by which honey and its Maillard reaction-like components 
kill bacteria has very recently been explained by Brudzynski et al, (2012) who 
suggest that DNA is degraded by these antibacterial agents which results from the 
interaction between phenolic compounds and hydrogen peroxide. However, different 
studies suggest that different aetions may be responsible for the antimicrobial activity 
of the Maillard reaction products. Field and Lichstein (1958) explained that adding a 
reducing sugar and casein mixture to the media during the heating process caused the 
production of factors that can displace carbon dioxide (~10 % CO2) from the media. 
These factors may affect the growth of Campylobacter as it requires 10 % carbon 
dioxide for optimal growth as reported by Bolton and Coates (1983).
Furthermore, Brudzynski c/ al, (2012) tested the antibacterial activity of 
honey (13 types including Manuka honey) against methicillin-resistant 
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium 
(VRE) and compared this activity to bacterial growth inhibition caused by hydrogen 
peroxide. They also examined the effect of both honey and H2O2 in causing DNA 
degradation.
4.7 Effect o f  honey-casein M R Ps in C. jejuni v irulence
Galleria mellonella (wax moth) larvae were used in this study as an animal 
model to determine C. jejuni virulence and its ability to cause infection in the 
presence of honey-casein MRPs. C. jejuni was introdueed to the larval body together 
with a selection of different concentrations of honey-casein MRPs 0 %, 1 %, 2 % and 
5 % (w/v). Following the challenge with MRPs and 24 hours of incubation at 37 °C, 
the viability and the appearance of the larvae were visually assessed. The appearance 
of a dark colour was observed in the larvae infected with C. jejuni only (i.e. no co­
treatment with honey-casein MRPs). This change in the colour from pale yellow to
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dark brown was associated with 90 % death of the larvae. It is apparent that this dark 
colouration is part of the larval immune response to infection and it is due to an 
accumulation of haemocytes being formed around the foreign bodies (Lackie, 1980). 
Nappi and Christensen (2005) reported that the production of the brown coloured 
compounds (melanogenesis) safeguards the endogenous tissues inside a cavity from 
any harm caused by the eradication of the pathogen. However, when the honey- 
casein MRPs were present in the inoculum at 2 % and 5 % concentrations, 90 % and 
100 % of the larvae survived, respectively. This result indicates that the presence of 
honey-casein MRPs decreases the ability of C. jejuni to infect G. mellonella.
In addition to the experiments above, cell culture was used to assess C. jejuni 
virulence in the presence of honey-casein MRPs. These experiments showed that 
there was no differenee between the numbers of bacterial cells able to adhere to 
Caco-2 cells in the control and the treated cells. No effect was observed on C. jejuni 
adhesion to Caco-2 cells when the mixture was added at the same time or even after 
one hour of infection and incubation. However, the ability of C. jejuni to invade the 
cells showed a different pattern. These experiments showed that there was a 
significant decrease in the number of cells invaded in the presence of MRPs. This 
result is supported by the findings of Jones et al, (1981) who showed that the 
adherence of Campylobacter to the host cells can be reversible or irreversible. In the 
case of the irreversible adherence the bacterial cells can cross the host cell’s 
membrane and then invade them. These results are in agreement with Hiramoto et al, 
(2004) who reported the effect of food melanoidins against the closely related 
species Helicobacter pylori. In their study they tested seven different melanoidins 
prepared by Maillard reaction with similar molecular weights, including casein- 
lactose, casein-glucose, 7S-globulin-glucose, Lactoglobulin-glucose, crust of English
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muffin and glycine-glucose. Only melanoidin I (derived from casein-lactose MRPs) 
suppressed H. pylori colonization and showed a significant effect on H. pylori 
growth, binding and colonization in both in vitro and in vivo experiments.
4.8 The toxicity o f  honey-casein M RPs
The effect of honey-casein MRPs on cellular viability was assessed after 
incubating the human colonic carcinoma cell line (Caco-2) with different 
concentrations of honey-casein MRPs using a cell viability assay. This colorimetric 
assay (MTT assay) was used to measure the ability of cellular enzymes to reduce the 
tétrazolium dye to formazan, (purple colour). The findings from this work showed no 
significant toxic effects of honey-casein MRPs when tested at 2 % against the Caco-2 
cell line. A similar result was obtained by Jing and Kitts (2002). Moreover, no toxic 
effects of MRPs have been observed against other cell lines such as COS-7 and HL- 
60 cells which have been studied by Chevalier et al, (2001) using beta-lactoglobulin 
(BLG) and six different sugars including arabinose, galactose, glucose, lactose, 
rhamnose or ribose. Sumaya-Martinez et al, (2005) also reported no enhanced effect 
of MRPs in vero cells and 3T3 cells. In addition, Jiang et al, (2013) confirmed the 
effect of sugar type in the toxicity of MRPs and showed that MRPs derived from 
galactose had a slight inhibitory effect on Caco-2 cell growth, whilst MRPs produced 
from ribose and lactose had no cytotoxicity. The role of different sugars in the 
toxicity of MRPs has also been reported by Hegele et al, (2009) and Kim et al, 
(1991). Moreover, the cytotoxic impact of MRPs using different cell lines has also 
been reported. For example Chibber et al, (1997) showed that MRPs from glucose- 
bovine serum albumin (BSA) affected the growth of bovine retinal capillary 
endothelial cells (BREC). However, the results showed that inhibition of cellular 
viability occurred at the higher concentration (10 %) of honey-casein MRPs.
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Nevertheless, previous research indicates that hyperosmolar solutions arise as a result 
of high concentrations of the mixtures experimented which can diminish the viability 
of cells in an undefined way (ScherlieB, 2011). This impact should not be ignored as 
it is considered to be the reason behind the general toxic effect of high concentration 
of any substanees.
4.9 H PLC  analysis
As the degradation products of honey-casein MRPs exhibited an antibacterial 
activity, HPLC of the mixtures before and after autoclaving was used to detect the 
active compounds. The chromatogram clearly revealed the appearance of some peaks 
after autoclaving. It was also evident that honey-casein MRPs, were generated during 
prolonged heating at 55 °C, and that an increase in some peaks paralleled the increase 
in the antibacterial activity. It is evident from the literature that different compounds 
are generated by the Maillard reaction and this is heavily dependent on the substrates 
present, the reaction conditions, the heating temperature and the length of the heating 
process, the initial pH, the initial water activity, the type of sugar and amino acids 
and the ratio between them. These conditions lead to a variety of complex structures 
and a range of unknown components. This complexity in the chromatogram observed 
in the HPLC analysis made it too difficult to obtain a clear structure for Maillard 
reaction products and this has been supported by other researchers in the field (Ames, 
1998). Additionally, honey is not only a saturated sugar; it is a complex natural 
substance and contains polyphenols, carbonyl compounds, ascorbic acid and 
minerals which all take part in the Maillard reaction (Manzocco et ai, 2001). 
According to Ames (1998) in many cases of the Maillard reaction the formation of 
its compounds is not clear and separating them is a difficult. Moreover, the efforts to 
detect unknown peaks derivatives were unsuccessful due to a lack of standards. As
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this work revealed that the active components were of high moleeular weight (>5000 
Da), compounds at that size could not easily be detected using the LC/MS facilities 
as the maximum detectable molecular weight is 2000 Da. This generated some 
limitations and further investigation will be required to determine these components.
Some further work was carried out to investigate some of the important 
substrates that may have been present in the honey reaction. As such the O- 
phenylenediamine (OPD) method was developed and used to detect one of these 
compounds: This was methylglyoxal (MGO) using an HPLC method after 
derivatization of honey-casein MRPs with OPD. The chromatogram confirmed the 
present of MGO in the mixture. MGO in food has been reported to have a correlation 
with antibacterial activity such as honey as well as MRPs (Adams et al, 2009, 
Marvic et al, 2008 and Chen and Kitts 2011). When the antibacterial activity of MGO 
was examined against C. jejuni it showed a high activity. The MIC was 1 mM which 
in agreement with (Adams et al, 2009). Moreover, MGO has been reported to be 
involved in further reactions in the presence of amino acids which generate more 
active compounds. These compounds may have antibacterial activity and enhance the 
activity of the final mixture. One of these possible compounds is 
Carboxymethyllysine (CML). The antibacterial activity of CML against C. jejuni 
was also investigated and the MIC was 15 mM and this result
4.10 E ffect on other bacteria
Regarding other microorganisms which were studied in this work, in general, 
10 % honey was able to inhibit the growth of all bacteria in this study. This in 
accordance with Lin et al, (2011) who showed that the growth of seven bacterial 
strains was completely inhibited by a concentration below 11 % (v/v). The inhibitory 
activity of honey against two other bacteria associated with diarrhoeal disease, E.
160
C hapter 4: Discussion
coli and S. Typhimurium, were identical with no inhibition of bacterial growth being 
observed at 0.1 to 5 % autoelaved honey. This is in accordance with the work of 
Wilkinson and Cavanagh (2005) who showed that 1 % of 13 different honey samples 
were not active against E. coli. In the present study, only 10 % (v/v) of honey was 
active and totally inhibited the growth of E. coli and S. Typhimurium. A variety of 
honey concentrations have been reported to prevent the growth of E. coli and these 
range between 2.5 % (Wilkinson and Cavanagh, 2005) and 22.5 % (Tan et al., 2009). 
In comparison experiments on the antibacterial activity of honey, artificial honey, 
fructose solution, and glucose solution, showed that only 10 % honey showed totally 
inhibited the growth of E. coli and S. Typhimurium. However, interestingly Listeria 
monocytogenes was slightly more sensitive and was inhibited by 5 % (v/v) in this 
study whereas it was inhibited by in 12.5 % of Manuka honey which is more than 2- 
fold higher when honey was used alone in the study by Majtan and Majtan (2009). 
Furthermore, Staphylococcus aureus and methicillin-resistant Staphylococcus aureus 
showed similar sensitivity and were killed by 10 %. The study by Einarsson (1987) 
was in part agreement. In his investigation, not all mixtures tested showed an 
inhibitory effect against Staphylococcus aureus.
The activity of honey was also evaluated against Helicobacter pylori and this 
showed similar pattern of growth with no complete inhibitory effect at less than 10 %. 
However, it was obvious that there was a gradual decrease in the number of colonies 
in the presence of 2 % with 2 log reduction after 24 hours of incubation. Comparing 
the growth of C. jejuni and H. pylori it is evident that the latter grows more slower 
and this should be taking into account when assessing the sensitivity to an 
antibacterial agents. Moreover, adding foetal bovine serum (PBS) to support the poor 
growth in Muller-Hinton broth may also have had a protective effect from
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antibacterial activity of the honey. As reported by Hiramoto et al, (2004) H.pylori 
only showed sensitivity to 14 % of the mixtures studied and only lactose-easein 
MRPs was able to prevent the growth of H. pylori in both in vitro and in vivo 
experiments.
Overall, honey showed great antibacterial activity against Campylobacter in 
all the ways in which was introduced to the media. The result showed that heat 
treatment increase the antibacterial activity of honey and a further enhancement was 
achieved by adding casein and which seems to have had a role in generating more 
active antibacterial agents. Controlling the conditions of the reaction had a positive 
impact and showed the possibility of creating mixtures with greater activity. 
Studying the effect in C. jejuni growth in media and a food stuff, as well as studies 
on virulence and changes in morphology confirmed the activity. Moreover, the 
honey-easein MRPs had an effect on the growth of all bacteria in this study including 
E. coli, S. Typhimurium, L. monocytogenes, S. aureus and H. pylori.
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Chapter five
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Chapter 5: General discussion
Nowadays, Campylobacter is a leading cause of bacterial diarrheal disease 
and human gastroenteritis in the world (Alios, 2001). In the UK it has been estimated 
that approximately half a million people are affected by Campylobacter food 
poisoning and this is associated with -100 deaths (FSA, 2011). It is therefore evident 
that reducing the risk of human infection by Campylobacter is a priority and needs 
more research activity. As poultry, chickens in particular, are considered to be the 
main source of Campylobacter contamination it is clear that this area would be a 
useful one to focus upon. There is evidence that controlling Campylobacter on farms, 
broiler units and slaughterhouses can lead to a significant reduction in the number of 
cases of human Campylobaeteriosis (EFSA, 2011) but at present this requires 
expensive investment in bioseeurity measures. Improving food safety is an 
important area of research which has a direct impact on public health. Using 
antibacterial agents to eliminate the presence of Campylobacter in food and reducing 
it from colonized chicken are two important strategies. Indeed, several approaches 
have been tested to reduce Campylobacter numbers in poultry including the use of 
bacteriophages, bacterioeins and organic acids with varying results (Doyle and 
Erickson, 2012). Disinfectants such as those containing phenol-related compounds 
and ethyl alcohol, which have been used in hospitals to control bacterial 
contamination, can be effective in the short term. However, these kinds of product 
are toxic to animals and this can limit their use. Hence, alternative compounds and 
preservatives with strong antibacterial activity but with no associated toxic effects 
are needed to control Campylobacter transmission in food and water.
Honey is a well-known antibacterial agent which has been used since ancient 
times (Molan, 1992). Its ability to combat many strains of bacteria has been proven
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in many studies. Up until now, however, the activity of honey had yet to be studied 
thoroughly in a bacterial species that causes gastroenteritis. This study, therefore, 
investigated the use of honey as an effective killing agent against C. jejuni using 
different kinds of honey that are commercially available. It also included expensive 
varieties of honey, such as Manuka honey, which is widely-used in therapeutic 
treatment. The results showed that C. jejuni is highly susceptible to honey and the 
minimum inhibitory concentrations ranged in narrow scale between 2 and 10 % (v/v) 
regardless honey type and price. The stability of this antimicrobial activity was also 
tested after heat treatment which surprisingly showed an enhancement in the 
antimicrobial activity of several honey varieties under study and this included the 
effectiveness of pure and natural honey samples. However, Rewarewa and Manuka 
honey were more sensitive to heat treatment and showed a decrease in their activity 
against C. jejuni after exposure to high temperatures.
Adding honey to the microbiological media before autoclaving, as a part of 
the sterilising procedure, had an even greater effect on enhancing the antimicrobial 
activity and the MIC of all honey samples treated in this way decreased to 2 % (v/v). 
Because of this dramatic enhancement of antibacterial activity which resulted after 
heating 2 % (v/v) honey with Mueller-Hinton media at 121 °C for 15 minutes, this 
study sought to examine the mechanisms and compounds involved in this. After 
further investigation the strong antibacterial activity, which caused a reduction in C. 
jejuni viability to below detection limits within 6 hours of exposure, was considered 
to be due to a reaction between the reducing sugars present in the honey and the 
amino acids present in the media. This is known as non-enzymatic browning or the 
Maillard reaction. The formation of the dark brown colour and the reduction in the 
pH of the medium during the heat treatment were important markers in this discovery.
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In addition, the temperatures and times required to generate the antimicrobial activity 
were consistent with it being due to the Maillard Reaction. More studies were 
performed by mixing 2 % honey with the main protein source in the Mueller-Hinton 
media (i.e. casein). The process of heating honey with casein showed a similarly 
enhanced antimicrobial effect and confirmed the presence of active agents in this 
mixture which had strong antibacterial activity against C. jejuni. The mixture was 
termed honey-easein Maillard reaction products (honey-easein MRPs) and more 
experiments were carried out on this to evaluate its antibacterial activity on the 
viability of Campylobacter populations in liquid medium. In addition, honey-easein 
MRPs were tested to see if the antimicrobial effectiveness would be applicable and 
usefiil in food stuffs such as milk, which can harbour Campylobacter. These results 
showed similar activity to that measured in the broth and so honey-easein MRPs may 
provide an important additive to reduce the incidence of Campylobaeteriosis related 
to raw milk derived products. However, further work would be required to assess 
whether the addition of honey-easein MRPs affected the use of such products.
The appropriate heating conditions required to create the honey-easein MRPs 
were also assessed in order to understand what heating conditions could be used to 
achieve the best active mixture. These experiments demonstrated that high 
temperatures (121 °C) were necessary to generate the active components as the 
incubations conducted at lower temperatures (80 and 100 °C) for the same duration 
did not produce products which showed similar antibacterial activity. However, it 
was interesting to observe that prolonged heating for 72 hours at 55 °C gave a 
product with a similar activity to that observed in the autoelaved preparation. This 
observation may be important in terms of the production of these active compounds
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in other food products that are heated over a prolonged time at lower temperatures 
and their food safety.
Further work, demonstrated the importance of three factors in this reaction 
and the efficacy of the products this produced; these were the type of sugar, the type 
of amino acid and the bacterial strain used in assessing the antibacterial activity of 
the new antibacterial agents. In comparative experiments with other sugars, including 
glucose, fructose and artificial honey, only the reaction products generated from 
honey was capable of killing C. jejuni in 6 hours under conditions that were 
preferable for C. jejuni (37 °C and a microaerobic atmosphere 5 % O2 , 10 % CO2 , 
and 85 % N2). In other words the presence of other compounds in honey rather than 
just the sugar components may play an important role in the creation of the 
antibacterial components and these may help enhance this activity by the generation 
of more complex compounds. In terms of the different effects of each amino acid, it 
was evident that replacing casein with just one of its amino acids confirmed that not 
all of the 17 amino acids were involved in the reaction and only four of them have 
obvious activity (lysine, phenylalanine, tyrosine and aspartic acid). Indeed the 
mixture with the whole protein (casein) showed the greatest activity and the zone of 
inhibition was 30 % bigger than that of the single most active amino acid (lysine) in 
combination with honey. The active part of honey-easein MRPs was found to have a 
high molecular weight which was greater than 5000 Da. Moreover, when tested 
against several bacteria strains, honey-easein MRPs showed good activity as a 
bactericidal agent against Campylobacter or as a bacteriostatic agent against other 
microorganisms such as E. coli, Salmonella, L. monocytogenes, S. aureus and H. 
pylori.
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The meehanism through whieh the honey-easein MRPs had their effect 
against C. jejuni appeared to be by causing a transition to a coeeoid shape which was 
clearly seen in the Transmission Electron Microscope images. Furthermore, the 
result confirmed that C. jejuni entered a non-reversible viable but non-eulturable 
state in the presence of honey-easein MRPs. In the same way, the effect was also 
observed when honey-easein MRPs were tested in a food product (milk). This may 
be a useful feature that can be utilised in this type of food product in the future. 
Moreover, the presence of honey-easein MRPs prevented Campylobacter from 
causing infection in an animal model {Galleria mellonella larvae). By using human 
colorectal epithelial cells (Caco-2), honey-easein MRPs were shown to produce a 
two log reduction in the number of C. jejuni cells whieh were able to invade without 
any detrimental effect being observed on the Caeo-2 cells (in the control). This result 
may highlight a role for honey-easein MRPs in vivo although further experiments 
would need to be conducted.
The results of current study shows for the first time that MRPs generated 
from a honey casein mixture have a great impact on the survival of Campylobacter 
jejuni in media and milk. These mixtures, supressed Campylobacter jejuni 
multiplication and caused its death within 6 hours of incubation. Moreover, a mutant 
kata A  of Campylobacter jejuni was more sensitive, with no viable bacteria being 
detected after four hours of incubation.
HPLC analysis showed the appearance of some peaks whieh were not in the 
mixture before autoclaving. These peaks were also increased in the honey-easein 
mixture which had been heated at a lower temperature (at 55 °C) for a longer time 
(24, 48 and 72 hours). As it had been previously reported that alpha-dicarbonyls are 
important intermediate compounds in the Maillard reaction, one of the well-known
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alpha dicarbonyls, methylglyoxal (MGO), was searched for in the honey-easein 
incubation. After derivatization with 0-phenylenediamine (OPD) the honey-easein 
MRPs were analysed using HPLC. MGO, which has antibacterial activity, was 
detected in the sample and it antibacterial activity was examined. The MIC for MGO 
against C. jejuni was found to be 1 mM. Owing to the high reactivity it would be 
expected that MGO may undergo further reactions with amino acids present in the 
media. Therefore the antibacterial activity of its main product, carboxymethyl lysine 
(CML) was also examined against C. jejuni and showed good activity with a MIC of 
15 mM. This was somewhat lower than that for MGO and it may be that other amino 
aeid-MGO reaction products have higher activity.
Our results point to an exciting new possibility in developing this mixture and 
finding more applications for controlling the contamination caused by C. jejuni in 
food preparation and processing. Moreover, it suggests the importance of some key 
compounds generated by the heat treated honey-easein mixture and highlights the 
possibility of separating and isolating different antibacterial agents whieh in their 
pure form might influence the future of health and food safety, particularly in 
relation to Campylobacters and poultry products. In addition, the compounds that are 
generated during food processing may be important components of a variety of heat- 
treated foods, thus combining easy administration, safety and efficacy. Further 
investigations are needed on the antibacterial activity of MRPs formed from honey 
and using a range of other proteins and amino acids. In this way novel, potentially 
useful antimicrobials will hopefully be discovered.
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C onclusion
This study initially examined the effieacy of honey against Campylobacter. 
All investigated honey samples showed antibaeterial activity regardless of the way 
which it was introduced to the media. The minimum inhibitory concentrations were 
in the range between 2 and 10 % (v/v). This activity appeared to be heat stable in all 
honey samples except for Manuka and Rewarewa whieh was sensitive to heat. A 
striking and novel finding of this study was the fact that when honey was mixed with 
MHB and heated at 121 °C for 15 minutes, that potent antimicrobial agents were 
formed as a consequence of the Maillard Reaction. Honey particularly, that whieh 
been heated with casein exhibited some potentially very useful antimicrobial 
properties. Moreover, these studies revealed the efficacy of these compounds in vivo 
as well as in vitro. Good preliminary work was done in this study to develop a 
method for assessing the Maillard reaction products from honey-easein using HPLC. 
The method was based on the work by Ames (1998) and by using acetonitrile instead 
of methanol as the mobile phase up to 30 % over 45 min gave good separation of the 
compounds present.
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Future w ork
• Studies that have examined the activity of honey against bacterial pathogens 
are relatively limited. Most of these studies have been carried out on honey 
and its use in the treatment of infected wounds. Furthermore, the 
susceptibility of S. aureus to honey is the only strain of bacteria that has been 
widely tested. Thus, building on what has been discovered in this thesis, it is 
really important to include more bacterial strains in this area of research to 
more understand the effectiveness of honey on a wide variety of bacteria as 
well as in food preservation.
• As honey in this study showed good antibacterial activity at low 
concentrations (as low as 2 %) against Campylobactev, it should be examined 
against wide range of strains and perhaps considered in eases of 
gastroenteritis. Campylobaeteriosis is the most common cause and its 
incidence is increasing every year around the world as reported by health 
agencies. Therefore, using honey in foods to increase its safety and 
controlling food borne pathogens, especially Campylobactev, maybe a 
promising research area for future research. As such there is the potential for 
a high number of applications for honey usage in a variety of foods and 
treatments.
• Considering the potential usefulness of the compounds produced form 
heating honey and casein, further investigations are needed on the 
antibacterial activity of MRPs formed from honey by using range of other 
proteins and amino acids, and their mechanisms of activity
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• Further studies are needed to examine the reaction between honey and casein 
and the generation of a range of compounds with potentially different levels 
of antibacterial activity.
• There is a high possibility that these or similar compounds are created during 
the heat processing of foods. This therefore highlights the possibility of using 
these products as ingredients in a variety of foods, whieh combines their ease 
of administration, safety and effieacy.
• Besides the pronounced antibacterial activity of honey-easein MRPs against 
Campylobactev and a range of other bacteria in this study, it is evident that 
the generation of more Maillard reaction products via this route may open up 
a new approach in food safety research. There is concern that some 
antibaeterial agents have detrimental effects on human cells, however, the 
studies shown in this work revealed that honey-easein MRPs were not toxic. 
This area may therefore lead to the discovery of new compounds whieh are 
highly active but also cost effective and safe.
• A deeper understanding of the kind of products created in this study, their 
structure and stability, is required using more sophisticated techniques (e.g. 
LC-MS). Furthermore, reference standards are required to assist in the 
estimation of the amounts present.
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